var title_f11_42_11936="Plain film destructive arth";
var content_f11_42_11936=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F66959&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F66959&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Destructive arthritis in mixed connective tissue disease (MCTD)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 217px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hand radiograph in the same patient as the previous picture shows a florid destructive arthropathy with digital osteolysis and deformity.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert M Bennett, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_42_11936=[""].join("\n");
var outline_f11_42_11936=null;
var title_f11_42_11937="Bromopride: International drug information";
var content_f11_42_11937=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"10\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Bromopride: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F13300481\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Bilenzima (BR);",
"     </li>",
"     <li>",
"      Bromopan (BR);",
"     </li>",
"     <li>",
"      Digerex (BR);",
"     </li>",
"     <li>",
"      Digesan (BR);",
"     </li>",
"     <li>",
"      Digesprid (BR);",
"     </li>",
"     <li>",
"      Digestil (BR);",
"     </li>",
"     <li>",
"      Digestina (BR);",
"     </li>",
"     <li>",
"      Pangest (BR);",
"     </li>",
"     <li>",
"      Plamet (BR);",
"     </li>",
"     <li>",
"      Pridecil (BR);",
"     </li>",
"     <li>",
"      Procirex (IT);",
"     </li>",
"     <li>",
"      Valopride (IT)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F13300482\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      Bromoprida;",
"     </li>",
"     <li>",
"      Bromopride Hydrochloride;",
"     </li>",
"     <li>",
"      VAL-13081",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F13300483\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antiemetic",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Gastrointestinal Agent, Prokinetic",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F13300484\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of nausea and vomiting, including postoperative nausea and vomiting (PONV); gastroesophageal reflux disease (GERD); as preparation for endoscopy and GI radiographic studies",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F13300486\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: 20-60 mg/day in divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.M., I.V.: 10-20 mg/day",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F13300485\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16862 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-813CF6A707-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_42_11937=[""].join("\n");
var outline_f11_42_11937=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300481\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300482\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300483\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300484\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300486\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300485\">",
"      Product Availability",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/16862\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/16862|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_42_11938="Number 10 cleft";
var content_f11_42_11938=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F61517&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F61517&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Number 10 cleft",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 315px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Middle one-third eyebrow and lid. Frontoorbital encephalocele. Inferior lateral displaced orbit.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Kawamoto, HK Jr. Cranofacial anomalies. In: Grab &amp; Smith's Plastic Surgery, 4th ed, Smith, J, Aston, S (Eds), Little Brown, New York 1991. p.158.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_42_11938=[""].join("\n");
var outline_f11_42_11938=null;
var title_f11_42_11939="Adult T-cell lymphoma erythema";
var content_f11_42_11939=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F72524&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F72524&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Generalized erythema accompanying adult T cell leukemia/lymphoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 265px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A generalized eruption of small, confluent violaceous papules with a prediliction for the trunk. The patient had fever, weight loss, abdominal pain, massive leukocytosis with S&eacute;zary cells in the peripheral blood smear, lymphadenopathy, hepatosplenomegaly and hypercalcemia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fitzpatrick, TB, Johnson, RA, Wolff, K, Suurmond, D. Color Atlas of Clinical Dermatology: Common and Serious Diseases. McGraw Hill, New York 2001. p.533. Copyright &copy; 2001 McGraw Hill Companies, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_42_11939=[""].join("\n");
var outline_f11_42_11939=null;
var title_f11_42_11940="Glucocorticoid effects on gene expression";
var content_f11_42_11940=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F59432&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F59432&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 519px\">",
"   <div class=\"ttl\">",
"    Glucocorticoid effects on gene expression",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 499px; height: 373px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF1AfMDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoqCG8tppnhhuIZJk+8iuCy/UdqnoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK81+NutXdlp2n6XZTSQf2g7meSNtreUgGUB7biygkc4z616VXG/E/wpN4m0mB9PaNdTsnMkAkOFkBGGjJ7ZGMHsQO2aAPAobaO3kjlsh9kuYjuintwEeNuxBH/AOo9819I+BNYl17wjpmpXKqtxNF+929N6kqxHsSCa8RtPBfim9uvssejT2chOGnumQRRf7WVYlsei9fave/Dmkw6FoVjpdqWaK1iEYZurkdWPuTk/jQB5LDeS6n4Q1nxdrc3im6livbxGtdF1L7KNMht5JF/1ZljRztjDHcHYlvu4qTQvEEuneKNXutP3Tx6hfaHbF7wZkMctuoLHaQN+DnPTPau91T4f+G9Tu724uLK4Rr47ryO2vp7eK6OMZljjdUkyODuBz3qe68E+HrqK8jk04Kt20DyGKaSNlaAARMhVgYyoAwUwaAOa1bxvqyarc6Rp8Ngt9L4gXRrSadGMcUf2KO5aSRQwLt8zgKCufl9yVudd8Zf2+/h63l8PJqdppzalPdSW8xhnVpXSJFTzAYyfLJZizgZGAa3U+H3hpNJn04WEpt5rwag7tdzGb7SFVRMJi/mK+EHzBgevqcx3Hw68M3FvFDLZ3X7tZUMq6hcLNKsjbpFklEgeRWPJVywoA5zw1428ReN5y/hePSbC3t7Cyu5k1GKSV5XuE8zYpR12KF43kNk9uKk0rxvrt0dJ1iaLTB4f1PVpNLjtUjf7VEBJJGkpk37Wy0eSgQYB+8cGul1LwF4c1C6iuJrB4pEgS2/0W5mtlkiQ/JHIsbKJFHZWBA6VJbeCPD9rrg1aCxZbtZnuUX7RKYUmcEPKsJby1c5OWCgnJ55NAHnd3rvjXWvCfhfWV1XR9OXUNVtY1ht7KckAylfnbz13KccpgZHG7vV2bxbqml67rel2tnon9sz61Y6Ut6lo0UckklkszzTKHLPgKwVd4ONq7u9d7N4Q0Sbw3b6C9mw0y3ZHhjSeRHiZW3KyyBg6sG5BDZqtN4E8OzWl7bz2UsovJIZppZLuZ5jJCipHIJS+9XCoo3AgnGSSSSQDEm1jxkfEcXhuCfw8upJZyahLevazGKSPzNkaLF5oKMTncd7AYGAc8czD8SJ7i7j1Gw0XTV1DUNF01oXdT5nn3N5JbhHlH3oUb5gMDqefm47ub4d+GpoYUe0u98XmYuF1C5WdxJjerzCTzHVsDKsxBwOKuS+DPD8pfOmou6zh08CN3QJBE5eJUCkbCrEkMuGBxzwMAGL4Fj1KLxt4vTWbmzursLZ/vbS3aBCvlvj5GdyD/wI/h0ru6xvD3hnS/D0l5LpkU6zXhVriWe6luJJSoIUs0jMTgHHWtmgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA4D4cfEX/hNPFXjTRv7L+xf8I5eiz877R5n2j55U3bdo2f6rOMn73Xjnv68A/Zw/wCSp/Gj/sND/wBH3de/0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFZuu69pXh+CCfW7+CwgnmECSztsTeQSAWPAzg9cUAeJfs4f8lT+NH/YaH/o+7r3+vmr4G+JNF0H4h/GW+1jVLSztZNZXy5JZAPMzPdYCDqx56DJr6VHIoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5f4m+FovGngTWNBlC77qA+Q7dEmX5o2/BgM+2a6imyyJFE8krqkaAszMcBQOpJoA+Dv2afA8viH4tQDUbci10Njd3SOOkiNhEPvvwceimvvOuA8Dv4J0/xJr8/h/VrGXUdcuxczosy/M4UDan94Z3txnlzXf0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAcfqfii//te4t9GtLW4trNvKneeVkMkmASqEA42gjJI6nHGCa4H4reKzrFrp2j+VPZM7vLeWsuMuFA2AEHDoSSeO64OOlb3hhjLoVrO/+suN1xJ/vuxZv1J/Ksvxz4aOuxWtxa4W/tC3lndtJVuoz07Dg8HkcZBHdLCr2acdyebU84liSePypRlDjvgj0IPYjse1eweDPiEk/hnTWu4L2+mhjCX15DHuSMgldx5y7YAZgoOAefSvNrXwvrEs/lX1vcRoD832ZF3OP9l2fYv1yxHoa9E8L6Wui+H7HT0RIzCnzKhJAYkk4J5PJPPesqOHc372g2z0u0uYby2iuLWWOaCVQ6SRsGVgehBHWpa4rwMRaa7q9hF8ls8cV2kQ+6jsziQgdslVOBxnJ7mtHx34hn8P6fYjT7aK51PUr2PT7OOZykfmuGO5yATtVUZjjk4x3rCcOSTixo6SivIvFnjHXdK0PxUkfirwle6lp2lz3Ai06Mx3drMmMboXllBUZ5JxyQMc12j+NLC3tdbeaK7Y6NNb29ztRfneWOJ1KfNyMTLnOOh68ZkDqaK5E+OrV9ZvLK10rVrq0srkWl3qUMcf2a3l2hmDEuHIUEbmVCBnk1Tsvibo8sKXN9Z6npmnzWUuo2l5eRIsd1BGAzMgV2YHaQwV1ViDkA0Ad1RXDn4iQRWMVxd+HfEFq1y8MdjDLDFvvXlztWMrIVDYUsRIUKgZOKH+JFiEtYk0jWZNTnv5NMOnJHF58U6RGUq/7zZgoAQwYrhgcgZIAO4oryu5+Il+F8ZjVdF1rSrHR3iAu7X7G80AaCKQq4aV1ZyZDjapXaRkg5rqX8bWza7c6bY6Vqt/HZ3MdpeX1tHGYLWVwpw5LhjtDKWKqwUHnFAHV0Vwln8RtN1OFCtnrFja31rPcadfyRRBbtY1LMYhuYhtoLqJFXIGcEVj+JfiM0PgLUJ/DlrrN/qEOgDUjfeVb/6IZIGeKSYMyqW43FY1YDH3cEZAPU6KxvEGvQeHvC9xrWoJPLBawiWRYFDO3QfKCQCefWsOfx95MiW58MeIGvzC101miW5ljtxwJm/fbQCcgLneSp+XigDtaK4kfEbTrqeNNC0zV9bQ2sF7NJp8KMsEUwzGWDupJI+baoZgB0qa18f6fc6pBbpYamLC4vH0+HVGiT7NLcIWBQfPv+8rKGKBSQQDQB2FFeb23xUtr/RoLy00LWbf7fYTXmmNdxwql2Y495QbZSVOMn5toIUkE1Y0j4iTT6NoLXnhzVm1rVLf7RFY232ctKixozzKTNtWPLgDewYkgYzQB6BRXEw/EWxvZtLh0bSdY1SfULVrtI7aOJTEqPscSGSRArK2QRnqMDNdtQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRXF+O/if4R8Dow17V4UuwMizh/ezn0+ReR9WwPegDtKzPEGv6T4dsGvdd1K00+1H/AC0uJQgJ9BnqfYc14K3xR+JPxIYwfC/ww2laW5K/2vqIHT1Un5AfUASGtLw9+zxb31+urfE3X77xNqh+9EZXWFe+3cTvYemNo56UAJrP7Qg1bUjpXwu8N3/iW+yAZ2jaOFR/exjdj3bZXvFs7y28UksTQyOgZomIJQkcqSCQSOnBxVTRNF0zQbBLLRbC1sLROkVvEI1+uB1Pv1q/QB5loUbWtm9jKCs9lNJA6kYIAYlT9CpUg+9aNdJrWgw6hI1zbyfZNQ2BBcKgbco5Cup+8ASfQjJwRk1zLWes2m5b3TTOEGfPsnDqw9djEMD7Dd9TXpUcTFxSloyGh1FUE1MMu7+ztYUZK/Np0w5H/Aaljmv7s7NO0bUJJCOGuYzbxj3Zn5x9AT7Vs60FrcVmXfC/Hje5HrpqE/8Af162/GXhyPxLpkNv9qmsru1uY7y0u4QC0EyH5WweGGCQQeoJFR+D/Df9grez3N013qN9IJbiXBVeBhURcnCqOB+feqHxZ8Q674W8FXer+GdITVry3ZWkhdjhIurvgctgDoOmc8gEHy6s+ebki1ojE174cap4lbUZvEHiG0ku7jR59Ihaz01oUjWVlZpGVpnLNlBwGUVZ1v4fahe3ur/YNfitNP1aa2uLuB7DzZC8KRphJPMAVWWJMgqTnJB5xWt8M/Huj/ELw3HqujSYcYW5tXI8y3kx91vb0PQj8QOtrMZxEPgzUbTU9VWw12KPQdVu2vLuxlsvMl3OAJUjm3gKrY7oxGTgjPGUvwukvdMttJ8Qa4b/AEix02bTLGKG0EEqJJGI/Mkfewd1QYBCoOSSDmvTKKAPP7rwV4g1CysE1PxRbzXelzQXOnTR6ZsVJYw6l5lMpMhdHZSFZB3ABqXTPAUsGt2Gs3+qrdapHqkup3UiW3lpMz2rWyxou8lFVCuMlidvPXI7uigDz7xL8P7zVpPFcVvrUFtp/iJY2uIpLEySRSpEkYZHEqjbtjXKlTznkVdi8IalY67qdxpOuRW+k6reJe3tlNZec5baqyLHLvARXVADlWI5Kkdu0ooA840z4bXVvbaZY3uurdaZo9rPbaXELPy5I/MjaINK+8iQrGzKMKmc5PNQ3Xw01BPDN5omk+ILe0t9Q0qHTL6SXTjM7+XB5PmR/vVCZXGQQ3Tgg816bRQBh+LNA/4SDwneaJ9p+z/aIhF53l79uCDnbkZ6etYHjj4e23iXXItXSLQ3vltfsbjWNJXUI9gYspRS6FWBZuckEHkcCu7ooA4Cz8C6po181x4b1+2sBc2lta3kb6WrqzQrsWSFVdFiJXI27WUcYHFV9I+F9ppHiGK+sk8Prbx3j3iu+hxtf5Z2cp9qL9AWIB2bgoAz3r0eigDybwD8O9XHhrwxD4vv4gdJ057eCxt7cI0EkkRicyS+Y4kKozKCoUcknNatl4E1yyj0Ke38RWI1bRrV9PguDpbGKW1ZYxtlj8/JcNErB1ZR224r0SigDjfCXgaPw5qFhdRX73Bt7CW0kDxgNNJLP58kpIPGX3fLjv14rsqKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiszxDr+k+HNPa917UbXT7Vf8AlpcSBAT6DPU+w5rxPXP2hH1e/fSfhX4bvvEWodBcyRMsKejbR8xHu2ygD32WRIo2kldUjUZZmOAB6k15B44/aC8H+HZTZ6TLJ4i1UnYlvp3zIW7Ay9OT/d3H2rlIvhH4/wDiHKtz8V/FUtpYFt39kacy4Uehx+7BHrhz71694H+HHhXwREo8O6PbwT42tdOPMnb1zI2Tj2GB7UAePeR8aPilzPLH4F8Py/wruW5df/RhP1MYIrtfAnwD8GeF5Furu1fXNUzvNzqOJAG65WP7o55yQT7161RQAiKqKqooVVGAAMACloooAKKKKACiiigDj/BXxA0rxhr/AIn0jTLe+iufD119kumuERUd98i5jIYkjMTdQOo/DsK8A/Zw/wCSp/Gj/sND/wBH3de/0AFFFFAHzx8TPAWsfDvxHJ8RPhdHtQZfVdHQfu5Y+rMqj+HuQOVPzD29a+Gfj3R/iF4bj1XRpMOMLc2rkeZbyY+63t6HoR+IHW188fEzwFrHw78RyfET4XR7UGX1XR0H7uWPqzKo/h7kDlT8w9gD6Horkvhn490f4heG49V0aTDjC3Nq5HmW8mPut7eh6EfiB1tABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVxnjfxRrfh6/0yKx0bS76DUbuOxt2m1R4JDK4YnKCBwFAViSGJwOldnXNa7oFzqnjPwzqRaAafpP2mZkYnzGndBGhAxjAVpcknOSMCgCC08aWsep/2LrCeX4hRVeaz02K5vo4kcnYxlEKgAgckgAfiCZE8eeH/ALJqVxPcXdmmnW32u5W90+4tXWHn5wkkaswypHyg88dax9W8Ia1caL41FlfQW+r63eLLBKkrxhIESKNY2dRuUlI2BKg4LkjNc9ZfC++B1lxp/h/SRqclhC0NhI7hbWGYyTbnMamSV8kbmHPGSMUAdtD8QvDMtjdXf9oSRxWwiZ0mtJopSJTtiKRsgdw5BClQdx6ZrZ0DXLDXrSW402SVkilMMizQSQSRuACVZJFVlOCDyO9cT4o8Falqura5etZ6RqMd9NZpFb3V3PbMkECsylZo1LRSCaR2BUHgDnJ40vDngy5Xw7Y2vijVtUu763lmkV7XVruIKrvuWNnV1aYKMKGkyeD0yaANnUfFelabq8Om3zX0M8sscCStp9x9naR8BF8/Z5WSSABu6nHXiqV58QPDdrdXVvJezO1sZEkeGznkiEkaF3jEioUaQKpOwEtx0riLX4a6xP4q06/1q30O7NtrEmozas88st7NGDI0ESK0e2FUJiBVXIITtjm3Z+DfF9t8PdS8HxTaHFbSWd3bxagJZWmnaUsVZ02ARn5yWIZ8nkAUAa2lfEyyvdB0jUrq0l05rqCS6uYLyG5jaGKOHzZGjzB++2gryMKc8MTgHprjxPpUE8cHnzTTyWZv1itraWdzACBv2opPJIAHU84BwcYEHhbUNS1iK81y30+1t49Fl0tLW1uHuFjMsg3kFo042Rxdgc7h0AJ5i0+G3iCHwVawXV7ZX3iGS4tTqX+lTW8FzawIUS2EqqXVMYY/LyxfIw1AHUa58SdJsNAuNRs4L+7nhu4LI2TWNxDP5spXaDG0e8ZDZB2/NwBkkCrcnjvSYZ7uS5mFvY20MDyGaG4juRLMzBI/IaIEkhcgAl+fugYJ43TfhzrGlWCTabY+HLe9/wCEgXVpLC2ke3tTCkBjjiV1iJUg4fOw5bJ71f1HwPrr61/b8D6ZPqaa7/aYtJ55FgeEWot0QyCMlWUZcHYRkn1oA6Wb4heGodKj1GW+mWCS8OniM2U/n/adpbyjDs8wPgZwV6Y9Rnb0PWLDXbAXulz+dBvaNtyNG6OpwyOjAMjAjBVgCPSuN0LwXqdv4msNY1S4spJPtN5qN2sO7AuZY44IljBH3FhRlLEgk84GTje8E6RL4b8NNHq01v8AbJLi4vbyZHPl75ZXkY7iBwNwHIHAoA6SivHvG/7QXhDw/MbLR3l8R6qTsS3075oy3YGXof8AgO4+1cj9l+NHxS/4+5o/Avh+X+BAy3DL7jPmZ56Exg+lAHrPjz4o+EfA6Ouu6vCLxRxZQfvZz6fIPu/VsD3ryk/FD4lfEhjD8MfDB0nS3JX+19SA6f3lz8mfUASGuz8CfATwX4VdLm5s21vUwdxudRxIA3qsf3RzzyCR616wqhVCqAFAwABgAUAeDeHv2eba91BdX+JmvX3ifVDyY2lZYV5+7nO9h6YKj2rs9A1e4isbuH4c+DtPfQbGV4Fka8FkLmRDtfyUETBsMCu5ygJHUjmvR6888GaH4v8ACulWmgWy6FdaXazt5d/LcTCcwNIWw0Ij2l8MRu8zHQ4oA1P+E8022nuU1E7GS5NpFDaRT3dxJKsSvKvlJFk7Nwyyb1x1IOQOl0vULXVdOt7/AE+UTWlwgkikAI3Ke+DyPxryu/8Ah5r0mlQRRxaTLqYkvboaimpXVnPaXNzK7M8bxJmRApRdjbQdgycV2Vz4WnGlrPFqV/ceIYLHyIp5dRuYreWcRbRJJArmPluT8h/EigBtt8RvDFzp8t9DfXDWaNsWf7DcBJn3FQkRKYlfIPyJubvipJfiB4ci062vXvLnZc3bWMcS2Nw05nVSzRmEJ5gYBScFR29Rnm/Efw7u5vD/AIIstKeGX/hHAqG3e+nshMBB5W5Z4QXRgeQcHOSD1rKs/DHiTSfE+k/2RpOnPPawXV/cvdajdvA1zOViU/aJEkeR1jiwQQuQ2fl4oA7Q/EfwubfTpo7+eY6gZltoYLG4lmdoSFlXylQupUkZBUGrMPjrw9NrCaZHfO1y8xtg32aXyfOCljEZtvliQAHKFtwxjGaxPAXgW78O682oX11b3TmzdWlQMGkuZ7h57l9p4VM+UFGScLz7854W+GWsaOtrbTx6fdR2Ms9zBcz6xfyrNMd5idrTIiQ7mBbBbPzYAJzQB28PxF8LyxXEw1J0t4YWuPPktJo4pIwwUtE7IFlG5lHyFuWHqKd/wm+m3AtF05ybia/jsDBfQ3FpIrMpkPyNEWyI1ZhuCqccsOtcTZ/DvXYdM1Cxa00c6LcRxQ/2BJq15Na4Vy7SRysm63bO3aqKVXbnk4xatfh54gureCHWNYVo0TUmiJuprqS0e4jWKJElkAaRUQynexDZYADFAHX6d4+8NajdPBaaiWIilnSR7eVIpo4ziRopGUJKF77C1S+F/G2g+KJEj0a8lld4PtMYltZoPNiyBvTzFXeoJAJXIBODzXEXXgTxPqvhyKwvpdGsJLDRpNHsks5pJEbzVSOSZi0alcRphUAbBY5Y8Y7Wx8PyweN5NXYwLYwaXFp1lEhO5f3jPKW4wAcQgYJ+6elAHkv7OH/JU/jR/wBhof8Ao+7r3+vAP2cP+Sp/Gj/sND/0fd17/QAUUUUAFFFFAHzx8TPAWsfDvxHJ8RPhdHtQZfVdHQfu5Y+rMqj+HuQOVPzD29a+Gfj3R/iF4bj1XRpMOMLc2rkeZbyY+63t6HoR+IHW188fEzwFrHw78RyfET4XR7UGX1XR0H7uWPqzKo/h7kDlT8w9gD6Hrh/EHirxFpvi7TtDs9C0e6Opec9rJJq8kTbIlUs0ii2bb95RgFuSKt/DPx7o/wAQvDceq6NJhxhbm1cjzLeTH3W9vQ9CPxAsf2BcyfEf/hIZ2gNpBpf2G2QEmQO8u+ViMYAwkQGCTw3TuAQWPjrS5p7qym+0yapY5S+h0+yuruOCRUDMgkWEBuDxwC3QDPFOl+IHhyDSLzUrq8uLa2s5o7edbmynhmjkkKhAYmQSfNuGPlxjnoDXO33gjW38Ew6dDPZy38uryanqMRupbeG7SSaSRofNRS6jDIPunOzBGDVbwx8N73TZrV5LbQ7CFtdOrXVtpoKxrGluY4IoxsUcPtdiQOcnqaAOsPj7w6LL7T9suM/afsf2b7FP9q87Zv8AL+z7PN3bfmxt6c9K3NG1Sz1rTYdQ02Uy2s2djFGQ8EqQVYAggggggHivNtY8BazdNeTfZNIvLq61S51BZm1G5sprYlFigaOaJS2REgDJgAk4zgc9ZovhSSDT9Gk1nVNT1DWbC2jie4XUbiCK4dOdzxI4Rsk8llJI65oAT/hYXhndqWdQkEWnSSQ3Vw1pMIIpEbayeaU2F9xACgkk9AaRviH4aTT5LyW9uYkjuks3ilsLhJxM67kTySgkyw5Hy4Nc1qnw81K6+GmgaItxbPqmn3seo3CrczW8VxLveSRRLGPMQb5CyuBkFVOKyU8K+ItP8VaJJZaPZTXST3Gp3JuNXvZ4SUiWCBGupUdmkAmmYAIowvQdaAO6b4i+GF063vDfz7J7x9PjiFlOZzcICWiMOzzAwCngqO3qMyP4/wDDiX0Vm97Os8jQxsGspwsDy48uOZtm2F23DCSFW5HFYvhbwPqOm+IrDVNTu7WeQG9vbvygw3XlwY1GwEcRpEhQEnJzkisKD4ZapFq+piVLO8sbvVpNU86bWb5Ad0nmIj2aERMysFG7djCjK8UAdqPiF4Y864RtSZI4BMzXEltMluwiz5myYoI324OdrGmN480q4tGfTJGa7+029ssF9b3FmS0zYThoi2CAxB27Tt5IGSOOtfh94gii1OJbbQ4dMurRreXRDqN3PZXUjyhnlAZR9mO3cAIw2C2STjm3pHgDxB51guq6oo0+31CW+jtPt0941oPszQxJHNKodwGdpPmxggYFAHYad438P6jrK6ZZ37SXLvJHE32eVYZmj5kWOYqI3ZcHIViRg+hqPwz488OeJriGHRr+SZp42lgMlrNCs6rgMYmkRRJtyM7ScZ5xXF2HgPxSnhjStLnk0SB9A0+e3014JZWFxcvA0KTS5QeWArsSq78s2c8YrrdM8KSWPiPQrgPCdM0bRzp1rGCQ4kYxhmxjAGyJQOe54oA6+iiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoorxz4/fGW0+HuntpmktFc+J7hMxxn5ltVPSSQevovfqeOoB7EGDZwQcHBx2NZniLxDpHhuwa91/UrTT7UZ+e4kCbj6KDyx9hk18l/CLx38TPEvhweF/AkNoLyGWS4vtZvZQ8gMsjNuIbPr/dcn2r07w7+zva3l+urfEvXr7xPqh5aNpWWEe2Sd7D0wVHtQBDrf7Qcus38mk/Crw1e+Ir8cfaZImWFP9raPmK+7FKpw/CDx78QpVuvix4rlt7IsHGkacw2r7HH7sEeuHPvXvuiaPpuhWCWOjWFtYWidIbeIIv1wOp9+tX6AOS8D/Drwr4IhVfDuj29vPjDXTjzJ29cyNk/gMD2rraKKACiiigAooooAKKKKACiiigAooooAKKKKACuS+J/i6XwN4WfXhpkmpWltKgu44pNrxxMcGReCGwxXg44JORiutqjrml2ut6NfaXqCeZaXkD28q+qspB/HmgD5D+D3xYtdH+IPjeTStIvNSvvFmrxvptuWWIANNOf3rfNtwJV6Buh9K+yhnHPWvkz9mT4YXOl/FbxDeazFkeG5Hs4WI4knfIDj28vJ/7aKa+s6ACiiigAooooAKKKKAPnj4meAtY+HfiOT4ifC6Pagy+q6Og/dyx9WZVH8PcgcqfmHt618M/Huj/ELw3HqujSYcYW5tXI8y3kx91vb0PQj8QOtr54+JngLWPh34jk+Inwuj2oMvqujoP3csfVmVR/D3IHKn5h7AH0PRXB+Efip4b8SeArnxVFdC3tLKIvfwucyWrAZKkDrn+Ej73bngd1FIksSSRMHjcBlZTkEHoRQA6iiigAooooAKKKKACiiigAorn9c8Z+HtDvPsmqapBDdYDGIAuyg9CwUHH41raXqNnqtlHeabdQ3VrJ92WJgyn8u/tQBaooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigCOW4hhOJpY0O0vhmA+UdT9BkV4LefEzxLeahJfabc29vZ7ybe0aFXR4weN7feyw5ypGM8ZxzvfEnS7HxJ8VtI07WLZbmzsNGmu1iYkK7STRoQwB+YYQcHiuKl8LpZ+JdS0dL+LTtIttObU4HaMtIIFJEscfO3KYGCc4DLkHFaezfJz9BX6HssvxF8NWWk6Le61qdvpr6rCksMMzZYbgM5wOFBOCxwPeud1L4FfD7UdTvNV1fS7i9ublmmmln1Cfliclshx/hiub8BeHLYeCxc6nbrPfavZA3RlGSIWT5IB6IqYGPXJ6muT+H3hO51/4U2WqNq+tjxJc2kot7p9QlIjG5lWMITt8tgFyuOc/StPq0tLdQudL4Wt/hJ4V1uLWPDmkajaSxZVb6K4uWQoeCShlJZO/Kn1x3r2zSdd0nWXuE0jVLG+e3IWZbadZTET0DbScZwetfK+jXF1qNhpiW2m3a319AzW8DRkK+z5XO/7u1TwTnj68V6Z4a0mLwp468B2umrHA1za3Gn3nkqFSdI4TKpI9Q4JB64YjvWSptxcuwXPbaKKKgYUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBQ1rVrTR9OvLy8kUJawNcOgYbiijsP0+teNL8WPEUdz9smtNPNmPmeyVW3hOpAkzy+O+3BPYdaueONB03xV8Wr6DW7UXNvp+jW6xxliAWmlmJY4PJHljGc4PNcPc6FNa/8ACW2+p6nHHb6HZ/bFIj/f3kDI23HO0MWUoTg884540dNqCn0Fc96uvHnhezvtOsrzWrOC91BUeCCR8MQ+Nu7+7nIA3YyeBmuhup4rW2muLmRYoIkMkjscBVAySfYCvAbvwvb6P8GtWtmWOPUJNNa6uroj53uFXzNxbr8rAY9ABWXqfh7UYvhINVt9e1+51gaYl1N9o1GWaK4UxhpI2iYlcFSRwMjArR4aS27Bc9KsfivoH9otjTry1s7mRS1+0SKHJCqJHUHcBgKNxGQAMgAcd7o+taXrSTvo+pWd+kEhila1nWURuOqttJwfavmE219qMkWmQ2Fwt/f23nRxyrhPJbAMpf7pQbhyCc9BzXqHg6yh8O/E/TLDSlSG0vtFlS4iRQqM1s8SxvgdGxK4PtislTbi59EFz16iiioGFFFFABRRRQAUjkqrEKWIGQo6n25paKAPgT47wXmk+MdVk07wxq/hTTdTUJcQSuDDdEOHyuz5MZCnaGYAjjHSvp39lzxf/wAJT8LbO3uJN1/o5+wS5PJRQDG302YX6qa9XvrO11C0ktb+2huraUbXhmQOjj0Kng1zHhL4eeHfCGt3+peGrRtON9GEuLaFz5DlTlW2HO0jLAbcDDHigDrqpatqtho9qbnVLuG1hzgNI2Nx9AOpPsOa5/xl4sOlSDTtKSO41d1DEP8A6u2Q9Hkx+ijk+wya8/FuXuzeXkst5ft965nO5voo6IP9lcCgDrb74gTzOV0TSmaLtcXzmEH3CAFiPrtrPPi/xLnIl0cD+6bOX8s+b+uKyaitriG6t47i1mjmgkUMkkbBlYHoQRwRQB33g/xZJq15Jp2qQR2+oBDLGYWLRToCASueQwyMqfUEE8462vGIbn+z9Y0jUM7Rb3aK5/6Zyfu2/D5gf+A17PQBkeJ9ZGjaeskcXn3k7iG2gzjzJDk8nsoALE9gD9K5e78Z6jo+m3M2t2cDxxxMwvLMtsVscb42+ZVz3BYDvgc1P4qZpPGdlHJzHDYSSRD0ZpFDH8gB+J9ahljSaJ4pVDxyKUZSOCCMEV20cPGcLvcluzPD7R3kgWeWRpZ5/wB9LKxy0jtyWJ75JrrPhn4jHh3xDdQFJ54r6DetpAAWknVlAYAkAfKTuYkDCjJ4FZ03gPV9Jl8nTJI7vSwcRAjM0S9hgsobH1/Kum8G+Fn0zUDqN2v+kmFosuQXOSDnAJVFAGAoLE7mJPQDKGHm5crQ7nqHh7xJDqsrWlxC1lqca7ntZGByv99GHDr7jp3ArdrzHXisFvb3wGJrK5hnjcdVHmKHAPoULKfUGvTqmvS9nKyBO4UUUViMKKKKACiiigAooooAKKKKACiiigAooooAZPNHbwvNPIkUSAszuwVVHqSegrl0+InhNpvLOuWqekkm5Iz9HICn8DXlvxS17+3/ABU1tC2/T9LJhjHUPP8A8tH/AOA/cH/A/Wsyw8IyyeDLzxihdHjcCOJeFltFOHcjuc7mB9F4+8aaOfFTq06TnSV2tbd/n/wGdp8TtRstI1rQvG8N1b3GjNC+l3ksMofajurRyLjO4KyncByA2exp2t6DonjGws5bxVvLZT5kM0ExAdGGGXcp5Rhwy9CK8k15Yba4g1CVFZMG3nO0Hcjcr9cMAP8AgVXte+G2n6E+lnVtMtZ5tRtftDiSIHyZgfniH+yAyYz3DfSumnV9n7jV0eTTzuNXAvHKGi3Seq/K/R9DuviF4ng0Ozg0mzuIYdY1H9xbggkW0Z4adwASFUdOOTgCqfwv1SxsopfCEeowXk+kj/RJkdT9qtCco4A6MudrL1BHvmuF8I+FbfVtci8L2tukCfaDMZIlCtDb/fMinHDD7gPrirPijRDPbapot+izXFrK8QLjq6HKP7bhtPH96qWIk53/AAHi83+rUqWIUb0521vqr/fc9M8P+ELHRNWuL62nvJmkEiwRTSbo7VJJDJIkQxwGc5OcnoOgqvomqadq/jqLXbrULS18P+HTNaw3UsyotzeyKFdVJPKomR7s3tXmeg+B7fxB4a1fXYxeS2WmRJKtvPdSzRzuMPIrK7EHan/jxHpio9aENrNa3xjVoNhtpAFByjcoAP8AeGMf7VTOtzwcYqyOjE5isNiqWHlHSptLpftb7vvPpPTvHHhnUJhDa63ZGVjhUkfy2Y+wbGfwro6+bdR8L3HhAaXaXLOReWn2gq3SKXd+8iX/AGV3JgfWvVPgzqf2rws+myHMulymADuYj80Z/I7f+Amudx0uThcylUxc8FVjaUVdO+6/p+Z31FFFSeuFFFFABRRRQAUUUUAFFFFABWFrvizQtCmWHVNRihnIz5ShpHA9SqgkD3IxWX8VdffQvCkq2smzUL5vstsQeVLA7n/4CoY/UD1rxLwx4aj8Sa1ZaEsWLNh5lyV4KQJjOD2ZiVUHrkk9qCZXt7u52finxJo1t46g8SWOp2d1pV7Zpp9+0UoL2jq7NFLInURneyFsfKSM8Vp674V0nxBd2l3qMLyvAAB5crKkybg4SQA4dNwVsHjIrzvXdG+yXOqaDe7nWCRoMucloyMxtnudpXn1BrF8MfDqy8WaXq+pf2VbfaNJi3OqxAfaLpeWjPHI2g8erqe1dUKvs48rV0ePgc0eKnVozhyzp9L3v6bf00ehfEW/g1e0uPCdreQQ3F6qpqF1I4WLT7Yn5nlY8BmAKqpOST6Cp/hnrlrqvhyLS3mgk1LS4xZXcKuGDBBsEi/3o3ABDDg5rzTUoLO3tbC9tooYre2IAKoFCwvwfoOVb8K1tT8ERWnhrRdQ1G3322ru8n2dl2i1fG6IoRyrMgYnB6j869vJVLsyoZyq+Dli4w0i9VfXTr92ttPU9D8MeErPw7cSTwXl7c7bdbWAXUoZbW3ViwiTgYUEnk5PA54FM+HOq6f4o+Il3rMGoWv2XTbd9OsIvOXzLlnZWmmC5zs/doqnvhjXkC+Hjq+vQ6LcTXuovcPGtlHfXMk8cYbIY7WODswzZOeK6vXtBXRNS1Hw/cNJcW0GFjaZtzSQOMqWPcjlc+q0p1FNezirIrF5wqGFhjaUOaEt9bNX+T66ep7hc+PPCtvOIZNesC5JB8uUOFI/vFchfxxW5p2oWWp2wuNOu7e7gPSSCQOv5ivmTwj4Wudd0fVtXjV1udCi8sFPlNzMpy6Mf4h5Yzj1kU9q2vCWrjRvE+laoj4tncW87A4DQyYGT7Bijfga5lG6LxGbfV8RSpyjeFTaV/0+a69T6LoooqT2gooooAKKKKACiiigD5x+Jlhc3WjeKrCaCS5v5L4GWNFLNIjSoUIA5x5e0e20+led3/h/XGvtU066s5bqGBtOtba5lt2mjngW5ZgXHG7argOM/wAJJIzmvrDxf4Yi1+KGaGX7LqdsD5FwBkYPVHX+JDgZHUYBBBrzeX7RZX32DVrc2l/jKoTlJh/ejb+Ie3UdwKAMTR9HvdKitoLSTRba1DFp4rTTGhEhJ6riXCnGBkhun4V5qlvrk3w0bStS0+9jeG3sRBaCxaaNo1miLs+BuLjDbo+MKOAeWr2migDzbw8suk6B4jZLPZaCeO4t8WcljHI5CAokD5ZFBVeeckk16LN8WNdLHytK0uMZ4DTSP+u0VzvjecG3srFT89xOJGHokfzE/wDfWwfjWFQB2cHjq51TxTp0utW1naxNFJaiWF2I3syFN24cDKkZz1YV3VeJfyq7ous6noQWPTp1ls1yBZ3OTGo/2GHzJ9OR7V14fEKC5ZbEtXPYKK4KP4hSgAT6HJnuYrtWH6gVqaB4rl17VP7O0/SmS8MZkRbq6SNXA67SN2SOMjHQ11/WKfcmzNLxaQPDWocgHy8L7nIwPrmvU65LRfDN0dSg1HXZbd5LYlra1t8mONyMeYzNyzYJA4AGTwTzXW1w4iqqktC0rBRRRXOMKKKKACiiigAooooAKKKKACiiigCO5nitbaW4uHWOGJDI7t0VQMkn8K8/8XfErSE8Pv8A8IxqdtqOpXSbbY2zCRYs8eY5HAA64PJOAK9ErmLzwD4UvLmSe40DT2lkO52EQXcfU4xz70AfP2nWAvLu30qOcQK4zPPI4HkQA/vJnY9OM8nqxFet+PfFuiad4PfQ/Dl5a3FzcW/2SCO1cSrBFjaWYjIUBc4zyTjGecdppfhfQ9Ksrm00/SrOC2uRtnjEQIlGMYbPUYzwfWsE/CvwgGYxabNArHOyG9njQfRVcAD2FAHgmmbp9LezaTFzanySxOSCvMb/AIgK2fWtz4heNH8Uz6XdRLJDFpCKbqIqQTM4Am4/uqp4PQ8kdjXs0vw28JvBFGukJCY84lglkilbPXdIrBm/4ETWHf8AwW8K304kuG1MrjaU+1Hlf7pYjdj8atyvY+fw2Tzw061OLTpVL6bNX7dP6Rwng7xBZeFfE0er6i4j0+W3a2uZ1QuUUkMjYUEkbhjgH7+axdW1qXVvGmo386mKHUj5ltGwwVEYCgH/AGim1iPr6V7TdfC3wrMjrDZ3ForfwW91IqD2CbigHtiqej/B3whp0kzvaT3rSJsH2mYkRD1QLgK3ow5HYjJo5tbkUsmq/UZYCtJNfZet1rdXXr59TzK18Tpp/grUPB9rG0VzeXLyb1UqPssp3SkN0LFiyYHOGB7Vz2mb5dKa1Dhbq0bygT1VkOY2/RTXt2qfCDwxfqqt/aMSqcgC7aTB9QZNxH4Yq1ZfCjwhZ2EVrDp0oKMzGcXUqzSE4zudWBI4GF6DsBQpJMeJyivisJTozklUp2tLXp8tPx1RieNrqDxd8N7PX7IBrjT5FmnjUZaI42ToR/shif8AgIPpXMfDzW4tB8Wwy3Uqx2F9H9lmkJ+VWzmJifTJZc/7YruH+EXh1rozLc6xGr48yOK+ZBIB2ZhhyP8AgVXLv4XeFp1kWK0ubVXzlYLqRUGewQkoB7YxSUlaxriMur1MTSxsGlOOjWtmvW3m+n5HcUVyng/wLpnhW7luLC51OeV4/JAurtnREyDhUGFHQc4yOgIGRXV1J7ivbUKKKKBhRRRQAUUUUAFYus+KtC0S6+y6vq1nZ3Ji88RTSBXZM4yo6nnjitqszXdA0nX4Y4tZ0+2vUiO6PzowxQ9yp6j8KAPCPiB4lXxLrzXyiSHS7OMxW3nKUJBOXlIP3c4UAHnC9s4rs/hg+j+FtEutS1/ULOx1K+AmaCeVVlitxny12H5snlsYyS2O1dda/D7wnbXMVxBoNissTB0by84YdDzU/iTwXoHiO6iutX09ZbuNdi3EcjxSBeu3chBI9iaAPAvFGvvrPjefV3DxWN6BawRuNpRUyYyw7M2X4PPKjtXQeFvGq+D9M1q1dWM96RLp42EqbkrsZWPRRhUbnGcNjJwK9Otfhp4StyxbSEudwK4u5pLgD6CRiAfcVRv/AIS+F7u3aEJqEMbDBC3kjgj6SFh+lVzaWZ4lXLKkMesdh2tVaSd9fmr+X3HhGm24k0280i6YyeUDEWfq0bjKk/mR/wABrsviB47HiLwhpmn6apbULTy7nUR5ZHlyxj/VLx1Y5PH8OP71eg6T8HfB+mpMVsrme4lwGuZbqQSgDOFVlK7RyemM981Xv/gv4WvbgSyvqi9sLdnJHpvI3frQ5XSFhsrnhq9Zqzp1d11T620s1r5fgea+HdXtNG8Q6T4hl2vZ22/zZVUuVgkXDMAMk4+U8ZOAaoeJtbfWfGUmvNuW0vmFrErfwxD/AFJx2JO4n/rpjtXt9x8MPCsmfIsJbPIAC2lzJEowMZ2BtufU4571n6P8HPCOnaj9se0mvmAYLFduHiUsCCdgABOCeoOOo55puWt0ZYXJ6lLCVMDVkpQd7Pqvl667mL8G9YistV1DRrmRY/trC6tg3AeQLtkUe+FRsf73oa4vxHoy6TreraK4/cROfKA/54SDKfkCV/4DXqt/8KPDN1HsjS/thncPKu3YA9sBywGO2OlSWfwr8MQwMtxFe3twx/4+rm8kM6j+6rggqv8AsjAPU5o5rO5nWyWtiMDHCVJLmh8Mlfp37aepq/DrWjrvhGxuJpFe8iU29zg5IlQ7WJ9M43c9mFdLXncnwj8Pm6M0V3rVuTjcIL5k3AdAWHzH8+O1egW8KW9vFBECI41CKCxY4AwMk8n6moPoKPtORKrbm62/4ZElFFFBqFFFFABRRRQAVxHxkuIYPAt2ssEU01w6W8BkQN5bucbxnoVG4g+ort68/wDjfA8ngyOdQSlrewyyeyklM/m4oA8cs9R1TTwFtrv7TCvAhvMuQPaQfN+e6tEeK7raQdH/AHnYi7XZ+e3P6VkUUAJI9xdXcl5fSK9y6hcIMJGg5CL7c8k8k/kFrB8Uz+S2nrcXEtrp8kxFzNG5TaNpKguOVUnGSMfUVy+sXlut/bRafrDPZvDcESXOqywIHBjxiQZL4ycA5zk80AejUV53p8+p6ndj7KdRM6wWbLI1xsjiznezpuw24DOAp/CvRKACgXM9hNDf2bbbuzcXEJ/2l5x9CMqfYmiortxFazOeiox/SgD6m067jv8AT7a8hz5VxEsqZ64YAj+dWKy/C1pJp/hnSbOcESwWkUTg9mCAH9a1KACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKx/EHiXSvD7WyancOLi5JWC3ggkuJ5ccnbFGrOwA6kDA71sV534nS60b4kx6/LZ6jcaXdaQdNNxp9sbmWylEpff5SqzEMGHIVgDGMjFAGrJ8RvDKW0Uxur0mW7NisC6bctP54TeYzCI/MB288r0qWT4geG00a01QXs8lrdXZsIlhsp5JjcAMTEYVQyKwCNkFR09xXmEll4t8Q6joRurvxD9nt/EspstSm06KG5itPsbASPGYQqgyFhl4x1x6VW1DS9V0/Q9F027s9eh1TTfFQvdR1bT7F7o3QkgnP2yMeXIpzuVWXaQh+XHQkA9y0TVrbWbV7izjvo41cxkXllNaPkAHhJUViORyBjqM8GtCuf8FT/aNKlf+0tb1HExHm6xp/2KYfKvyhPJhyvfdtPJIycYHQUAFFFFABRRRQAUUUUAFFFFABRRRQAVkeLdet/DHh291m8guZ4LRQzRWyhpHywUBQSATkjuK165n4k6Xeaz4K1Gw02HzruXy9ke4LnEiseSQOgNAC6P400rWLjRIrAzSLq9hLqNvJtAVY4zGrK/OQ2ZVGMHo2cY50NM8SaHqsV1Lpes6Zex2n/Hw9tdJIIev3ypO3oevpXlOsfDjXm8Y6/baQY4PDl9ouox2U29R9kursxF49ud2wtGXyBxvYZ6VQ1PwnqZ0TVLq+tdWtVtNKit86zd6bDbPFFcRStAPsygBCsbKHkIADngZJAB65B4z8L3GnXV/b+JNFlsbXb9ouUvomjh3Hau9g2FyeBnqaz9X+I/hTTLbSbqXXNOlstTumtIbqG7iaFWVGZmZ9wAUbQpIzhnUd64DS9c1zxHfeL9b8DWHlGUabao6TWs7OiNL5xjZZGgMio64BcjpnB4DdM8MeKbS6l1abSdSu3j8TRasLeeeyW6nh+wmBm/dFIQ+5skZXIXqx5IB6tpfiCzvbuWD7dpLOZjHbLbXyzPKBGsnK4G1trbto3fKVbPPD9Q8TaDptq9zqOt6ZaW8cxt3lnu440WUdUJJwGHp1rzi/8AC3iE2/ibV9P03Zraa9DrWkwSzRgzBbeGN42YMQu5RNGckevTBqvL4E1rSl8MX1u2qT3VtY3KXw0s2Rn+1XEiSyyD7WDGVZt4JBDY2gZBNAHrzXdutkbwzxfZBH5xm3DZsxndnpjHOa5TTvHY1FbO5svDXiKXSbuRUg1FYIvLdWOBJ5fmecI++4xgY56Umi+Ff+LUnwvItzZCfT5rMiaVJZIRIGHLRhVJG7+EADoOlcncaX4vvrTwxY/2Rqum6pplzaR3N/aawE0+a3jdTIREswZ96gjDxZGcZx1AOj034mafe3trG2kaxbWN1qMmlQahMsJge4RmXbhZWkGSjAEoB9Ku6d42fVNTvrXTPDWt3UFlfPp894rWixLIhAY4acOVGQeFz6DPFcBonw/1vRVstejsZrzU7PWry5fSJ70PFLBNO+2WFWfyoplRtwI25BYHk5F/w34cv9N8Ta5LqPh3xVJ9r1ya8gubDW1htfKZl2s8Iu0z0JIMZJHHPSgD1+iiigAooooAKKKKACiiigAqrqlhb6ppt1YXsYktrmNopF9VYYNWqKAPmTX9GvPDervpepbmYAtb3BGFuY+zA/3h/EvY89CDVGvpbxDoeneIdOay1a2WeEncpzho27MrDlWHqK8g8Q/DHW9MdpNHddXsxyEZljuFHoc4V/qCp9jQBxFFJeb7CXy9SguLGX+5dRNEfwLDB/AmmJPC4yk0TD2cGgCSioXureP788K/VwKu6XY3+rsq6Pp15fZ4DwxER/jI2E/WgCCur+GnheTxJrMV9cRn+xbKUOzkcXMqnKovqqkAsemQB643/DPwonndJ/FU6LD1+wWrk7vaSTgkeygfU161a28NpbRW9rFHDBEoRI41CqoHQADoKAJaKKKACiiigAooooAKKKKACiiigAooooAKKKKACivIfEnjK/tfFts+i32uXFgNetdIuknhshYq0jqjxoSFuC43bsjcMjnjomn654kNzDqU/iCeW2m8VXWjCx+ywCNbcTzRqdwTfvXapB3YOMEHk0Aer3d7a2ZgF5cwQG4lEEIlkC+ZIQSEXPViAeBzwaL++tNPt/Pv7qC1g3KnmTyBF3MQqjJ4ySQAO5IFeM+CbnVNC8F+E5bXXry5i1DxAbKWGaO3KJH59xvVSsYYFioJJJII42jiut8c+KtZs/CF9eW2k6lolzBeWMUc12bWQSrJdxRuFEckn8LEfMB94Y56AHoNZA8TaCdUbTBremHUlkELWgu4/NDkEhCmc7iFJxjOAfSvOl13xFFeNqkmuzSWo8Vf2ONPNtCIvs7TeVy2zfuGQQQw6YIPWuZ0GzmstE8FXd1qt5eLN40u2ZJ0hCoytqAZwY41YlsZO4kZ+6FHFAH0FRXimleNtVl1e1ksdQ1y60fU9Kvbu2l1aCxTcY1Vo5IRCFkA5IIlXnjFWNAl8Xalqnhywl8aXy/2roDatLKljaBo5VMKhY8xEBT5+TuDH5OCuaAPY6K8V03xL4m8TWGnXUOvTaUT4Uj1eVLW2gcSXJLgk+YjYX5eVGPYjrViw8WappEdvc+JvEV1LYah4Yk1iWWO1hVrKVWhH7hRHyMT8CTfyo7EigD2KivnfxRrOt6jYa9oupajrcMFtLol9DJqMVit1H5l8EIbyFKbflRwGVXBHzAqcHqfEet69YXHi9IvFUtsPC+nRXUK3Fvbk37MjOWnxGPlJURgRBOc9TQB6/RXmOlz+J/Eus+Lxa+ILrSvsJhisrNbaBlikksYpP3jPGzMBJITgEHryRgC38MfFmpeNb+61B0ez0yyto7Ka1aMfNqH3p/mxnEfyoMHBJbPQYAPQ6KKKACiiigAooooAKKKKACq/wBrjF+LPbP5piM27yX8vaDjHmY2bufu53Y5xiuJ+MV2bXR9K/4nVvpMTX6+b9pvpbCO5QI+YjcxAtDztbPfbjvXnsXiLWX0+BtJu9Xgz4cu5ALi7a7Zdt9HGbhXIxLtjLMjlclcZ6mgD3SPU7STWJ9LSXN/BBHcyRbT8scjOqNnGDkxuMZzxz1GblfPupX8NveeM5vh/rc2pIumaTHNftqkt0YkN3cCZlnbzCoWMliVBCfMQMjFdz8Hr6W7udfVNYsNR05HgMEdrrM2rC3Yq28G5lRSQcKduW2nPTIFAHpNctcePvD0DXQa6unFtc/Y2aKwuJFknyVMURVCJXBByqbiMHOMGvLta1bWR461JLjXbPTtRj1iGOyt7jXZ4ma1DR4VbBISsyyKWy5JwSfmXYcU9G8M2L6D4JLXOsZufFt/DJjV7sYVW1DBXEvyN8oyy4Y85J3HIB9BW8q3FvFMgcJIocCRGRgCM8qwBB9iARTL67trC0mu764htrWFS8s0zhERR1LMeAPc14Vpuq6yPHMUN5rlnZ6ouvNB9juNeuGlazEhRYxYeUUIaLawlLZJO4sOQMrULi11/wCFOvJqOv6vceOJdOvH1DSFv5v3ciEkobYHbEi7QFwFDDg7gSCAfSNFeAeN9c0i0a3k8P8Ai17/AEoae0sFnF4nuYbqWXzTl4Jj5guJONggcnBA4Gefe7Zt9vE5WRSyA7ZBhhx0PvQBJRRRQAUUUUAFFFFABRRRQAVz/jjULrTNFtp7GXypX1PTrdm2hsxy3kMcg5B6o7DPUZyMHmugrzL4w+NfD+jRWej6tqKWd8b/AEy+VZlZVeFL+FnYNjadoRiRnIAzjFAHompXsOnWE95c+b5ECF38qJ5WwOuEQFm+gBqr4b13T/Euj2+q6PJLLYXA3RSSQSQ7x/eCuqnB7HGD2rOi8Sadrvgm51rSWubrTpoZfKeK2kZ5QNy5SMLvbJBxgc9RxXl/g3wvHrdl8LrXX9AuZrTTtFvYLuDULGREimH2UKsiyKAc7X25GDtJGcZoA9S8QeJLbTtVttJOnXmo3FxC9xIlusZWGBWVWkkMjqNoLDhdzHnANQaBYeGfE/h/TdZt9BsRbahbx3Uaz2ce8K6hgGxkZwexNeb+D/B/m32i3OseHjJPZ+H54opruy3PDKlz+5AZhkOE+7znHSuU17TNUm+H2maZN4PVdTs/C9stpevoFxeXrTiNj5Ucse37M0bDPzknLcK2cEA+ibbw/o1q4e20nT4WHRo7ZFI/IVp14Z4t8HnV4vHep3ehTXOsNFYmwuPszGYMsMe4wkDIIYEErzxg+lSeKvBotv8AhMNH0XQ5otEun0GRLe1t2WORxeH7Qy7RywjRC7DkAAk96APb6K8M1/wBZ2i+O59H8NLDPbS2k2jm2tCPKcJGXa3AGFO5fmKdcHNR+KrfULz4h291aeGIbK9tvEFmv2q20Gdrme2EiCSZ75SI/LKFgUIYgDnGMgA9q0bVbPWbH7Zps3nW3myw79rL88cjRuMEA8MjD3xkcVdr58s/DNrp/hmLTk8KXMT2niCSTW4rfSHH23TzcTtEqsqYuEG+A+WpYhVxt4xWhp/hUanrGjQvoFynhBvEdzcWthc2jxpBbfYHUl4iB5cTz7iEYAfOAR82KAPc6K8Z1Pw5JB8R4/CGlQW8PhXU/I1q7toRsW3FvhDEqDgLI623p92TrXs1ABRRRQAUUUUAFFFFABRRRQAUUUUAY03hXw9Pq39qz6FpMmp7lf7Y9nGZtykFTvI3ZBVSDnjA9KuLpOnKiothaBFuDdhRCuBMWLGUcffJJO7rkk1drldU17XP+EqutG0HSNNu/stlb3ks17qT23+ueZFVVWCTOPIJJJH3hxQBpw+GdBgvZbyHRNLju5pluZJ0tIw7yrnbIzAZLDc2GPI3H1rQvrO1v7c299bQ3MBZXMc0YdSysGU4PGQwBHoQDXOfbvHH/QveG/8AwfT/APyHR9u8cf8AQveG/wDwfT//ACHQBunSdOKbDYWhT7R9r2+SuPO3bvN6ffzzu655pF0fTUjt4106zWO3na5hUQKBFMxYtIoxw5LvlhydzeprD+3eOP8AoXvDf/g+n/8AkOj7d44/6F7w3/4Pp/8A5DoAvWPhHw3p9xJcWHh/R7aeQMHkhso0Zw3DAkLk57+taUGm2MEtvLBZ20ctvCbaF0iUNFEdpMakDhflX5Rx8o9BXP8A27xx/wBC94b/APB9P/8AIdH27xx/0L3hv/wfT/8AyHQBt22i6XaxrHbabZQxrbi0CxwIoEIziMAD7nJ+XpzQ+jaW6Ij6bZMiWzWaqYFIWBsZiHHCHauV6fKOOKxPt3jj/oXvDf8A4Pp//kOj7d44/wChe8N/+D6f/wCQ6AL1p4Q8NWVpc2tn4e0e3trmPyp4YrKJElTJO1lC4YZJOD6mlbwj4bb7Bu8P6OfsAxaZso/9GGc/u/l+TnnjHNUPt3jj/oXvDf8A4Pp//kOj7d44/wChe8N/+D6f/wCQ6AOjgtLa3nuZ4LeGKa5YPPIiBWlYKFBYj7xCqoyewA7VQ8L6Da+HNIXT7J5pV8ySaSachpZpJHLu7kAAksx7D0rFXxB4js9c0Sz1zQ9IgttTuntFms9VkneN1glmBKNbxggiEj73cda7CgAooooAKKKKACiiigAooritO8ReKtXW7uNK8P6I1lFe3VnG9zrMsUj+RO8JYqtqwXJjJxuPBHNAHa0Vyv27xx/0L3hv/wAH0/8A8h0fbvHH/QveG/8AwfT/APyHQB1VFcr9u8cf9C94b/8AB9P/APIdH27xx/0L3hv/AMH0/wD8h0AdVRXK/bvHH/QveG//AAfT/wDyHR9u8cf9C94b/wDB9P8A/IdAHVUVyv27xx/0L3hv/wAH0/8A8h0fbvHH/QveG/8AwfT/APyHQB1VFcr9u8cf9C94b/8AB9P/APIdH27xx/0L3hv/AMH0/wD8h0AdVRXK/bvHH/QveG//AAfT/wDyHVrwlrd9q76zb6rYW1je6ZeizkS2umuI3zBDMGDNHGekwGNvUdTQB0FFFFABRRXP+LdbvtIfRrfSrC2vr3U702caXN01vGmIJpixZY5D0hIxt6nqKAOgorlft3jj/oXvDf8A4Pp//kOj7d44/wChe8N/+D6f/wCQ6AOqryH9o74aT/ETQNJGlqo1SyvEUOccQSMFk/75+V/ohxya7T7d44/6F7w3/wCD6f8A+Q6Pt3jj/oXvDf8A4Pp//kOgDe0bTbbRtIstNsE8u0s4UgiX0VQAP0FXK5X7d44/6F7w3/4Pp/8A5Do+3eOP+he8N/8Ag+n/APkOgDqqK5X7d44/6F7w3/4Pp/8A5Do+3eOP+he8N/8Ag+n/APkOgDqqK5X7d44/6F7w3/4Pp/8A5Do+3eOP+he8N/8Ag+n/APkOgDqqK5X7d44/6F7w3/4Pp/8A5Do+3eOP+he8N/8Ag+n/APkOgDqqK5X7d44/6F7w3/4Pp/8A5Do+3eOP+he8N/8Ag+n/APkOgDo1s7VL6S9S2hW8kjWJ5xGBIyKSVUt1IBZiB2yfWp65X7d44/6F7w3/AOD6f/5Do+3eOP8AoXvDf/g+n/8AkOgDqqK5X7d44/6F7w3/AOD6f/5Do+3eOP8AoXvDf/g+n/8AkOgDqqK5X7d44/6F7w3/AOD6f/5Do+3eOP8AoXvDf/g+n/8AkOgDqqK5X7d44/6F7w3/AOD6f/5DrV8J6v8A8JB4V0bWfI+z/wBo2UN55O/f5fmIH27sDOM4zgZ9KANWiiigAooooAK5XTf+Sp+If+wLpn/o+/rqq5XTf+Sp+If+wLpn/o+/oA5v4pfFO08D+MfCGjTmPbqlwftjMeYYCCit7fvCDn0jYV6dXiXxX+EugeJvG+h6hrk2oXFxrF+bF9swRbeFLK5kVYwBx88asS2cnPY4r160RNF0KJL28kmjsrcCW6nxvdUXl3x3wMnAoAv0V5J4M8b65Db6/P4n/wBId9L/AOEk0y3KJEUtW3/6OSo6ptjBJyf3nNXrv4mX+maXqF3q/h6G3ki0RtbtootQ83zo1IDI58sbGyydN4wfbFAHptFeb6v8S5vDsWrjxRo8Fjd2ltb3UEcWoLIkyzytEivIyIIyHHzH5lAyQSBTdG+KC6jaarMlnp10ukzQG/l0vVBeQR20gJ85JAi7im1tyEKQFJBPAIB6VRXCQ+KxqGueF2bT5VtdUurpLC4jv3CyQpAzrM8agK4cLlQ2cAq2QeBT8I/Ee71aLQbvWtFttI03WrKW8trj+0RMYxGodvNBjUKNpJDBj05AoA9Horkdf8RJqvgnWNR8D6/pM01rDI32qLbexoyoWK4RwA2MEZJAyCVI4rb8L3U194a0m7un33E9pDLI2ANzMgJOBwOTQBkeMv8AkY/An/Yak/8ATdeV1Vcr4y/5GPwJ/wBhqT/03XldVQAUUUUAFFFFABRRRQAVyvw0/wCRcvP+w1q3/pxuK6quV+Gn/IuXn/Ya1b/043FAG/FqFrLqtxpqS5vbeGK4lj2n5Y5GkVDnGDkxScA5G3nqM1fEmv6d4bsI7zV5pYoJJkt08qCSd3kc7URUjVmJJ4AArK03/kqfiH/sC6Z/6Pv6zfjDYajqGi6HHo8TPdx67p8wYQNMsQWdSZHRSCUXqeV4HUdaANRfHvhs6PNqZ1Blt4bn7G8b28qzifGfK8kr5m/Bzt25xzik/wCE+8NjRdV1WW/khtdKx9uWe1mimt89N8LIJBnt8vPauL1Twjf+HfE+leLroz69cjUpbnVBZWpBVXtfIjaGAFmIjCgYBZiGJ5qh4usb/wAUXXizWtO0bUYrGTTbTToVns5Ipr2RbkyM4hZQ+1VbGWUZyccCgD0288YaDZ32hWc+oxi51wE6ciozfaAFDZBAIAwRycDmqf8AwsHw2b5rZL2eXbcfZGuIrKeS2WbOPLM6oYg2SBgt14rzOf4capoviPwxMZJL6G21oW9g1vGz/wBn6csNwyBzjAIeXaT0wsYz2rp/hpq8nhfwjo/hjU9B11NWsCLJxBp0skEuGx56zgeVsOdxywbrxnGQD1CiiigAooooAK5Xwb/yMfjv/sNR/wDpus66quV8G/8AIx+O/wDsNR/+m6zoA6qiiigArlfGX/Ix+BP+w1J/6bryuqrlfGX/ACMfgT/sNSf+m68oA39W1C10jSr3UtQl8mys4XuJ5NpbZGilmOACTgA8AE1brlfix/ySzxl/2Bb3/wBEPXVUAczq/jrw/pWo3NjdXVxJc2qq1ytpZT3QtgRkea0SMI8jn5iOOeldFbzR3FvFPAweKRQ6MOhUjINebeG9Rk8Gaj4osdX0fWp3u9Vn1G1ubHT5bpLqOUgqu6NSEZfuYcqMKDnHTI1fSry9+JaeH4I9nh/XfI8QahC5w8BgwrRlQcASOtvnnnbJ1oA9X0nVbPV4Z5dPm86OC4ltZDtZdssTlHXkDoykZ6HHGai1jWLfSrjS4bhJWbUbsWcRjAIVzG75bJHGI26Z5xxXiX/CNW1lpWrWUPhW5SWPxHLcaklrpTqbzTDdO6okiqBMgVoz5SsThSNvGKsXeg63cW5XwVZ3Gi6fJ4iWbSkubF41tE+wyJJL5JUGKMyE4DADcc7fmwQD2+W4kS+ggW0neKRWZrhSnlxEYwrAsGycnGFI4OSOM2K8Ri0mZrjw0NP8PanYfZtK1qC9jmheRhdOsGS0uMSmRgxV8/PzjkECm3gzUdK0fTYvB2lz6bqV74QuYbuWGJo2e6H2cosjnGJeZgpYgjnBAHAB71RXz1H4aT+ydditYtRtrG4traKWDS/Cd1aRM6Tq294ZZS1wSAVfYMshOSTXpXwgtZLPQdRiOkW+l25v5Gtxb2UtjHOhVP3gtpSWhydw29PlyOtAHd0UUUAFFFFABRRRQAUUUUAFFFFABXK/Cf8A5JZ4N/7Atl/6ISuqrlfhP/ySzwb/ANgWy/8ARCUAdVRRRQAUUUUAFcrpv/JU/EP/AGBdM/8AR9/XVVyum/8AJU/EP/YF0z/0ff0AHjL/AJGPwJ/2GpP/AE3XlbHiXR4fEGg32kXcs8VteRGGVoGCuUP3lBIPUZB9iax/GX/Ix+BP+w1J/wCm68rQ8awG68I6zbLqi6Q09pJEt+zhRbsykB85GMEjuPqKAMK8+F/hZ7pbjTdNt9Fk+zXFpL/ZdvFb+fFMmxlfCfNjhl9CO4yDPrnw/wBK1m1eC6uL5EfR5NFJjdAfJcoS3Kn5/kHPTrxXmUtnaeGLa80i+8K6Fp+rXfhu+aHUtDuWdLhI4/mMyFEbJypDsXySfmzmtXx+iSfAPwqktr9sjZtHDW2FPnDzIcphiFOenJA55oA9D13wbputald313JdLcXFrDagxuF8ryZjNHInHDq5Bycj5Rx1zEPBxmhaLVPEOuamj3ENxIty8Kq4jOVjKxxIoQnBYAAtgAkjIPkXi3witr4X1GbUPD1tpek3XiLTW0/SJhFL9lUyxJKwVC0aeZk5RCRjr1NfQscaRRpHEipGgCqqjAUDoAKAOYtPBOn2up6ddxXN8Rp93cXlrAzqY4jMjK6D5c7PnYgZ4J64wKdo3grTtIt/DMNtNdsvh+B7e1MjqS6sgQmTCjJwO2K6eigDM8S6Sdc0a5077fd2CXCmOSW1EZcoRhl/eI64IOOmfQijw1pJ0PRrbTvt93fpbqI45boRhwgGFX92iLgAY6Z9Sa06KAOV8Zf8jH4E/wCw1J/6bryuqrlfGX/Ix+BP+w1J/wCm68rqqACiiigAooooAKKKKACuV+Gn/IuXn/Ya1b/043FdVXK/DT/kXLz/ALDWrf8ApxuKADTf+Sp+If8AsC6Z/wCj7+rnjLxGnhrS4bgWkt7d3VxHZ2lpEQrTzOTtXceFGASSegBPtVPTf+Sp+If+wLpn/o+/qTx94euvEGm2TaZcQ2+q6bex6hZvOpaIyoGG1wOdrK7qSORnPagDH8ReMPEfhvw/falrHhiwBha3SEW2rGSOV5Z0i2sxhVlI37uEYHHWqeofEq80vS/Fj6hoduNT8P8A2bzILe/MkEwnIC4lMSspHOQUyOOuRUvjHQPFXjPwrf6Pq1p4etIpntWWKO6luQ/l3Mcj72aJMAojALtPOMnHTK8QfDK+XRfEvh7wx/ZNv4b1jZcpaTbo/styJIy4QKhBiZUzj+FuAMHgA9E0OfXZjN/b2naZZAY8r7FfyXW7rnduhj2446Zzk9Mc0Nf8TzaT4p8P6R/ZFxNb6tM0H2/zo1iiYRSybduS7NiL+6Fw33s8Uo8EeHorI2mnacNIt2k81l0eaTTi7Yxljbshbjscisvxno3iG71nwxNoFppc9po1x9qLX+pTRySsYZYdnEMnaQNvLEkggjvQB3FFFFABRRRQAVyvg3/kY/Hf/Yaj/wDTdZ11Vcr4N/5GPx3/ANhqP/03WdAHVUUUUAFcr4y/5GPwJ/2GpP8A03XldVXK+Mv+Rj8Cf9hqT/03XlAB8WP+SWeMv+wLe/8Aoh66quV+LH/JLPGX/YFvf/RD11VAHE/8JdrOpajqsXhbw9b6hZ6ZO1rNcXeofZfNmXG9IVEb7tucEsUGcgHgms3T/HelWvjbxFba9bQ2F7bz2dmk8dnJIwjkgikVZ51DIoEszqu4qvp3JtWOh+KfDWo62nhyPRb3TNSvJL+P7dcSwSWsspzIMJG4lUtlgMoeSM9xBqfgrVr7T/Gkbz2H2jXLm0uIiGcIvlw26Pu4JGWibGM8EZPXAB0cvjXQItc/sh75heeetqWFvKYVmYZWIzBfLEh4+Qtu5HFZa/FHwm0iIl/eOZJHhiKaZdMJpEOGjjIjxI4P8K5OOcYrn2+HN5F4indIILzTZ9YGrNLca3fR7CZRKVFmn7lmVh8rFgPukqcYOrovgvUbGLwWss1oTouoXl3cbXY7kmjuFUJ8vJBmXOcdD14yAbMvj3w7Hpmn3wvZpYr9pEto4LOaWeQxkiQeSiGQbCCGyo298VUk8dWC6xBL9ss/+Eck0eTVDenOflkRRznphj8uM5wOvFYNj4I1/RNZg1rSTpV1exXeqk2tzPJFG8F3cechEixsVddq5G0g5Iz0NZ5+Et+0ejSf2pBHe6ZazSxSqCYxfSXP2gExEYeEEsACcgYIwQCADs7vxxpGmzalc6nqscNha21pO0TWE6SwCd2RGcnOdzAAKEBXB3deJ4/Hnh19Lu783s0UVpMlvNHNaTRTiRwCiCFkEjFgwKgKc54zXL614I17Wr7Vb+5fTILi/h0cNHHNI6o9rdmaXBKAkFTheOT1x1qTxb8P73WdX1TUI5oiXvbO9tYlvJrUuYYnjZXliG+PIkJDLu5AyO1AHRnx74d+wxXS3dzJ5k72q28djO9z5qLudDAEMoKrycqMAgnqK3dJ1G11bTbe/wBPl860uEDxvtK5B9iAR9CK8w/4QDVVslZdI0o3b38l3J/xUWoidCYUjV1vSpkLYUgjaFK7R2JPonhKwv8ATPDWm2WsXzahqEEKpPcnJMjdzk8n0yeTjJoA1qKKKACiiigAooooAKKKKACuV+E//JLPBv8A2BbL/wBEJXVVyvwn/wCSWeDf+wLZf+iEoA6qiiigAooooAK5XTf+Sp+If+wLpn/o+/rqq5XTf+Sp+If+wLpn/o+/oAPGX/Ix+BP+w1J/6bryuh1I2g0+5bU/s4sVjZpzcY8sIBli27jAHXPFc94y/wCRj8Cf9hqT/wBN15U3xN/5Jv4r/wCwTd/+iXoAgsdP8DaJp0U1haeGtOsdYCW8ckMcEMd8JB8qAgASbh0HOar22gfDzTba51C20nwnaQQS+RPcx21vGsciSL8jOBgMsirwTkMB3ArxrVvCWrabYeGTqLKfD+lavp39iYkBZvtNxE8m4dR5eDGuf4WNafhWabTPEl9q3iVY5vCMPifU0hZc7bG7NywS4nHRl5Kq3RCQepyAD1rWrzwP4g1NNC1u48NanqMMmF0+8eCaVHx2jbJDY9s11McaRRpHEipGgCqqjAUDoAK8Q0vQNU8Vaj4y0y3TT4NKTxel5LfPMxuY2ijtpNsUYTaCdqjfv4DMNvr6bLPPNpWpjx3p+gWejKnzlr43MLpk580Swxqo+73br2xyAbtjeW1/ax3NjcQ3NtJkpLC4dGwccEcHkGp68++BOoabefDjTYNKvLOcWvmRyR20qt5OZHKqQp+XjBA9K9BoAKKKKAOV8Zf8jH4E/wCw1J/6bryuqrlfGX/Ix+BP+w1J/wCm68rqqACiiigAooooAKKKKACuV+Gn/IuXn/Ya1b/043FdVXK/DT/kXLz/ALDWrf8ApxuKADTf+Sp+If8AsC6Z/wCj7+mfEfWb/SrDSrXR5Y7e/wBX1KHTormSPzFt94Zmk29GIVGwDxkjNP03/kqfiH/sC6Z/6Pv61PFGgWXiTSjY6h5yKJEmimgcxywSodySIw6MCOv9KAOG1bxHrHgTX5LXVL688SafcaVc6hAGgiS6jktzHvT90iKUYSAg7cgqetUrv4g+INTtNGn0G38PSCfVobVntNaF1BOjxOxjLiDdGQVGfkBGBjOTjrLfwJAtze3t5rmt3urXNt9kTUJZo45raLcG2xCONEXLAEnaScDOagf4c2UouJ59Y1eXV5rqC7OqEwLOrwqVjwqxCIgKzDBQ5DHOeMAGDq3xftdL1q5sbqDSVNhPDaXsZ1dFuTK4Qt9ngZA0yJvALEoThsA4xWnZ/ESaaWzvptGWHwzeX8mnQX/2vM3mIzoHeHZ8qM8bKDvLcjKjPGsfBmy6lmtfEOt2i3LpNeRW7QKt1KqqpkY+VuRmCLuEZQHHQZNQWnw80y21G3lW91J9NtruS+g0l3Q2sU77izgbN55dyFLlQWyAOMAFfQfGWt61oqa1F4fsLXRrq2a6s7m71XyztyNnnr5R8sMp3AqZMd8VyurfEOXxBoskdhPZwXVjrulQST6Pqn2uCaKa4jyBKqoTkb1ZSo/EGukPws05tCk0Nta106IE8u2sDNEYrUeYsi7f3e59rINokLgDIxgmrK/DixdruS/1fV764urqyu5Jp3hB3Wr741ASNVC54IA+mDzQBSbxtqOqaHquqW3h7f4ajS9j+1jU2guWECyAsECZRWeMqGV94yG2iqtx8Q9Rtbe8/svw7HdWelaLbavdST6oVcRyJI2xcxsXcCJuWIDc5IOM7Mfw7soY721tdY1q30i6NyzaZHLGLdGnVxIVzHvxl2YKWKhudvAq2ngXTFtNXtxPebNU0qHSJjvXKwxJKisvy8PiZsk5HA4HcA6a0uEurWG4hJMcyLIuRg4IyK5rwb/yMfjv/sNR/wDpus66Sytks7OC2iLGOGNY1LdSAMDP5Vzfg3/kY/Hf/Yaj/wDTdZ0AdVRRRQAVyvjL/kY/An/Yak/9N15XVVyvjL/kY/An/Yak/wDTdeUAHxY/5JZ4y/7At7/6Ieuqrlfix/ySzxl/2Bb3/wBEPXVUAeW+J/F+r2PxBiktblV8K6bdWmmanGY1O6e5DYffjKhC9tnkA+Yc9KXxp4s1e8t7pdGslg0qy12w0+bUftzRzM/2uASKkSodyHcYzl1zluCOurqPwo8J6lYatFqGnRXN9qMk00mqSQxG8jeRiQY5dmV2ZAX0CjOec2L74fW15N82tazHZtew6jJZRvCIpbiN0fex8rf8zRglQwXOSADggA57w94v1jTr+/XULH7VpE3iabTEvJL4mWIvLtjCxFCPLBwv3xjPAIFJpHxjsNS121tIoNPktby6mtLdbfVI5r3cgchntQuURthAO4nlcgZrr28Fac1sYDNd7DrA1rO9c+cJRJt+79zI6dcd+9RWfgtbKZVtNf1yHTUeSSPTo5YkhjL7icMIxKQC7EAuQDjAwAAAcavxP/tnwnqOoy6dZtaQxwSmLT9eP2mJnnRRFOERHhcZyQNwOCpPPO8/xCuBe3FwujKfDlvqw0aW/N3iZZvMEJfydmPLEpCZ3577cVLcfDSwvo7r+19Y1nUria3jtFubl4RLFCkqyhAUiXdllXJcM3vyasv8PtObVnuvt2pCwfUBqj6WJE+ytdA7vMPyeZ98B9u/buGcUAZui/ELUL660yW70CK10jUNUuNJhuVv/Ml82JplDGLywAjGFhndkHtjk7vi/wARX+j6lomn6TpUOo3mqSyRKJrv7OkWyMuWZgjnGB2GfrSW3gnTbew0m0Se8MWm6nLqsJLrlpZHmZlb5eVzO+AMHgc9c6uo6Lb3+saTqUzyrPpryPCqkbWLoUO7jJ4PGCOaAOK0L4j3942kT6roEOn6XqN7cactwl/5zpcQiUvlPLH7smCQBt2TgEqAagj+IV7qOkWs9xo/9nWGu2NzNpN1HeeZKSkLSKJUCARs0alxtZ+mDg101v4H0yCx0i0Et20WmanPqkW9lO+WUzllf5eU/wBIfAGDwvJ5zQ0z4baZYeRH/aGq3NnZ281tYWk8sbR2KSgq3lkIGJCkqC7PgHAoA4q3+MEOg+G9Kt7n7Bd3Vnodne3z6hrCW1xOzwhisKMGM0hHzHJUEsBkk12+meMtQ1zWLmPw9oaXekWd3FaXN5NeeRIGZUdmjiKEOEWRScspPIANPj8AQWltBDo+u63pSrZQWMxtHh3XCQrsRmLxNtcKSN0ewnj0GJ4vBFvba5PqOnaxrFil1cRXV3Z28yeTcyxhQGfchcbgihgrKGA5zzQBQg8cNqOheH7hLEwPrkVzjE+TbmOJ3znaN2dmO2M1xGi/FxNE8HeH7a6ksLzUIdBtNQvZdU1hbWWYumdsW8MZpTtYkHaOVy2TXdab8N7CwvLGRNX1mW1sPPFnZSSRGGBZlZWUYjDNgOcFmYjgZxxT7P4e22m2Vnb6Jres6X5FjDp0kts0Be5iiBEe/fEwDDc3zIFPPsMAGbB8TBeeLodHsbKwETvbAfbNTW2upUmjWTzIYGTEqKGwcODkMADjn0euQu/A0F7qEE19rWtXVnDcw3a2E80bwiaLBRwxTzByoYgOATnI5NdfQAUUUUAFcr8J/wDklng3/sC2X/ohK6quV+E//JLPBv8A2BbL/wBEJQB1VFFFABRRRQAVyum/8lT8Q/8AYF0z/wBH39dVXK6b/wAlT8Q/9gXTP/R9/QAeMv8AkY/An/Yak/8ATdeV0Gq3ZsNNubtbaa6MEZk8mAoHfHZd7KufqRWJ4stp59e8GSQQyyR2+rSSTMiEiNDYXa7mI6Dcyrk92A7itfXjMNFvvs1rLdzmFwkETIGkJGAAXZVH4kCgDmvDvj2DXX8OSW+m3Vraa1Z3F7E928aukcXlYJVGYYYS5+8CMcjniPVfiLYW2pvZ6Vpmo66qacuqvcaY9s8QgLugIZ5l3HMbcKD2rgI/h/4l1bwd4H0yW2k0q40nSrm0vI7iWJ45X/cbYpPLckxSeWwO052jBxnBu694c1LVvFy6pqfg7XXsLjw9Dp72el6vFbeVKs0xeJytxGHj2uuOowegOQAD1vQ9Utdb0Ww1XT2Z7O9gS4hZl2ko6hhkdjg1AniPRJNVbS01nTW1NX8trQXSGYPtLbSmc52qxxjopPaue8G+HNetfDXh6HVdfvbO6soVjmtLNLZoZFViVRy0JbITahKFQcEjHWua0Xw7rNpe+DtObw7Ksejarc3l3qzTW+yYSRXA3oA/mHe0qFsqpBA4IGQAet0UUUAFFFFAHK+Mv+Rj8Cf9hqT/ANN15XVVyvjL/kY/An/Yak/9N15XVUAFFFFABRRRQAUUUUAFcr8NP+RcvP8AsNat/wCnG4rqq5T4bDd4bvRkjOs6sMg8/wDIQuKAF03/AJKn4h/7Aumf+j7+sv4zareaNoGjXenteGUa5YK0Vo5WSdDOu6IcjO4fLgnBzzXjfgrXPiHd/tBXvhXUNSUi0ESaheLbIsk1lbvJJFnjC+Z9oAJAB+cYxjn6T1jR7HWYrWPUoPOS2uYryIb2XbLGwZG4IzggHB4PcGgDyu38Z31p4Th8SrczXes65qK6f9j8m4nh0lgHLRG2jG9nQI24gBnYjkLtxcsfGvizULrTNNgtbO0u7rUJ7QXt/pd1bxzQpAJRMlvIyyDklSpYjKnDV2154M0G7utQuZbJlnv2je4eG4liLSR/ckXYw2SDpvXDY4zil0vwfoumT209tbztcW88lyk1xdzTyeY8YjZmeR2LZQBfmJwAMYoA4678d6jYeKdPsBqem6tbyajHpt2lpot1EIJG+U/6T5jw7g+MxnBwcZyOcXw5quvQ+D9Gu9euNK1pJ/E5s4hc2MhkhP8AaEsZkDtM3Kgfu8AbAAMtjJ9BbwB4cbVhqJs7j7Qt5/aCp9tnEK3Gc+aId/lhieSQvOTnOakj8DeH47h5UtJwHvV1Dyvtk/krcK/mCRYt+xTuJJ2gA980AcpoXjTxJPLot/qK6OdJ1PWrrSFgggkWdBG9wqSmQyFTzBgrt75B/hHqNYkPhbRobWxtorPbDY3r6hbr5rnZO7SMz5zk5MsnByPm6cDG3QAUUUUAFcr4N/5GPx3/ANhqP/03WddVXK+Df+Rj8d/9hqP/ANN1nQB1VFFFABXK+Mv+Rj8Cf9hqT/03XldVXK+Mv+Rj8Cf9hqT/ANN15QAfFj/klnjL/sC3v/oh66quV+LH/JLPGX/YFvf/AEQ9dVQB43fatfeHPEPxR1Oxubq5l02K0e0tr69nmto2lTc+Iy+FBbHQDA4GBxTPH+s+JJdA8WeHtUudKF1DBp8wuLS2lRGhuZ2ieJlMucgofmDDcrdBXV2uieBNV8QeI7a1voL7Vr9Suq2iaxLM+EYD5ovNPl7ThRgDbnaMA4rW8VaT4bitNW1jxBEqQSW8K3kzSSAGOCRpIxhT1DsT8oyc454FAHnnh9k8Fal44hivNE0h4ptPjRrfSZPsxd4slY7WOTeS2Twrk5yeat6Z8QPEmrvp+nWI0yLUJtdn0mW5u9OuYUMaWhuRILd3WRGwQNrNzjrgg10tlZeEPGdzrBhtrw3pmt5rzzUu7GeKVFPkuN2x42CjgrjIPvWrpPgjw/pM8E1lZSieG8fUFlluppXNw8PkvIzO5LEx8HOfXrzQBx+heMvFMlzp0+rDRHsZtcn0GWK1t5UkLxmVPPV2kIALRfc2ng/eqtp3jDxrfnw68cnhyOPXb66soVaznY24hEreYx84b8rCw2ALyR83WvQ4/C+jxxxIlnhYtQfVEHmvxcuzs0nXuZHOOnPTpRa+F9HtF0pbez2DS5pbi0/eufKkkDq55PORK/ByBnjGBgA4cePNRl0O0EmpaZY66Ly+spLdNHutQ+1NbTGNniihkEirwCc7sbuvGTR8OeJ/EXiLxN4f1SK+tbKyuPD5vbqxa2llUss6iTYPNTDHkKzKSoyCDmu3uvAPh25ZHazuIpUmuJxLbXs8D7p33zAsjglWbkoTt6cUyDwh4Xtb3R7S1ja1vdLgP2OOC/milEG9SQ21w0ke8LkPuXNAHKaV4+8QNp2g6rqUWktZeIbO4ubO3t45BJaMkDToJHLkSAohDEKmGwOc1Pb+Nde0fSvDWv8Ai6bRl0HVkX7Q1pbSxmyZ4t8RZ2kbepIKn5VwWX8eo07wD4b02eSWz09k3RSwLG1zK8cKSHMixRsxWIN32BaXxR4PtNc8J2vhtWW30mN7ZZImj83fBC6t5QLHIzsA3HJxnvzQAeH9evpfACeIdctUhna1kvjbQqQUiwXRCCSd+zaD/tZwB0rz+0+Jfif+wtQ1K402OSNdDutUjb+xr21itJo496RSSzYWZWBPzJt+6cDBBr2VkVkKMqlCNpUjII9K5aL4feHI4LmD7JdyW89pJYmGbULiSOOCRdrxxI0hESkADCBcAADGBQBiWniPxJHd3lhq9/4ftJTpKatFeizlMNsvmYkSRDMC4C9HDJ6kcYNDSfG/iW18OaZ4j8SxaamiXeoiFpEtJbaSOzk+SG4dWlfZmQoSCThXBODmuy1/wVoHiCGWLVbJ5o5bVbNwtxLGTCrhwmUYH7wBz1PQ8cVT1vwLaX/hDUvD9re30VtqG1Z5L26nvm8vcN6qZpCVyoIBB4JzgkUAc3ZeMPFWt3fhmLSxo9jFrsV/fQyXdrLKUtYnhEB2iRMs6y7jyB8wx0wYdB8f+IRY6Fquvw6VJYaraXUwt7GGRZYXgjMn32chwwR+NoIyOWr0k6Lp51HT777MoudPgktrZlYgRxybNyhQcHPlp1HGOMc1naToPh1rbTk0yKCaDSHmgt/LnaRYXO6OVD8xyRllIbODnoaAPPNL+InjC7sWnh0I6hJPpsl5DHDo97arbTDaViaSYBZwVYkFNpJQgDkGu2+HviC612LUlvryzuZ7SZYyIdPuLCWPKBsSwTksp54OSCOaB8OfDXkvC1pePA0XkJFJqNy6Qx5U7YlMhEQBRcbNuNoAxitnQNA0/QUuF06ObfcOJJpri5kuJZWACjdJIzOcAAAE4A6UAatcr8J/+SWeDf8AsC2X/ohK6quV+E//ACSzwb/2BbL/ANEJQB1VFFFABRRRQAVyum/8lT8Q/wDYF0z/ANH39dVWLrfhPw5r12l1rmgaRqVyiCNZbyyjmcICSFDMpOMknHuaANqiuV/4Vx4H/wChN8N/+CuD/wCJo/4Vx4H/AOhN8N/+CuD/AOJoA6qiuV/4Vx4H/wChN8N/+CuD/wCJo/4Vx4H/AOhN8N/+CuD/AOJoA6qiuV/4Vx4H/wChN8N/+CuD/wCJo/4Vx4H/AOhN8N/+CuD/AOJoA6qiuV/4Vx4H/wChN8N/+CuD/wCJo/4Vx4H/AOhN8N/+CuD/AOJoA6qiuV/4Vx4H/wChN8N/+CuD/wCJo/4Vx4H/AOhN8N/+CuD/AOJoAPGX/Ix+BP8AsNSf+m68rqq5/S/BXhXSL+K+0rw1oljexZ8u4trCKKRMgg4ZVBGQSPoTXQUAFFFFABRRRQAUUUUAFcr8NP8AkXLz/sNat/6cbiuqrmrvwD4OvLqa6vPCfh+e5ndpJZZdOhd5HY5LMxXJJJJJNAGnBoenW/iG71uK2VdTu4I7aabuyIWKj/x4898D0FaVcr/wrjwP/wBCb4b/APBXB/8AE0f8K48D/wDQm+G//BXB/wDE0AdVRXK/8K48D/8AQm+G/wDwVwf/ABNH/CuPA/8A0Jvhv/wVwf8AxNAHVUVyv/CuPA//AEJvhv8A8FcH/wATR/wrjwP/ANCb4b/8FcH/AMTQB1VFcr/wrjwP/wBCb4b/APBXB/8AE0f8K48D/wDQm+G//BXB/wDE0AdVRXK/8K48D/8AQm+G/wDwVwf/ABNH/CuPA/8A0Jvhv/wVwf8AxNAHVVyvg3/kY/Hf/Yaj/wDTdZ0f8K48D/8AQm+G/wDwVwf/ABNbWiaJpWg2r2uh6ZY6bbO5kaKzgSFGcgAsVUAZwAM+woA0KKKKACuV8Zf8jH4E/wCw1J/6bryuqrlfGX/Ix+BP+w1J/wCm68oAPix/ySzxl/2Bb3/0Q9dVXK/Fj/klnjL/ALAt7/6IeuqoA8G8Q67Aus/GJdJ1dItRSCx2NaXIE0ZRNjkbTkFWIU+hODUnjqwazTxhoJ1HV7nT47bSLxPtOozSSJLJdyRuQ5bcAwjU7QdoIyAK9a0rxTpWq6/qWi2Ul02o6dj7UkllPGseen7xkCHPUYJyORkc1a8R6xbeH9Eu9UvhK0Fsm4pEu53JIAVR3JJAHuaAPH9Uu7HwvqfjuOVb+a2N1plssj6vPbGMtDw813uMiID1Yk9hWd4W1K98Q3WkaXLrV9/Zx8U3VoH0/WZ5vMt104zrGLo7JJE3kkMecYweA1exeGfE0eu32p2T6bf6be6cYxcQXnlEjzFLLgxSOp4569/rXQUAeI+HVvbGXSL9db1u4mHiy70cpdahLNG1qj3EaoyM21iAineQXyOtVtDsbq+HgmW41/xGW1rVL+3vQurTqHijW4dEUBsJgwoNy4bGRnmvd6KAPBLrxKlto1jpGr3N3JKmpata2+oXniK40uNY7e5KIsk8eWlkK7QqlWJ2k+pqLwneW97rXgnV/Emq3Md/d+HzHbTS6nNbJd3KXCBIyVZFkZsjKEfP1Knt9AVSOqWY1ldKM3+ntbm6EW08xhgpbOMdSBjOaAPDPDOu3Mttosljr+p3viCfTb2TxHaTXkj/AGN1hY7jETi3ZZgqKFVcqT161r3Mt94N8B+GPGtve65qrJBC2q21xqE0/wBpSeMKCqMxRWWRoyNqjjd6mvaao6vpNlrEMEOpQefFBPHcohZgPMjYMhIBGcMAcHIyBxQBj+HLLUtK8AxRaveTXGri1ea5meQsRM4LsFJJwqsxVR2AAryt/wC0tP8Aht4E1JdXv3i1aG1m1m91LXri2TBtmdVM4D/Z1ZyAWRVLEKC2WzXvVFAHgVjrM2/w9b+J/FJi8JyzX4/tCy1ebyy6lDBBJfEROwCtLhsjeVAJbFUfE2t6hHd34tPFEdtaxWVsdAvNS164tJJlMYYzfZ0hb7WTJlSGycADAzk/RdUn1WzTWodJabGoTW73SRbW5iRkVmzjHBkQYznn2NAHiN9q7f23rItfEeoyeL4vEkMFlpUeoyMht90PmA227aYthlJYrhdvBBHNS0mstF0fWba21rULO5XxPPHrCrqkzS2mntdufO2FyYgwMeZgASGJ3dTXu9lptppS38lhbMHupmu5lVyTJKQASNxwMhQMcCrNnM9xaQzS28trJIgZoJipeMkfdYqWXI6cEj0JoA8RF5PqN3YadpWvatN4Ym8Ux2tpfQ6hIZJ4DYSvLEtxuLyRiUHDZJyODlQRJfXy6T8S47GLW7zUETUbO3gsIteuUvLZCqhg9tIGW5iJJdpCxYAnn5a9wooAK5X4T/8AJLPBv/YFsv8A0QldVXK/Cf8A5JZ4N/7Atl/6ISgDqqKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArlfGX/Ix+BP+w1J/6bryuqrlfGX/ACMfgT/sNSf+m68oAw/jp4p0fQvAWuabq12LW51XSb2Gz3o22WQQkbNwGAx3DAOM9s11fhTxTo/i2zuLzw/di8s4JjbmdUYIzgAnaSBuA3Dkce/Fcp8fvBL+O/hrqGn2cQk1S3Iu7IcAmVM/Lk/3lLL9SK6H4b+F4fBvgfR9Bg2k2kAWV16PKfmkb8WLGgDzPxPbXep33xZtrfStXk+3QWaW5Onzolx5ShJBG5QBsE8YJyORkDNO8X+CYbeTxdpmj+Hf+JPPa6TNHbw2heKSdbqQSsBggv5YTeeuMFvWvb6KAPFda0h9FuvGcGn+EbS70m4utNiht5dKa4tY4xFh5Vt41zKEbqqc5PtWP4V8LT6ndaRY6voTy6FF4puplgfSZbO2W3OnEqwgkLGOIykjaxxuJXA+6PoKigDxHw94MTSJdIv7DQpbXUIPFl3GJ0t2EiafvuERc4yINmzA+5yCOuaraH8PbKQeCZL7wzumuNUvzqrS2rZeHbcNGs+RzGXWEhW+Unbxzz7vRQB4Jc6ddWujWOh3nhS2udLi1LVkt59Q0GbUxZwi5PkJHDHhlV0PyvuVQqjnpTvCegCC98F33iXw7cT3Y0P7HFdXGkvcvbXSTr5PmfKzRFV5DvgAA/NXvNFAHz/4Z0K5ittFjsdA1Oy8QQabex+I7uazkT7Y7QsNplIxcM0xV1Ks2FB6dKv6toCeBfh94W8UeG9HtrbxHYR28dxC0YjlvTOixPFIx+Zm3sjAE8FMV7jUF3Z214IRd28M4hkWaPzUDbHX7rLnow7EcigDnvD+hf8ACN/D9NLaTzZ4rWRrib/ntO4Lyyf8CdmP414r4U0eK78IaFL4T0C/tZh4SuI9WuRYSwC9kktUEaBmA+0MXyyldwA4BGQK+kXVXRkdQyMMEEZBFR2ltBZ2kNrZwxQW0KLHFFEgVI0AwFUDgAAAACgDx7VPCOmaUngt7nwybjw8IpG1e1t9Pa5aS6MSCGWeFVZ5dv70ZIbaWHTrWb4c8NxWmv8AhPUfFHhm4ubEWl9bWgm01r2WyU3iSWaS7VZkKRbgGOAuSMjmveKKAPn3wf4c1S21rTm1FZl16M3Z1Ga38O3MbXRaKQETXrSmOVCxQqFBOQgAXnBongc6jo8X9u+Hpp5rXwLZW9uLm1bMV0v2nKqCOJVynT5lyOma+gqKAPBLrS7t/FOmXs2jXmq6sf7LLJqOjzkxFUTzHt75WCw7fmZ0kHzMpGDu597oooAK5X4T/wDJLPBv/YFsv/RCV1Vcr8J/+SWeDf8AsC2X/ohKAOqooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACua8aabqt5P4fvNDhsZ7nTNQa7aG8uXgSRGtp4SA6xyEEGYH7vY9K6WigDlft3jj/oXvDf/AIPp/wD5Do+3eOP+he8N/wDg+n/+Q66qigDlft3jj/oXvDf/AIPp/wD5Do+3eOP+he8N/wDg+n/+Q66qigDlft3jj/oXvDf/AIPp/wD5Do+3eOP+he8N/wDg+n/+Q66qigDlft3jj/oXvDf/AIPp/wD5Do+3eOP+he8N/wDg+n/+Q66qigDlft3jj/oXvDf/AIPp/wD5Do+3eOP+he8N/wDg+n/+Q66qigDlft3jj/oXvDf/AIPp/wD5Do+3eOP+he8N/wDg+n/+Q66qigDlft3jj/oXvDf/AIPp/wD5Do+3eOP+he8N/wDg+n/+Q66qigDlft3jj/oXvDf/AIPp/wD5Do+3eOP+he8N/wDg+n/+Q66qigDlft3jj/oXvDf/AIPp/wD5Do+3eOP+he8N/wDg+n/+Q66qigDlft3jj/oXvDf/AIPp/wD5Do+3eOP+he8N/wDg+n/+Q66qigDlft3jj/oXvDf/AIPp/wD5DrQ8EaVPoPgvQNIvHie50/T7e0laIkoXjjVSVJAOMg4yBW1RQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Glucocorticoids may regulate gene expression in several ways. Glucocorticoids enter the cell to bind to glucocorticoid receptors in the cytoplasm. The resultant GR&nbsp;homodimers translocate to the nucleus. GR homodimers then bind to glucocorticoid-response elements (GRE) in the promoter region of steroid-sensitive genes, which may encode anti-inflammatory proteins. Less commonly, GR homodimers interact with negative GREs to suppress genes, particularly those linked to side effects of glucocorticoids. Nuclear GR also interact with coactivator molecules, such as CREB-binding protein (CBP), which is activated by proinflammatory transcription factors, such as nuclear factor-kB (NF-kB), thus switching off the inflammatory genes that are activated by these transcription factors.",
"    <div class=\"footnotes\">",
"     SLPI: secretory leukoprotease inhibitor; MKP-1: mitogen-activated kinase phosphatase-1; IkB-&alpha;: inhibitor of NF-kB; GILZ: glucocorticoid-induced leucine zipper protein; POMC: pro-opiomelanocortin; CRF: corticotrophin-releasing factor; GR: glucocorticoid receptor.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_42_11940=[""].join("\n");
var outline_f11_42_11940=null;
var title_f11_42_11941="Lichen sclerosus perianal";
var content_f11_42_11941=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F62753&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F62753&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Perianal lichen sclerosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 258px; height: 396px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Ridley, CM, Neill, SM (Eds), The Vulva, 2nd ed, Blackwell Science, Oxford 1999. Copyright &copy; 1999 Blackwell Science.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.blackwell-science.com\">",
"      file://www.blackwell-science.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_42_11941=[""].join("\n");
var outline_f11_42_11941=null;
var title_f11_42_11942="Lymphangitis";
var content_f11_42_11942=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Lymphangitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/42/11942/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/42/11942/contributors\">",
"     Denis Spelman, MBBS, FRACP, FRCPA, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/42/11942/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/42/11942/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/42/11942/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/42/11942/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/42/11942/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymphangitis is inflammation of lymphatic channels due to infectious or noninfectious causes. Potential pathogens include bacteria, mycobacteria, viruses, fungi, and parasites. Lymphangitis most commonly develops after cutaneous inoculation of microorganisms into the lymphatic vessels through a skin wound or as a complication of a distal infection.",
"   </p>",
"   <p>",
"    The pathophysiology, clinical manifestations, microbiology, diagnosis, and treatment of lymphangitis will be reviewed here. Further information about the individual etiologies of lymphangitis is discussed in detail separately.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major function of the lymphatic system is to resorb fluid and protein from tissues and extravascular spaces. The absence of a basement membrane beneath lymphatic endothelial cells affords the lymphatic channels a unique permeability, allowing resorption of proteins that are too large to be resorbed by venules.",
"   </p>",
"   <p>",
"    Lymphatic channels are situated in the deep dermis and subdermal tissues parallel to the veins and have a series of valves to ensure one way flow [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/1\">",
"     1",
"    </a>",
"    ]. Lymph drains via afferent lymphatics to regional lymph nodes and then by efferent lymphatics to the cisterna chyli and the thoracic duct into the subclavian vein and venous circulation.",
"   </p>",
"   <p>",
"    Lymphangitis most commonly develops after cutaneous inoculation of microorganisms that invade the lymphatic vessels and spread toward the regional lymph nodes. Organisms may invade lymphatic vessels directly through a skin wound or an abrasion or as a complication of a distal infection.",
"   </p>",
"   <p>",
"    Lymphangitis can occur in the setting of:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Normal lymphatic channels with acute infection &mdash; A virulent infecting organism (such as Streptococcus pyogenes) gains entry to lymphatic channels through a distal skin breach or disruption from local trauma or dermatophyte infection.",
"     </li>",
"     <li>",
"      Damaged lymphatic channels &mdash; Damage to lymphatic channels with obstruction can occur in the setting of surgical procedures, malignancy, radiation, and trauma. In the lower limbs, for example, saphenous vein harvesting for coronary artery bypass surgery can result in damage to and obstruction of lymphatic channels. The same is true in the upper limbs in the setting of radical mastectomy including dissection with removal of axillary lymph nodes [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/2\">",
"       2",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/44/24262?source=see_link\">",
"       \"Recurrent cellulitis after saphenous venectomy for coronary artery bypass graft surgery\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14803?source=see_link\">",
"       \"Cellulitis following pelvic lymph node dissection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Anatomic abnormalities &mdash; Congenital or developmental defects resulting in hypoplastic or hyperplastic changes can result in obstruction of lymphatic channels with complicating secondary lymphangitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/39/1657?source=see_link&amp;anchor=H87257370#H87257370\">",
"       \"Pathophysiology and etiology of edema in children\", section on 'Primary lymphedema'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Lymphatic damage and anatomic abnormalities can result in tissue protein and fluid accumulation, leading to non-pitting lymphedema with induration and predisposing to invasion of microorganisms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS AND MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymphangitis has a spectrum of clinical presentations and etiologies. The clinical manifestations of lymphangitis are variable and may be characterized by erythematous streaks with pain and rapid spread, or by nodular swellings along the course of the lymphatic vessels. A detailed clinical history including epidemiology of occupational or recreational exposure should be combined with careful clinical assessment and collection of targeted clinical specimens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Acute lymphangitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute lymphangitis may occur in the setting of skin abrasion with infection at a distal site, such as interdigital dermatophyte infection or cellulitis of the lower leg. This may be accompanied by lymphangitis with red, tender streaks extending proximally with involvement of regional lymph nodes (lymphadenitis). Acute lymphangitis often occurs in the setting of systemic symptoms including fever.",
"   </p>",
"   <p>",
"    In individuals with normal immunity the most common causative organism is Streptococcus pyogenes; lymphangitis can also occur in the setting of Staphylococcus aureus infection. In immunocompromised patients, gram-negative organisms are also important causes of lymphangitis following lower limb cellulitis.",
"   </p>",
"   <p>",
"    Pasteurella multocida from dog and other animal bites can result in localized infection with concomitant lymphangitis. Lymphangitis also occurs in up to 30 percent of Erysipelothrix infections, a zoonosis occurring in persons in contact with fish and some animals. Cutaneous anthrax can present with extensive edema, regional lymphadenopathy, and lymphangitis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/28/1478?source=see_link\">",
"     \"Erysipelothrix infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7224?source=see_link\">",
"     \"Clinical manifestations and diagnosis of anthrax\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/0/13321?source=see_link\">",
"     \"Pasteurella infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Lymphangitis has been reported as an uncommon manifestation of herpes simplex virus in the setting of limb or genital infection [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/4\">",
"     4",
"    </a>",
"    ]. Lymphogranuloma venereum spreads from the primary site of infection to the draining lymph nodes and may produce a local lymphangitis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/36/21063?source=see_link\">",
"     \"Lymphogranuloma venereum\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Lymphangitis associated Rickettsiosis has been described with the causative organism R. sibirica mongolotimonae and in African tick bite fever due to R. africae [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. The presence of an inoculation eschar suggests tick-transmitted infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28808?source=see_link\">",
"     \"Other spotted fever group rickettsial infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Nodular lymphangitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nodular lymphangitis (also known as sporotrichoid lymphangitis, sporotrichoid spread, or lymphocutaneous syndrome) presents as painful or painless nodular subcutaneous swellings along the course of the lymphatic channels [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Some of the lesions may ulcerate with accompanying regional lymphadenopathy. The incubation period between exposure and the onset of nodular lymphangitis can be prolonged and the presentation may be indolent with few or no systemic symptoms.",
"   </p>",
"   <p>",
"    The epidemiology and appearance of the lesion may point to a specific etiology. Causes of nodular lymphangitis include Sporothrix schenckii, Nocardia (most often N. brasiliensis), M. marinum, leishmaniasis, tularemia, and systemic mycoses [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/9,11,12\">",
"     9,11,12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sporotrichosis has been described in the setting of gardening trauma or injury due to a thorn or wood splinter [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/9\">",
"       9",
"      </a>",
"      ]. It can have an incubation period of up to three months and presents in a cutaneous or a lymphocutaneous form accompanied by lymphangitis; painless ulcers may also be observed. Lesions on the upper limbs are the most common presentation [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/10,11\">",
"       10,11",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12469?source=see_link\">",
"       \"Clinical features and diagnosis of sporotrichosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      M. marinum has been described to cause \"fish tank granuloma,\" an entity that can occur following a hand injury while cleaning a fish tank. It has an incubation period of up to eight weeks [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/9,10\">",
"       9,10",
"      </a>",
"      ]. Infection due to rapidly growing mycobacteria can also occur in the setting of thorn or splinter injury. Other mycobacterial causes of lymphangitis include M. kansasii, M. chelonae, and M. fortuitum. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/60/31687?source=see_link\">",
"       \"Soft tissue infections following water exposure\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nocardia infections may present with cutaneous, subcutaneous, or lymphocutaneous manifestations following traumatic injury. Although this may mimic the appearance and clinical course of acute staphylococcal or streptococcal infection, the clinical course is usually much more indolent [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/12\">",
"       12",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16489?source=see_link\">",
"       \"Clinical manifestations and diagnosis of nocardiosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cutaneous leishmaniasis can present with subcutaneous nodules with lymphangitis or lymphadenitis up to 24 weeks following exposure [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/10\">",
"       10",
"      </a>",
"      ]. This presentation is more frequent with New World leishmaniasis caused by L. braziliensis or L. mexicana than with Old World Leishmaniasis due to L. major or L. tropica [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/9\">",
"       9",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"./clinical-manifestations-and-diagnosis-of-cutaneous-leishmaniasis?source=see_link\">",
"       \"Clinical manifestations and diagnosis of cutaneous leishmaniasis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nodular lymphangitis is a rare manifestation of Francisella tularensis and Burkholderia pseudomallei infection [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/10,13\">",
"       10,13",
"      </a>",
"      ]. The initial skin lesion of F tularensis infection may be a papule or an ulcer or contain an eschar. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30888?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and treatment of tularemia\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/41/39577?source=see_link\">",
"       \"Epidemiology, pathogenesis, clinical manifestations, and diagnosis of melioidosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The systemic mycoses, including coccidioidomycosis, blastomycosis, and histoplasmosis, can present with nodular lymphangitis. This most commonly results from hematogenous dissemination, although primary skin inoculation followed by sporotrichoid spread has also been described [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/9,10\">",
"       9,10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The nature of a distal primary lesion may aid the diagnosis. Painless ulcers may be observed in Sporothrix schenckii, leishmania (with or without satellite lesions), and Franciscella tularensis infection, while tender lesions may due to Nocardia or M. marinum [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/10\">",
"     10",
"    </a>",
"    ]. However, initial lesions may manifest in a variety of forms, and the primary lesion may have healed prior to presentation.",
"   </p>",
"   <p>",
"    In general, the microbiologic diagnosis of nodular lymphangitis generally requires aspiration or biopsy of a nodule for microscopy and culture. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Filarial lymphangitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymphangitis due to filariasis has distinctive clinical manifestations. The presence of the parasite within the lymphatic channels causes inflammation and subsequent dilatation, thickening, tortuosity of the lymphatic channels with valvular incompetence. Filarial lymphangitis often occurs in a retrograde progression with distal or peripheral spread away from the regional lymph nodes where the adult parasite resides. Lymphangitis can also occur as a result of inflammation due to dying parasites. Subsequent lymphedema with thickening of skin and subcutaneous tissue can predispose to repeated episodes secondary bacterial infection [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Wuchereria bancrofti, B. malayi, and B. timori are the causes of lymphangitis due to lymphatic filariasis. Filarial lymphangitis is uncommon in short-term travelers but may be considered in individuals who have spent prolonged periods in endemic areas. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/25/13719?source=see_link\">",
"     \"Epidemiology, pathogenesis, and clinical manifestations of lymphatic filariasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Lymphangitis at non-peripheral sites",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to involvement of distal extremities, lymphangitis can also present at non peripheral sites. Examples include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mycobacterium tuberculosis can penetrate the ileocecal mucosa to reach the lymphoid tissue, which may generate an inflammatory response with lymphangitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/53/43862?source=see_link\">",
"       \"Tuberculous enteritis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Filariasis can present with genital lymphatic involvement of the testes, scrotum, and epididymis, as well as involvement of the renal lymphatics resulting in discharge of intestinal lymph into the urine (chyluria). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/25/13719?source=see_link\">",
"       \"Epidemiology, pathogenesis, and clinical manifestations of lymphatic filariasis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Recurrent episodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent episodes of lymphangitis should prompt evaluation for epidemiological clues as outlined above. In addition, evaluation for predisposing conditions such as history of damage to lymphatic channels or developmental defects should be pursued. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Pathophysiology'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/52/1866?source=see_link&amp;anchor=H6#H6\">",
"     \"Clinical manifestations and diagnosis of lymphedema\", section on 'Primary lymphedema'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Noninfectious causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammation of the lymph vessels can occur in the setting of malignancy (known as neoplastic lymphangitis or lymphangitis carcinomatosa). Breast, lung, stomach, pancreas, and prostate cancers are the most common tumors that result in lymphangitis; lymphangitic spread of lymphoma has also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other underlying disease that can cause lymphangitis include Crohn's disease (granulomatous intestinal lymphangitis) and sclerosing lymphangitis of the penis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. Lymphangitis has also been described following tuberculin skin testing [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;An etiological diagnosis of lymphangitis is made on the basis of epidemiology, clinical features, and laboratory analysis of clinical specimens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Microbiological investigations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Detailed information on diagnostic investigations for each etiology is discussed in detail separately. In general, diagnostic evaluation may include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Swab, aspirate,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      biopsy of the primary site, nodule, or distal ulcer for histology and microscopy (including gram, fungal and acid fast staining), as well as culture (including bacterial, fungal, and mycobacterial cultures). Cultures may require prolonged incubation for identification of nocardia.",
"     </li>",
"     <li>",
"      Serology (eg, F. tularensis, Histoplasma)",
"     </li>",
"     <li>",
"      Blood film (eg, filaria)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Imaging may be helpful for defining anatomic abnormalities such as dilated and tortuous lymphatics, although it is rarely useful for the diagnosis of infectious etiologies. Lymphangiography (using dye injection into the lymphatics) and lymphoscintigraphy (using intradermal technetium injection at distal site of affected limb) have been used to evaluate for lymphedema",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lymphatic obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/22\">",
"     22",
"    </a>",
"    ]. This may be useful if surgical management of lymphedema is a consideration [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/1/33817?source=see_link\">",
"     \"Prevention and treatment of lymphedema\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific therapies for individual infections are discussed in detail separately. Some cases of nodular lymphangitis require surgical debridement. In the setting of lymphedema with significant lymphatic obstruction, surgical intervention may also be appropriate [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11942/abstract/23\">",
"     23",
"    </a>",
"    ]. Pending diagnostic evaluation, empiric antibiotic therapy with activity against skin flora may be initiated as outlined in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12825?source=see_link\">",
"     \"Cellulitis and erysipelas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lymphangitis is inflammation of lymphatic channels and most commonly develops after cutaneous inoculation of microorganisms into the lymphatic vessels through a skin wound or an abrasion or as a complication of a distal infection. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lymphangitis can occur in the setting of normal lymphatic channels with acute infection, damaged lymphatic channels, or anatomic abnormalities. Lymphatic damage and anatomic abnormalities can result in tissue protein and fluid accumulation, leading to non-pitting lymphedema with induration and predisposing to invasion of microorganisms. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical manifestations of lymphangitis are variable and may be characterized by erythematous streaks with pain and rapid spread, or by nodular swellings along the course of the lymphatic vessels. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical manifestations and microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The causes of acute lymphangitis include Streptococcus pyogenes; Staphylococcus aureus and gram-negative organisms. Animal exposure can confer risk for lymphangitis due to Pasteurella, Erysipelothrix, and anthrax. Additional causes include herpes simplex virus, lymphogranuloma venereum, and rickettsiae. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Acute lymphangitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The causes of nodular lymphangitis include Sporothrix schenckii, Nocardia (most often N. brasiliensis), M. marinum, leishmaniasis, tularemia, Burkholderia pseudomallei, and systemic mycoses. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Nodular lymphangitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory evaluation for lymphangitis may include swab, aspirate",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      biopsy of the primary site, nodule, or distal ulcer for histology, microscopy (including gram, fungal and acid fast staining), and culture (including bacterial, fungal and mycobacterial cultures). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Microbiological investigations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of lymphangitis includes targeted medical therapy. Some cases of nodular lymphangitis may require surgical debridement. In the setting of lymphedema with significant lymphatic obstruction, surgical intervention may also be appropriate. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/1\">",
"      Suami H, Taylor GI, Pan WR. The lymphatic territories of the upper limb: anatomical study and clinical implications. Plast Reconstr Surg 2007; 119:1813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/2\">",
"      Simon MS, Cody RL. Cellulitis after axillary lymph node dissection for carcinoma of the breast. Am J Med 1992; 93:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/3\">",
"      Wenner KA, Kenner JR. Anthrax. Dermatol Clin 2004; 22:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/4\">",
"      Sands M, Brown R. Herpes simplex lymphangitis. Two cases and a review of the literature. Arch Intern Med 1988; 148:2066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/5\">",
"      Mabey D, Peeling RW. Lymphogranuloma venereum. Sex Transm Infect 2002; 78:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/6\">",
"      Fournier PE, Gouriet F, Brouqui P, et al. Lymphangitis-associated rickettsiosis, a new rickettsiosis caused by Rickettsia sibirica mongolotimonae: seven new cases and review of the literature. Clin Infect Dis 2005; 40:1435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/7\">",
"      de Sousa R, Duque L, Anes M, et al. Lymphangitis in a Portuguese patient infected with Rickettsia sibirica. Emerg Infect Dis 2008; 14:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/8\">",
"      Roch N, Epaulard O, Pelloux I, et al. African tick bite fever in elderly patients: 8 cases in French tourists returning from South Africa. Clin Infect Dis 2008; 47:e28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/9\">",
"      Smego RA Jr, Castiglia M, Asperilla MO. Lymphocutaneous syndrome. A review of non-sporothrix causes. Medicine (Baltimore) 1999; 78:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/10\">",
"      Kostman JR, DiNubile MJ. Nodular lymphangitis: a distinctive but often unrecognized syndrome. Ann Intern Med 1993; 118:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/11\">",
"      Schubach A, Barros MB, Wanke B. Epidemic sporotrichosis. Curr Opin Infect Dis 2008; 21:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/12\">",
"      Beaman BL, Beaman L. Nocardia species: host-parasite relationships. Clin Microbiol Rev 1994; 7:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/13\">",
"      Capellan J, Fong IW. Tularemia from a cat bite: case report and review of feline-associated tularemia. Clin Infect Dis 1993; 16:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/14\">",
"      Taylor MJ, Cross HF, Ford L, et al. Wolbachia bacteria in filarial immunity and disease. Parasite Immunol 2001; 23:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/15\">",
"      Pani SP, Yuvaraj J, Vanamail P, et al. Episodic adenolymphangitis and lymphoedema in patients with bancroftian filariasis. Trans R Soc Trop Med Hyg 1995; 89:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/16\">",
"      Wu JW, Chiles C. Lymphangitic carcinomatosis from prostate carcinoma. J Comput Assist Tomogr 1999; 23:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/17\">",
"      Kohmo S, Tachibana I, Osaki T, et al. Multiple organ mucosa-associated lymphoid tissue lymphoma presenting with lymphangitic pattern of spread in the lung. J Thorac Oncol 2007; 2:1057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/18\">",
"      Murphy MJ, Kogan B, Carlson JA. Granulomatous lymphangitis of the scrotum and penis. Report of a case and review of the literature of genital swelling with sarcoidal granulomatous inflammation. J Cutan Pathol 2001; 28:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/19\">",
"      Van Kruiningen HJ, Colombel JF. The forgotten role of lymphangitis in Crohn's disease. Gut 2008; 57:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/20\">",
"      Rosen T, Hwong H. Sclerosing lymphangitis of the penis. J Am Acad Dermatol 2003; 49:916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/21\">",
"      Morrison JB. Lymphangitis after tuberculin tests. Br Med J (Clin Res Ed) 1984; 289:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/22\">",
"      Lohrmann C, Foeldi E, Bartholom&auml; JP, Langer M. Interstitial MR lymphangiography - a diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema. Acta Trop 2007; 104:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11942/abstract/23\">",
"      Garfein ES, Borud LJ, Warren AG, Slavin SA. Learning from a lymphedema clinic: an algorithm for the management of localized swelling. Plast Reconstr Surg 2008; 121:521.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2741 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-08BE826B45-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_42_11942=[""].join("\n");
var outline_f11_42_11942=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL MANIFESTATIONS AND MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Acute lymphangitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Nodular lymphangitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Filarial lymphangitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Lymphangitis at non-peripheral sites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Recurrent episodes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Noninfectious causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Microbiological investigations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12825?source=related_link\">",
"      Cellulitis and erysipelas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14803?source=related_link\">",
"      Cellulitis following pelvic lymph node dissection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12469?source=related_link\">",
"      Clinical features and diagnosis of sporotrichosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7224?source=related_link\">",
"      Clinical manifestations and diagnosis of anthrax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"./clinical-manifestations-and-diagnosis-of-cutaneous-leishmaniasis?source=related_link\">",
"      Clinical manifestations and diagnosis of cutaneous leishmaniasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/52/1866?source=related_link\">",
"      Clinical manifestations and diagnosis of lymphedema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16489?source=related_link\">",
"      Clinical manifestations and diagnosis of nocardiosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30888?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of tularemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/25/13719?source=related_link\">",
"      Epidemiology, pathogenesis, and clinical manifestations of lymphatic filariasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/41/39577?source=related_link\">",
"      Epidemiology, pathogenesis, clinical manifestations, and diagnosis of melioidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/28/1478?source=related_link\">",
"      Erysipelothrix infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/36/21063?source=related_link\">",
"      Lymphogranuloma venereum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28808?source=related_link\">",
"      Other spotted fever group rickettsial infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/0/13321?source=related_link\">",
"      Pasteurella infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/39/1657?source=related_link\">",
"      Pathophysiology and etiology of edema in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/1/33817?source=related_link\">",
"      Prevention and treatment of lymphedema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/44/24262?source=related_link\">",
"      Recurrent cellulitis after saphenous venectomy for coronary artery bypass graft surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/60/31687?source=related_link\">",
"      Soft tissue infections following water exposure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/53/43862?source=related_link\">",
"      Tuberculous enteritis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_42_11943="Clinical features and diagnosis of allergic contact dermatitis";
var content_f11_42_11943=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features and diagnosis of allergic contact dermatitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/42/11943/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/42/11943/contributors\">",
"     James Yiannias, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/42/11943/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/42/11943/contributors\">",
"     Joseph Fowler, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/42/11943/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/42/11943/contributors\">",
"     Rosamaria Corona, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/42/11943/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H27385235\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergic contact dermatitis (ACD) is the classic presentation of a T cell-mediated, delayed-type hypersensitivity response to exogenous agents [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/1\">",
"     1",
"    </a>",
"    ]. The words &ldquo;dermatitis&rdquo; and &ldquo;eczema&rdquo; are often used interchangeably to describe a pattern of inflammation of the skin characterized acutely by erythema, vesiculation and pruritus. Chronic exposure typically leads to moderation of the erythema accompanied by lichenification and persistence of itch. The clinical presentation may vary depending upon the triggering agent and individual&rsquo;s reactivity, but in most cases the lesions are primarily confined to the site of contact [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will discuss the clinical presentation, diagnosis, and differential diagnosis of ACD. The pathophysiology, patch testing for, and management of ACD are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7223?source=see_link\">",
"     \"Basic mechanisms and pathophysiology of allergic contact dermatitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/31/28150?source=see_link\">",
"     \"Patch testing\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32758?source=see_link\">",
"     \"Management of allergic contact dermatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27385242\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY AND RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence and prevalence of allergic contact dermatitis in the general population are not known. Data are often extrapolated from surveillance studies on occupational dermatitis. In industrialized nations, up to 30 percent of all occupational diseases involve the skin. Irritant and contact dermatitis account for more than 90 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surveillance studies have reported an annual incidence of contact dermatitis (including irritant and allergic contact dermatitis) of 13 to 34 cases per 100,000 workers [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. The agents most frequently implicated included latex materials, protective equipments, soap and cleansers, resins, and acrylics. Information on the main allergens responsible for contact dermatitis in the general population is derived from retrospective studies of patch testing referral centers. In one study, metals, fragrances, topical antibiotics, preservatives, chemicals used in hair-care products, topical corticosteroids, glues, plastics, and rubber were the most common allergen groups associated with positive patch test reaction [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/7\">",
"     7",
"    </a>",
"    ]. Among children, nickel sulfate, ammonium persulfate, gold",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/18/17700?source=see_link\">",
"     sodium thiosulfate",
"    </a>",
"    , thimerosal, and toluene-2,5-diamine (p-toluenediamine) are the most common sensitizers [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Multiple studies from around the world indicate that of patients presenting for patch testing, 20 up to 40 percent will be allergic to nickel [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/9-14\">",
"     9-14",
"    </a>",
"    ]. In North America, the most common cause of ACD is from contact with poison ivy, oak, and sumac. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/44/20168?source=see_link\">",
"     \"Poison ivy (Toxicodendron) dermatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Risk factors for allergic contact dermatitis include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Occupation &ndash;",
"      </strong>",
"      Workers at highest risk of ACD include health professionals, chemical industry workers, beauticians and hairdressers, machinists, and construction workers.",
"     </li>",
"     <li>",
"      <strong>",
"       Age",
"      </strong>",
"      &ndash; ACD was once considered a disorder of the adult population. Children were thought to be spared because of a low exposure to potential allergens and an immature immune system. However, it is now recognized that contact sensitization begins in early childhood via exposures such as vaccinations, piercing, topical medications, and cosmetics [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/15,16\">",
"       15,16",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/31/26104?source=see_link&amp;anchor=H9#H9\">",
"       \"Contact dermatitis in children\", section on 'Allergic contact dermatitis'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The incidence of ACD increases with age. Repetitive and prolonged exposure to potential sensitizers may account for the high rate of ACD in the elderly. Medical comorbidities, including stasis dermatitis and venous ulcerations, are contributing factors [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/17\">",
"       17",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/38/29288?source=see_link\">",
"       \"Stasis dermatitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       History of atopic dermatitis",
"      </strong>",
"      &ndash; The role of atopy in ACD is controversial, although several studies report a high rate of positive patch tests among atopic individuals [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/18-22\">",
"       18-22",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27385267\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27385276\">",
"    <span class=\"h2\">",
"     Lesion morphology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute ACD lesions consist of erythematous, indurated, scaly plaques (",
"    <a class=\"graphic graphic_picture graphicRef51066 graphicRef70989 graphicRef51220 \" href=\"UTD.htm?30/46/31466\">",
"     picture 1A-C",
"    </a>",
"    ). Vesiculation and bullae may be seen in severe cases (",
"    <a class=\"graphic graphic_picture graphicRef74631 \" href=\"UTD.htm?29/19/30005\">",
"     picture 2",
"    </a>",
"    ). Edema may be prominent in areas in which the skin is thin, such as the eyelids, lips and genitalia (",
"    <a class=\"graphic graphic_picture graphicRef72864 \" href=\"UTD.htm?11/54/12131\">",
"     picture 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Repeated or continued exposure to allergens results in chronic disease. The skin becomes dry, scaly and thicker as a result of acanthosis, hyperkeratosis, edema, and cellular infiltration in the dermis (",
"    <a class=\"graphic graphic_picture graphicRef69623 \" href=\"UTD.htm?3/17/3348\">",
"     picture 4",
"    </a>",
"    ). Lichenification and fissuring may develop later [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/23\">",
"     23",
"    </a>",
"    ]. Secondary changes include excoriation or impetiginization (",
"    <a class=\"graphic graphic_picture graphicRef73185 \" href=\"UTD.htm?40/24/41351\">",
"     picture 5",
"    </a>",
"    ). Subacute dermatitis has a mixture of both acute and chronic features [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8829787\">",
"    <span class=\"h2\">",
"     Lesion distribution",
"    </span>",
"    &nbsp;&mdash;&nbsp;ACD is typically localized to the skin areas that come in contact with the allergen (",
"    <a class=\"graphic graphic_picture graphicRef77613 graphicRef70264 graphicRef60422 \" href=\"UTD.htm?14/28/14794\">",
"     picture 6A-C",
"    </a>",
"    ). However, patchy or diffuse distributions may occur, depending upon the nature of the allergen or secondary transfer of the allergen from the primary site of contact to distant skin areas.",
"   </p>",
"   <p>",
"    The involvement of hands, face, or eyelids, which most commonly come in contact with the environment, occurs most frequently in ACD.",
"   </p>",
"   <p>",
"    Allergens applied to the scalp, including hair dyes and shampoos, may elicit dermatitis in adjacent areas, such as the neck, retroauricular folds or eyelids (",
"    <a class=\"graphic graphic_picture graphicRef51066 \" href=\"UTD.htm?24/1/24596\">",
"     picture 1A",
"    </a>",
"    ). Facial lesions may result from direct contact with cosmetic products or tools or from involuntary transfer of allergens to the face (eg, eyelid ACD from nail polish). A pendant-like distribution of lesions (",
"    <em>",
"     berloque",
"    </em>",
"    dermatitis) in the neck and chest suggest a reaction to fragrances in perfumes and lotions (",
"    <a class=\"graphic graphic_picture graphicRef81457 graphicRef68245 \" href=\"UTD.htm?21/53/22359\">",
"     picture 7A-B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A diffuse or patchy dermatitis of the trunk, often with accentuation in the axillary folds, may be caused by cloth dyes or textiles. Rubber components may induce ACD at the site of contact with elastic waistbands (",
"    <a class=\"graphic graphic_picture graphicRef81309 \" href=\"UTD.htm?17/8/17537\">",
"     picture 8",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Occupational ACD frequently involves the hands and requires a careful ascertainment of occupation-specific exposures. Dermatitis involving the dorsal aspect of the foot suggests ACD related to shoe chemicals (eg, rubber accelerators or potassium dichromate) (",
"    <a class=\"graphic graphic_picture graphicRef51220 \" href=\"UTD.htm?1/55/1910\">",
"     picture 1C",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Periorificial ACD may be induced by fragrances, detergents, or preservatives in hygiene products, including moist wipes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/25\">",
"     25",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27385283\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The dominant symptom of ACD is itch. However, ACD may cause a variety of other symptoms, including burning, stinging or pain [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3204593\">",
"    <span class=\"h1\">",
"     DISEASE COURSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;If left untreated, ACD can evolve from an acute form to a subacute and then chronic eczematous dermatitis. Chronic dermatitis can negatively impact an individual&rsquo;s health related quality of life, particularly in social functioning and psychological well-being [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/27,28\">",
"     27,28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27385290\">",
"    <span class=\"h1\">",
"     HISTOPATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The histology of ACD mirrors the clinical picture. In acute ACD, the epidermis is of normal thickness and spongiosis (intercellular edema leading to the disruption of intercellular adhesion and formation of vesicles) is the dominant feature (",
"    <a class=\"graphic graphic_picture graphicRef57868 \" href=\"UTD.htm?33/30/34281\">",
"     picture 9",
"    </a>",
"    ). An additional feature is the exocytosis of lymphocytes and eosinophils into spongiotic foci. The upper dermis contains an infiltrate of lymphocytes, histiocytes, and eosinophils, with perivascular accentuation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/29\">",
"     29",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    In subacute ACD, there are mild to moderate spongiosis, moderate acanthosis (epidermal hyperplasia from increased mitotic activity of keratinocytes), and a denser dermal lymphohistiocytic infiltrate. Chronic lesions may show prominent epidermal acanthosis with hyperkeratosis and areas of parakeratosis. Spongiosis may be present focally, but often is minimal. The inflammatory infiltrate is sparse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1646554\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of ACD is based upon a combination of:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Clinical features (morphology, location, and symptoms) of the eruption",
"     </li>",
"     <li>",
"      History of exposure to a putative allergen during work, hobbies, or home activities",
"     </li>",
"     <li>",
"      Patch testing results",
"     </li>",
"     <li>",
"      Laboratory tests",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      histopathologic examination",
"     </li>",
"     <li>",
"      Lack of recurrence after empirical treatment of the dermatitis and avoidance of the suspected allergen",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8451683\">",
"    <span class=\"h2\">",
"     Clues from clinical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The morphology, regional distribution, and temporal course of dermatitis frequently suggest the diagnosis of ACD. (See",
"    <a class=\"local\" href=\"#H27385276\">",
"     'Lesion morphology'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H8829787\">",
"     'Lesion distribution'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The typical appearance of ACD is a well-demarcated, pruritic, eczematous eruption localized to the area of skin that comes in contact with the allergen (",
"    <a class=\"graphic graphic_picture graphicRef51066 graphicRef70989 graphicRef51220 \" href=\"UTD.htm?30/46/31466\">",
"     picture 1A-C",
"    </a>",
"    ). The eruption may be acute, with vesiculation and weeping, or chronic (lichenified or scaly plaques).",
"   </p>",
"   <p>",
"    The eruption may not remain anatomically limited to the initial site of contact. For example, a patient with a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/57/14229?source=see_link\">",
"     neomycin",
"    </a>",
"    contact allergy may exhibit a modest eruption at the site of application on the torso and a diffuse, concomitant dermatitis of the face due to passive transfer of the allergenic ointment to the face. Body washes or shampoos, or cloth dyes and textiles may cause a patchy or diffuse dermatitis.",
"   </p>",
"   <p>",
"    Less commonly, ACD may present with a photosensitivity reaction: the eruption is limited to photo-exposed skin areas and follows the application of sunscreens, fragrances, or topical NSAIDs (",
"    <a class=\"graphic graphic_picture graphicRef63557 \" href=\"UTD.htm?7/46/7907\">",
"     picture 10",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/63/18426?source=see_link&amp;anchor=H25#H25\">",
"     \"Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment\", section on 'Photoallergy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H111504337\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;A comprehensive multi-year history is helpful for the diagnosis of ACD (",
"    <a class=\"graphic graphic_table graphicRef65321 \" href=\"UTD.htm?10/43/10939\">",
"     table 1",
"    </a>",
"    ). The source of contact with allergens may be identified by reviewing the patient&rsquo;s activities, including occupation and hobbies. Products and objects for personal use, including prescription or over-the-counter topical preparations, cosmetics and toiletries, hair dyes, fragrances, eyeglasses, gloves, and clothing should be reviewed. A patient's recall may not be complete and revisiting the history after obtaining the results of patch testing may be useful.",
"   </p>",
"   <p>",
"    A history of long term exposure to an allergen does not rule out contact allergy, since multiple exposures are typically necessary for sensitization and dermatitis to occur. In addition, an individual&rsquo;s susceptibility to ACD may change over time because of aging, customs, or comorbidities (eg, stasis dermatitis and leg ulcers) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/24\">",
"     24",
"    </a>",
"    ]. Infrequently, sensitization may occur after a single exposure.",
"   </p>",
"   <p>",
"    Health professionals, chemical industry workers, beauticians and hairdressers, machinists, and construction workers have an increased risk of developing occupational ACD [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/30\">",
"     30",
"    </a>",
"    ]. However, exposure to common industrial allergens, including cements, glues, plasters, and solvents, may also occur at home.",
"   </p>",
"   <p>",
"    A history of improvement during weekends or holidays suggests an occupational origin, whereas worsening during weekends or holidays suggests recreational exposure to allergens. A seasonal variation may indicate photo-aggravation or photoallergy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/63/18426?source=see_link&amp;anchor=H25#H25\">",
"     \"Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment\", section on 'Photoallergy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A previous history of contact dermatitis may provide a clue to the origin of a relapse. For example, earring dermatitis may precede nickel dermatitis of the hands by several years.",
"   </p>",
"   <p>",
"    Patients with ACD often report a history of atopy (childhood flexural eczema, asthma, hay fever, or conjunctivitis).",
"   </p>",
"   <p>",
"    A detailed history questionnaire which can help capture a thorough ACD history is available at",
"    <a class=\"external\" href=\"file://www.truetest.ca/PDFs/CD_questionnaire.pdf\">",
"     file://www.truetest.ca/PDFs/CD_questionnaire.pdf",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8451814\">",
"    <span class=\"h2\">",
"     Patch testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patch testing is an essential investigation in patients with persistent eczematous eruptions when contact allergy is suspected or cannot be ruled out [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/31\">",
"     31",
"    </a>",
"    ]. Patch testing may help to identify allergens that should be avoided and is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/31/28150?source=see_link\">",
"     \"Patch testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H48321080\">",
"    <span class=\"h2\">",
"     Laboratory tests and biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory tests are not routinely necessary in the evaluation of patients for ACD, but may be helpful in excluding other disorders with similar clinical features. For example, a KOH examination of scale from the eruption or swab cultures may rule out a fungal or bacterial infection [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The evaluation of the general health status, including CBC, liver, kidney, and thyroid function tests, should be performed in patients presenting with a widespread, recalcitrant dermatitis.",
"   </p>",
"   <p>",
"    Histologic examination on itself may provide little help in differentiating ACD from other eczematous dermatitides (including ICD, atopic, nummular, dyshidrotic, and seborrheic dermatitis), since all present eosinophilic spongiosis as the key feature. However, histologic examination may be helpful when the diagnosis is not clear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1042995662\">",
"    <span class=\"h2\">",
"     Response to empiric therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the possible offending allergen is identified on the basis of clinical features and history, response to empiric therapy may avoid the need for patch testing. Improvement or resolution of the dermatitis with allergen avoidance and empiric treatment supports the diagnosis of ACD [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32758?source=see_link&amp;anchor=H1039422426#H1039422426\">",
"     \"Management of allergic contact dermatitis\", section on 'Treatment approach'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3204492\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1646445\">",
"    <span class=\"h2\">",
"     Clinical",
"    </span>",
"    &nbsp;&mdash;&nbsp;ACD can mimic or complicate other types of eczema and other dermatoses as listed in the table (",
"    <a class=\"graphic graphic_table graphicRef50914 \" href=\"UTD.htm?5/1/5149\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef63945 graphicRef55722 graphicRef60650 \" href=\"UTD.htm?20/2/20522\">",
"     picture 11A-C",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Differentiating ACD from irritant contact dermatitis (ICD) is particularly difficult, since they have a similar clinical and histopathologic morphology [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/34\">",
"     34",
"    </a>",
"    ]. Patch testing may be useful to confirm the diagnosis of ACD. There is no specific test for the diagnosis of ICD. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/20/29001?source=see_link\">",
"     \"Irritant contact dermatitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10326699\">",
"    <span class=\"h2\">",
"     Histopathologic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eosinophilic spongiosis and exocytosis of eosinophils and lymphocytes are the key features of ACD and other eczematous dermatitides, but may be seen also in other skin diseases.",
"   </p>",
"   <p>",
"    For example, eosinophilic spongiosis may be the only histologic feature in the early, urticarial phase of bullous pemphigoid [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11943/abstract/35\">",
"     35",
"    </a>",
"    ]. Direct immunofluorescence staining and measurement of circulating anti-BP antibodies will differentiate ACD from bullous pemphigoid.",
"   </p>",
"   <p>",
"    Early, patch stage mycosis fungoides (MF) may be difficult to differentiate from subacute or chronic ACD. Both diseases show minimal or no spongiosis and lymphocytic exocytosis. However, in MF lymphocytic exocytosis is more prominent, lymphocytes may have atypical features (hyperchromatic, cerebriform nuclei), and clusters of atypical lymphocytes (Pautrier microabscesses) may be seen in the epidermis (",
"    <a class=\"graphic graphic_picture graphicRef61650 \" href=\"UTD.htm?39/13/40150\">",
"     picture 12",
"    </a>",
"    ). &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H48321072\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Allergic contact dermatitis (ACD) is a T cell-mediated, delayed-type hypersensitivity response to exogenous agents. Contact allergens may be found at home or in the workplace and may include metals, glues, plastics, rubber, fragrances, topical antibiotics, preservatives, and chemicals used in hair-care and cosmetic products. (See",
"      <a class=\"local\" href=\"#H27385235\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H27385242\">",
"       'Epidemiology and risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute ACD lesions consist of pruritic, erythematous, indurated, scaly plaques (",
"      <a class=\"graphic graphic_picture graphicRef51066 graphicRef70989 graphicRef51220 \" href=\"UTD.htm?30/46/31466\">",
"       picture 1A-C",
"      </a>",
"      ). Vesiculation and bullae may be seen in severe cases (",
"      <a class=\"graphic graphic_picture graphicRef74631 \" href=\"UTD.htm?29/19/30005\">",
"       picture 2",
"      </a>",
"      ). Edema of the eyelids, lips, and genitalia may be prominent (",
"      <a class=\"graphic graphic_picture graphicRef72864 \" href=\"UTD.htm?11/54/12131\">",
"       picture 3",
"      </a>",
"      ). In chronic ACD, the skin is dry, scaly and thicker. Lesions are typically localized in the skin areas that come in contact with the allergen (",
"      <a class=\"graphic graphic_picture graphicRef77613 graphicRef70264 \" href=\"UTD.htm?30/0/30728\">",
"       picture 6A-B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H27385276\">",
"       'Lesion morphology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8829787\">",
"       'Lesion distribution'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The source of contact allergens can be identified through a detailed review of the patient&rsquo;s exposures at home and in the workplace (",
"      <a class=\"graphic graphic_table graphicRef65321 \" href=\"UTD.htm?10/43/10939\">",
"       table 1",
"      </a>",
"      ). A detailed history questionnaire is available at",
"      <a class=\"external\" href=\"file://www.truetest.ca/PDFs/CD_questionnaire.pdf\">",
"       file://www.truetest.ca/PDFs/CD_questionnaire.pdf",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H111504337\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical diagnosis of ACD is based upon the lesion morphology and distribution. The involvement of hands, feet, eyelids, and lips, which most commonly come in contact with the environment, suggest the diagnosis of ACD. However, patch testing may be required to confirm the diagnosis and differentiate ACD from other types of eczematous dermatitis (",
"      <a class=\"graphic graphic_table graphicRef50914 \" href=\"UTD.htm?5/1/5149\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1646554\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/31/28150?source=see_link\">",
"       \"Patch testing\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H3204492\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Pathogenesis of Allergic Contact Hypersensitivity. In: Fisher's Contact Dermatitis, 6th ed, Rietschel RL, Fowler JF Jr (Eds), BC Decker Inc, Hamilton, ON 2008. p.1.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/2\">",
"      Krasteva M, Kehren J, Sayag M, et al. Contact dermatitis II. Clinical aspects and diagnosis. Eur J Dermatol 1999; 9:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/3\">",
"      Clark SC, Zirwas MJ. Management of occupational dermatitis. Dermatol Clin 2009; 27:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/4\">",
"      Meyer JD, Chen Y, Holt DL, et al. Occupational contact dermatitis in the UK: a surveillance report from EPIDERM and OPRA. Occup Med (Lond) 2000; 50:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/5\">",
"      Turner S, Carder M, van Tongeren M, et al. The incidence of occupational skin disease as reported to The Health and Occupation Reporting (THOR) network between 2002 and 2005. Br J Dermatol 2007; 157:713.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.bls.gov/news.release/archives/osh_10212010.pdf (Accessed on August 22, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/7\">",
"      Davis MD, Scalf LA, Yiannias JA, et al. Changing trends and allergens in the patch test standard series: a mayo clinic 5-year retrospective review, january 1, 2001, through december 31, 2005. Arch Dermatol 2008; 144:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/8\">",
"      Bonitsis NG, Tatsioni A, Bassioukas K, Ioannidis JP. Allergens responsible for allergic contact dermatitis among children: a systematic review and meta-analysis. Contact Dermatitis 2011; 64:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/9\">",
"      Aguilar-Bernier M, Bernal-Ruiz AI, Rivas-Ruiz F, et al. [Contact sensitization to allergens in the Spanish standard series at Hospital Costa del Sol in Marbella, Spain: a retrospective study (2005-2010)]. Actas Dermosifiliogr 2012; 103:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/10\">",
"      Zug KA, Warshaw EM, Fowler JF Jr, et al. Patch-test results of the North American Contact Dermatitis Group 2005-2006. Dermatitis 2009; 20:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/11\">",
"      Nonaka H, Nakada T, Iijima M, Maibach HI. Metal patch test results from 1990-2009. J Dermatol 2011; 38:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/12\">",
"      Yin R, Huang XY, Zhou XF, Hao F. A retrospective study of patch tests in Chongqing, China from 2004 to 2009. Contact Dermatitis 2011; 65:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/13\">",
"      Car&oslash;e C, Andersen KE, Mortz CG. Fluctuations in the prevalence of nickel and cobalt allergy in eczema patients patch tested after implementation of the nickel regulation in Denmark. Contact Dermatitis 2011; 64:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/14\">",
"      Uter W, R&auml;msch C, Aberer W, et al. The European baseline series in 10 European Countries, 2005/2006--results of the European Surveillance System on Contact Allergies (ESSCA). Contact Dermatitis 2009; 61:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/15\">",
"      Sharma VK, Asati DP. Pediatric contact dermatitis. Indian J Dermatol Venereol Leprol 2010; 76:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/16\">",
"      Simonsen AB, Deleuran M, Johansen JD, Sommerlund M. Contact allergy and allergic contact dermatitis in children - a review of current data. Contact Dermatitis 2011; 65:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/17\">",
"      Prakash AV, Davis MD. Contact dermatitis in older adults: a review of the literature. Am J Clin Dermatol 2010; 11:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/18\">",
"      de Groot AC. The frequency of contact allergy in atopic patients with dermatitis. Contact Dermatitis 1990; 22:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/19\">",
"      Giordano-Labadie F, Ranc&eacute; F, Pellegrin F, et al. Frequency of contact allergy in children with atopic dermatitis: results of a prospective study of 137 cases. Contact Dermatitis 1999; 40:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/20\">",
"      Czarnobilska E, Obtulowicz K, Dyga W, et al. Contact hypersensitivity and allergic contact dermatitis among school children and teenagers with eczema. Contact Dermatitis 2009; 60:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/21\">",
"      Belhadjali H, Mohamed M, Youssef M, et al. Contact sensitization in atopic dermatitis: results of a prospective study of 89 cases in Tunisia. Contact Dermatitis 2008; 58:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/22\">",
"      Thyssen JP, Linneberg A, Engkilde K, et al. Contact sensitization to common haptens is associated with atopic dermatitis: new insight. Br J Dermatol 2012; 166:1255.",
"     </a>",
"    </li>",
"    <li>",
"     Beck MH and Wilkinson SM. Contact Dermatitis: Allergic. In: Rook's Textbook of Dermatology, Eighth Edition, Burns T, BreathnachS, Cox N, Griffiths C.  (Eds), Wiley-Blackwell, Oxford, UK 2010. Vol II.",
"    </li>",
"    <li>",
"     Cohen DE, Jacob SE. Allergic contact dermatitis. In: Fitzpatrick's Dermatology in General Medicine, 7th ed, Wolff K, Goldsmith LA, Katz SI, et al (Eds), McGraw-Hill Professional, 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/25\">",
"      Gardner KH, Davis MD, Richardson DM, Pittelkow MR. The hazards of moist toilet paper: allergy to the preservative methylchloroisothiazolinone/methylisothiazolinone. Arch Dermatol 2010; 146:886.",
"     </a>",
"    </li>",
"    <li>",
"     Regional contact dermatitis. In: Fisher's Contact Dermatitis, 6th ed, Rietschel RL, Fowler JF Jr (Eds), BC Decker I, Hamilton, ON 2008. p.66.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/27\">",
"      Kiebert G, Sorensen SV, Revicki D, et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol 2002; 41:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/28\">",
"      Hutchings CV, Shum KW, Gawkrodger DJ. Occupational contact dermatitis has an appreciable impact on quality of life. Contact Dermatitis 2001; 45:17.",
"     </a>",
"    </li>",
"    <li>",
"     Lever's Histopathology of the Skin, 10th ed, Elder DE, Elenitsas R, Johnson BL Jr, et al (Eds), Lippincott Williams &amp; W, Philadelphia 2009.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/30\">",
"      Beltrani VS, Beltrani VP. Contact dermatitis. Ann Allergy Asthma Immunol 1997; 78:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/31\">",
"      Bourke J, Coulson I, English J, British Association of Dermatologists. Guidelines for care of contact dermatitis. Br J Dermatol 2001; 145:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/32\">",
"      Usatine RP, Riojas M. Diagnosis and management of contact dermatitis. Am Fam Physician 2010; 82:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/33\">",
"      Rietschel RL. Clues to an accurate diagnosis of contact dermatitis. Dermatol Ther 2004; 17:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/34\">",
"      Ale IS, Maibacht HA. Diagnostic approach in allergic and irritant contact dermatitis. Expert Rev Clin Immunol 2010; 6:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11943/abstract/35\">",
"      Gupta K. Deciphering spongiotic dermatitides. Indian J Dermatol Venereol Leprol 2008; 74:523.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13655 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-61.234.146.186-C04F1AFADF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_42_11943=[""].join("\n");
var outline_f11_42_11943=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H48321072\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27385235\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27385242\">",
"      EPIDEMIOLOGY AND RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27385267\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27385276\">",
"      Lesion morphology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8829787\">",
"      Lesion distribution",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27385283\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3204593\">",
"      DISEASE COURSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27385290\">",
"      HISTOPATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1646554\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8451683\">",
"      Clues from clinical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H111504337\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8451814\">",
"      Patch testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H48321080\">",
"      Laboratory tests and biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1042995662\">",
"      Response to empiric therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3204492\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1646445\">",
"      Clinical",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10326699\">",
"      Histopathologic",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H48321072\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/13655\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13655|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/1/24596\" title=\"picture 1A\">",
"      Contact dermatitis allergic 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/27/33203\" title=\"picture 1B\">",
"      Nickel allergy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/55/1910\" title=\"picture 1C\">",
"      Contact dermatitis feet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/19/30005\" title=\"picture 2\">",
"      Contact dermatitis bullae",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/54/12131\" title=\"picture 3\">",
"      Contact derm eyelids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/17/3348\" title=\"picture 4\">",
"      Contact dermatitis chronic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/24/41351\" title=\"picture 5\">",
"      Contact dermatitis impetiginized",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/39/36466\" title=\"picture 6A\">",
"      Contact dermatitis drug",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/50/26404\" title=\"picture 6B\">",
"      Contact dermatitis nickel 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/47/25330\" title=\"picture 6C\">",
"      Contact dermatitis neomycin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/11/13490\" title=\"picture 7A\">",
"      Contact dermatitis berloque 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/52/6978\" title=\"picture 7B\">",
"      Contact dermatitis berloque 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/8/17537\" title=\"picture 8\">",
"      Contact dermatitis rubber",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/30/34281\" title=\"picture 9\">",
"      Contact dermatitis histology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/46/7907\" title=\"picture 10\">",
"      Photoallergic eruption 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/3/4147\" title=\"picture 11A\">",
"      Asteatotic eczema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/57/43925\" title=\"picture 11B\">",
"      Dyshidrotic eczema hand",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/36/35393\" title=\"picture 11C\">",
"      Mycosis fungoides patches",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/13/40150\" title=\"picture 12\">",
"      Pautrier microabscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13655|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/43/10939\" title=\"table 1\">",
"      History taking in ACD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/1/5149\" title=\"table 2\">",
"      ACD differential diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7223?source=related_link\">",
"      Basic mechanisms and pathophysiology of allergic contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/31/26104?source=related_link\">",
"      Contact dermatitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/20/29001?source=related_link\">",
"      Irritant contact dermatitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32758?source=related_link\">",
"      Management of allergic contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/31/28150?source=related_link\">",
"      Patch testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/63/18426?source=related_link\">",
"      Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/44/20168?source=related_link\">",
"      Poison ivy (Toxicodendron) dermatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/38/29288?source=related_link\">",
"      Stasis dermatitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_42_11944="Use of stents for venous stenosis associated with dialysis vascular access";
var content_f11_42_11944=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Use of stents for venous stenosis associated with dialysis vascular access",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/42/11944/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/42/11944/contributors\">",
"     Gerald A Beathard, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/42/11944/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/42/11944/contributors\">",
"     Steve J Schwab, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/42/11944/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/42/11944/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/42/11944/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of the endoluminal stent in the management of venous stenosis of dialysis access is unclear. Although stents can help manage some access difficulties, they are sometimes inappropriately utilized. Stents are not permanent solutions. With the exception of the Flair&trade; Endovascular Stent Graft (C. R. Bard, Inc.; Tempe, AZ), they are not FDA approved for dialysis vascular access use. In addition, they add significant cost and a new set of possible complications.",
"   </p>",
"   <p>",
"    The clinician should therefore be very selective in the use of stents for the treatment of stenotic dialysis access. Stent placement is justified only when its use will clearly result in one or more of the following benefits:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Extends access life",
"     </li>",
"     <li>",
"      Saves an otherwise failed access",
"     </li>",
"     <li>",
"      Avoids surgery",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although a stent can improve the appearance of a lesion, it is unclear if these devices provide benefits and long-term outcomes that justify their increased cost and potential complications. Angioplasty alone should therefore be used as the",
"    <strong>",
"     primary",
"    </strong>",
"    treatment modality for all venous lesions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/37/18010?source=see_link\">",
"     \"Percutaneous angioplasty for the treatment of venous stenosis affecting hemodialysis access grafts\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Primary patency rates following the venous use of stents have been relatively poor, being approximately 20 percent at one year [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. However, with aggressive reintervention, the cumulative patency rate is approximately 70 percent at one year.",
"   </p>",
"   <p>",
"    Modalities that have been used for stent maintenance include thrombolysis, stent angioplasty, new stents, and the use of the Simpson atherectomy device. The principal difficulty underlying the inability to maintain patency is the development of neointimal hyperplasia, which necessitates frequent retreatment.",
"   </p>",
"   <p>",
"    An introduction to the use of stents for venous stenosis associated with dialysis vascular access is presented herein. A discussion of the use of percutaneous transluminal angioplasty is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/37/18010?source=see_link\">",
"     \"Percutaneous angioplasty for the treatment of venous stenosis affecting hemodialysis access grafts\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;At the present time, there are three generally accepted indications for stent placement in the patient with dialysis vascular access abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute angioplasty failure, ie, a peripheral lesion that has failed balloon angioplasty and one of the following is present: surgical access is difficult; surgery is contraindicated; or there are limited remaining access sites.",
"     </li>",
"     <li>",
"      Rapid recurrence of a lesion, ie, a central vein lesion that has either failed balloon angioplasty (and is elastic) or recurred within a three month period after an initially successful balloon angioplasty.",
"     </li>",
"     <li>",
"      Vessel rupture, ie, rupture of an outflow vein after balloon angioplasty that cannot be managed with more conservative measures.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Recurrent peripheral lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of a stent has been suggested in cases in which there is a rapid recurrence of a peripheral stenotic lesion following angioplasty [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/5\">",
"     5",
"    </a>",
"    ]. A reasonable standard for such intervention is two such recurrences within a three-month period [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/6\">",
"     6",
"    </a>",
"    ]. However, most of these lesions are characterized by a residual stenosis following angioplasty treatment and, with the advent of the ultrahigh-pressure balloon, there may be better ways to treat these lesions than stenting [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/37/18010?source=see_link\">",
"     \"Percutaneous angioplasty for the treatment of venous stenosis affecting hemodialysis access grafts\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Elastic lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some lesions appear to be elastic and recoil after what appeared to be a successful angioplasty treatment. The use of a stent has been suggested in these cases in which a rapid recurrence of the stenotic lesion occurs. A reasonable standard for such intervention is two such recurrences within a three-month period [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/6\">",
"     6",
"    </a>",
"    ]. However, even in these cases, first consideration should be given to surgical correction, if possible, since this offers a more definitive treatment for these recurrent problems.",
"   </p>",
"   <p>",
"    The indication for stent usage appears to be best established in the case of central venous lesions, a category of lesion that is generally poorly amenable to a surgical approach. This approach has been used in both upper and lower extremity grafts. The long-term success of this approach has been better than that seen with angioplasty alone, but nevertheless has been somewhat variable. [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/8-13\">",
"     8-13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In all series that have been reported, multiple repeated interventions have been required to maintain patency of the access. In one study, for example, the outcomes of 20 hemodialysis patients who underwent Wallstent insertion into a subclavian (n = 11) or brachiocephalic (n = 9) vein were reported [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/8\">",
"     8",
"    </a>",
"    ]. Technical success, and primary, assisted primary, and cumulative patency rates were calculated. Twenty-three Wallstents were inserted for stenosis (n = 18) or occlusion (n = 2). Technical success was 100 percent. Eight patients underwent 11 reinterventions to maintain patency of the Wallstent during the follow-up period. Primary patency rates at 1, 3, 6, and 12 months were 90, 67, 42, and 25 percent, respectively. Assisted primary rates at 3, 6, and 12 months were 88, 62, and 47 percent, respectively, while secondary patency rates at 3, 6, and 12, and 24 months were 89, 64, 56, and 22 percent, respectively (",
"    <a class=\"graphic graphic_table graphicRef70111 \" href=\"UTD.htm?9/45/9947\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Vein rupture",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of a hematoma at the site of angioplasty or the extravasation of contrast may or may not be a problem. Vascular injury represents a spectrum ranging from the inconsequential to the disastrous. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/37/18010?source=see_link\">",
"     \"Percutaneous angioplasty for the treatment of venous stenosis affecting hemodialysis access grafts\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Whether or not a hematoma is a problem depends upon two related factors: does it interfere with flow and does it continue to enlarge. A hematoma, even if sizable, that is stable and does not impede flow does not require treatment.",
"   </p>",
"   <p>",
"    If the hematoma continues to enlarge, it will eventually affect access flow even if it is not obvious early. If the hematoma is enlarging or if flow is affected, successful treatment is frequently possible. The first step is to place the angioplasty balloon across the site and inflate to a low pressure, just enough to expand the balloon. One or two atmospheres for three to five minutes are generally adequate. This serves to lift the torn edge of the vessel back in place. If this technique is unsuccessful, the insertion of an endovascular stent has been recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/14-16\">",
"     14-16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one study, 23 patients with venous rupture attributed to balloon angioplasty during dialysis graft thrombolysis were treated by Wallstent deployment across the area of rupture [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/16\">",
"     16",
"    </a>",
"    ]. Twenty-one ruptures occurred in peripheral veins and two occurred in central veins. Complications were limited to four moderate-sized hematomas of the arm, and a single pseudoaneurysm developed 6 months after stent placement in one patient [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/16\">",
"     16",
"    </a>",
"    ]. Stent placement allowed completion of graft thrombolysis in all 23 patients. The primary patency rate of stents was 52 percent at 60 days, 26 percent at 180 days, and 11 percent at 360 days. The secondary patency rate was 74 percent at 60 days, 65 percent at 180 days, and 56 percent at 360 days.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Newer possible indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are new developments that may expand the list of indications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Extrinsic compression of the left innominate vein",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extrinsic compression of the left innominate vein can occur in patients with an ectatic aorta. Although this does not usually have any hemodynamic consequence, elevated venous pressure sometimes occurs and collateral veins can develop. The use of an endovascular stent has been advocated in these cases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/17\">",
"     17",
"    </a>",
"    ]. Certainly, angioplasty is clearly of no value since the compression is extrinsic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Pseudoaneurysm formation",
"    </span>",
"    &nbsp;&mdash;&nbsp;With the advent of covered stents (see",
"    <a class=\"local\" href=\"#H14\">",
"     'Stent grafts'",
"    </a>",
"    below), there has been an increasing interest in applying them to the treatment of pseudoaneurysms that develop over time in aging dialysis access grafts [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/18-22\">",
"     18-22",
"    </a>",
"    ]. It appears that the stent graft can withstand routine venipuncture at dialysis without flow-limiting stent distortion in many instances. Controlled studies are need in this area.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIFFERENT STENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The characteristics of an ideal endovascular stent for use in the management of dialysis vascular access problems should include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      High radiopacity for clear visualization",
"     </li>",
"     <li>",
"      High hoop strength to resist recoil",
"     </li>",
"     <li>",
"      Minimal or no foreshortening in deployment",
"     </li>",
"     <li>",
"      Simple and easy-to-use delivery system",
"     </li>",
"     <li>",
"      Longitudinal flexibility to avoid kinking around curves",
"     </li>",
"     <li>",
"      Radial elasticity to resist external compression without permanent deformation",
"     </li>",
"     <li>",
"      High expansion ratio and low profile for passage through small sheath",
"     </li>",
"     <li>",
"      Retrievability in case of faulty deployment",
"     </li>",
"     <li>",
"      Allows for cannulation in stented site",
"     </li>",
"     <li>",
"      Minimal induction of intimal hyperplasia",
"     </li>",
"     <li>",
"      Resistance to thrombosis",
"     </li>",
"     <li>",
"      Easily removed if surgery at site required",
"     </li>",
"     <li>",
"      Low price",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Unfortunately, the ideal stent does not exist. There are four general categories of endovascular stent:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Balloon expandable stent",
"     </li>",
"     <li>",
"      Self-expanding stent",
"     </li>",
"     <li>",
"      Covered stent",
"     </li>",
"     <li>",
"      Drug-eluting stent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Balloon expandable stent",
"    </span>",
"    &nbsp;&mdash;&nbsp;Examples of balloon expandable stents are the Palmaz&reg; stent (Cordis Corporation, a Johnson &amp; Johnson company; Warren, NJ) and the Strecker&trade; stent (Boston Scientific Corp.; Natick, MA). These stents come mounted on a balloon. They are put in place within the lesion and are then expanded using the balloon; they are also relatively rigid and malleable.",
"   </p>",
"   <p>",
"    They are therefore",
"    <strong>",
"     unsuitable",
"    </strong>",
"    for use in dialysis access applications:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Since the central veins change size with respiration or a Valsalva, a stent will migrate unless it is self-expandable.",
"     </li>",
"     <li>",
"      With more peripheral applications, external pressure on the stent (because of the superficial location of the vessel) can result in crimping of the stent. Since the compressed stent will not recover, it is permanently deformed, resulting in obstruction.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Self-expanding stents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Self-expanding stents come preloaded in a sheath-like catheter, and are delivered using a obturator to discharge the stent. Once released, the stent self-expands. There are two types of self-expanding stents: 1) those constructed of stainless steel and 2) those constructed of nitinol alloys.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Stainless steel stents",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Wallstent&trade; (Boston Scientific Corp.; Natick, Massachusetts), the classic example of a self-expanding stent, is perhaps the one most commonly used in this type of application. It is constructed of a stainless steel alloy filaments woven in a criss-cross pattern in a tubular mesh configuration. The stent is also highly flexible in its longitudinal axis without kinking. Although there is a good expansile force in the radial direction, considerable (10 to 30 percent) foreshortening of the stent during release is observed. The radiopacity of this stent is rather poor.",
"   </p>",
"   <p>",
"    Stent diameters of 6 to 10 mm can be inserted using a 7 French (F) sheath. Wallstents from 12 to 16 mm in diameter require a 9F introducing sheath.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Nitinol stents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nitinol is an alloy composed of titanium and nickel. Its best-known properties are super elasticity and thermal shape memory. The term \"shape memory\" describes the phenomenon of restoring a predetermined shape through heating (after plastically deforming that shape); \"super-elasticity\" refers to the enormous elasticity of these alloys, which is up to 10 times greater than the best stainless steels used in medicine today.",
"   </p>",
"   <p>",
"    Examples of nitinol stents include the Symphony&reg; Stent (Boston Scientific Corp.; Natick, Mass), the S.M.A.R.T.&trade; Stent (Cordis), the Bard Luminex Stent (Bard Peripheral Technologies), the Zilver stent (Cook, Inc.), and the Memotherm&trade; Stent (Bard Peripheral Technologies, Covington, GA). All nitinol stents are not equivalent. Some are very flexible (S.M.A.R.T. Stent) and can be implanted at locations where there is an angulation. Others are more rigid (Symphony stent). Some may even break when they are bent or placed in a flexion site (Memotherm).",
"   </p>",
"   <p>",
"    The effectiveness of stent placement for venous stenosis associated with a dialysis access graft has been evaluated in retrospective studies [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. In one retrospective, single-center study, the effectiveness of a SMART stent versus angioplasty was evaluated in 211 stent and matched angioplasty controls (112 AV fistula and 99 AV grafts) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/24\">",
"     24",
"    </a>",
"    ]. Primary AV graft patency was significantly higher with stents, with patency at 30, 90, and 180 days being 91 versus 80 percent, 69 versus 24 percent, and 25 versus 3 percent, respectively. Although there was no significant difference in patency in those with AV fistulas, access blood flow was significantly higher after stent placement compared with angioplasty.",
"   </p>",
"   <p>",
"    A major advantage of nitinol stents is that they do not shorten during placement. As previously mentioned, some of the reports using stents constructed of this material suggest that it may give results that are superior to stainless devices. Additional studies would be required to provide a definitive answer to this speculation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Stent grafts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stent grafts (covered stents) combine the features of a stent with the features of a segment of graft material, either PTFE or Dacron. Examples of stent grafts are the Cragg&trade; (Boston Scientific Corp.; Natick, Massachusetts) Wallgraft&trade; (Boston Scientific Corp.; Natick, Massachusetts), the Viabahn&trade; (WL Gore; Flagstaff, Arizona), the Fluency&trade; (C. R. Bard, Inc.; Tempe, AZ), and the Flair (C.R. Bard, Inc.; Tempe, AZ).",
"   </p>",
"   <p>",
"    Results reported with these devices have raised the possibility that they may offer results that are superior to those seen with uncovered stents. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Access patency with different stents'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Drug-eluting stents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although not yet evaluated clinically for dialysis vascular access, there is preliminary evidence in animals that sirolimus-eluting stents may provide short-term effectiveness in animal model arteriovenous grafts [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Access patency with different stents",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reports of primary patency rates following the venous use of stents have been variable. This is due to a number of factors including use of different types of stents, small numbers of enrolled patients, and lack of controls.",
"   </p>",
"   <p>",
"    Despite these issues, outcomes appear to differ among the different stents. All of the earlier studies were performed using stainless steel stents, such as the Wallstent. In general, these studies showed that stenting could be used to treat lesions that might not be adequately treated with angioplasty alone and demonstrated a high procedural success rate. However, primary patency was generally no better than that reported with PTA alone.",
"   </p>",
"   <p>",
"    Representative studies are as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/1-3,27,28\">",
"     1-3,27,28",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ninety-two self-expanding vascular stents were placed in 65 patients with a failing hemodialysis access [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/2\">",
"       2",
"      </a>",
"      ]. Although initial stent placement was successful in all patients, rethrombosis of the access occurred in six patients (10 percent) within one week. There were 96 episodes of reobstruction. In 87 cases, percutaneous or combined surgical and percutaneous repeat intervention was performed. With reintervention, the cumulative access function rate was 88 percent after six months, 86 percent after one year, and 77 percent after two years.",
"     </li>",
"     <li>",
"      In another study, stainless steel stents were placed in 52 patients with 56 venous stenoses and occlusions related to hemodialysis access [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/3\">",
"       3",
"      </a>",
"      ]. Thirty-two lesions were in central veins and 24 were in peripheral veins. The procedural success rate was 96 percent. The primary patency rate was 46 percent at six months and 20 percent at 12 months. With repeat treatment, the cumulative assisted patency rate was 76 percent at 6 months and 33 percent at 12 months.",
"     </li>",
"     <li>",
"      In a third study, stenting with stainless steel stents was used to treat 26 patients with 26 central venous stenoses, while angioplasty alone was used to treat 47 patients with 49 central venous stenoses [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/28\">",
"       28",
"      </a>",
"      ]. Primary patency was equivalent between groups, with 30-day rates of 76 percent for both groups and 12-month rates of 29 and 21 percent for the PTA alone and stent groups, respectively. Assisted primary patency was also equivalent for both groups.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Subsequent studies have utilized the newer nitinol stents. These reports have generally shown primary patency rates that are superior to those reported for angioplasty alone. However, these studies have been retrospective and have often failed to include controls [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/24,29-31\">",
"     24,29-31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a retrospective study, 64 patients with polytetrafluoroethylene grafts were treated with the SMART stent (nitinol) at 69 locations in the venous outflow tract [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/29\">",
"       29",
"      </a>",
"      ]. Stents were used for elastic recoil after percutaneous transluminal angioplasty, venous rupture, or recurrent stenosis less than three months after angioplasty. Primary patency was determined, and, when applicable, compared with that of previous angioplasty treatments of the same lesion. Stents were placed in 15 central veins and 54 peripheral veins. The mean primary patency times were 14.9 months and 8.9 months in patients who received central and peripheral stents, respectively. In 19 patients whose central or peripheral venous stenoses were previously treated with angioplasty alone, the mean primary patency was significantly increased from 2.5 months to 10.6 months. Angiography in 29 patients after an average of 348 days showed 55 percent mean in-stent stenosis.",
"     </li>",
"     <li>",
"      The outcomes of 34 patients treated with self-expanding nitinol stents placed at the venous anastomosis following graft thrombectomy and failed angioplasty procedures were reported in a second study [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/30\">",
"       30",
"      </a>",
"      ]. Patients were selected for stent placement if conventional angioplasty alone was unsuccessful, due to immediate elastic recoil or residual stenosis. Eight-eight percent of grafts were functioning at six months' follow-up, and 63 percent of the entire group had survived without the need for additional procedures.",
"     </li>",
"     <li>",
"      In a retrospective single-center study, the effectiveness of a SMART stent versus angioplasty was evaluated in 211 stent and matched angioplasty controls (112 AV fistula and 99 AV grafts) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/24\">",
"       24",
"      </a>",
"      ]. Primary AV graft patency was significantly higher with stents, with patency at 30, 90, and 180 days being 91 versus 80 percent, 69 versus 24 percent, and 25 versus 3 percent, respectively. Although there was no significant difference in patency in those with AV fistulas, access blood flow was significantly higher after stent placement compared with angioplasty.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    With the advent of the stent graft, reports of their use in hemodialysis vascular access applications soon followed. Although most of these studies are retrospective and uncontrolled, there is evidence from a prospective randomized study that these grafts may provide an improved result compared with angioplasty alone [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. In this randomized study, optimal (and successful) angioplasty, performed in 93 patients, was compared to successful PTA, immediately followed by stent graft placement in 97 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/33\">",
"     33",
"    </a>",
"    ]. Both clinical follow-up and angiographic follow-up were performed at two months and the final study time point of six months. Angiograms were sent to a core lab for independent quantification. The study and control groups were very homogeneous. There was no statistical difference for any clinical, graft, or lesion parameters. Six-month results demonstrated superior treatment site patency for the covered stent (51 versus 23 percent), as well as superior primary patency of the entire shunt circuit for the group treated with the covered stent (38 versus 20 percent).",
"   </p>",
"   <p>",
"    The six-month circuit primary patency rate of 38 observed in this study is not better than the 30 to 60 percent range reported in many uncontrolled series that evaluated PTA and stents. But since this was a controlled comparative trial using a core lab for lesion evaluations, the observations made and the conclusions drawn gain extra significance. However, further study is required to better understand the role for these stents and whether they may be preferred to other stents [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A particularly difficult location to manage optimally when stenosis occurs is the cephalic arch. The unique anatomy of this vein as it passes though the coracoclavicular ligament just before it joins the subclavian vein, accompanied by the thoracoacromial artery and vein, and lateral pectoral nerve appears to predispose to recurrent and resistant stenosis. Stenting of these lesions is frequently considered. Evidence from a randomized controlled trial suggests that the use of stent grafts in angioplasty for recurrent cephalic arch stenosis significantly improves short-term restenosis rates and long-term patency compared with the use of bare stents [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Choice of stent",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal choice of stent is unclear. Most interventionalists prefer a nitinol stent rather than the stainless steel variety. The exact role of the stent graft is yet to be determined. Current data suggests that a stent graft might be preferable if the area to be stented is to be cannulated for dialysis (as in the treatment of a pseudoaneurysm). In other applications, the fact that its cost is almost twice that of a bare stent should temper a decision to use it preferentially until additional information is made available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     CONCERNS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several points of concern relating to the use of stents:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Neointimal hyperplasia",
"     </li>",
"     <li>",
"      Vein depletion",
"     </li>",
"     <li>",
"      Expense",
"     </li>",
"     <li>",
"      Inaccessibility for cannulation",
"     </li>",
"     <li>",
"      Migration",
"     </li>",
"     <li>",
"      Shortening",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Neointimal hyperplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;It appears that the presence of a stent promotes the development of neointimal hyperplasia. This intimal lesion appears to grow through the stent, generally involving its entire length. This is a relentless progressive process. The limited primary patency rates for these devices are primarily due to this phenomenon. As a consequence, the placement of a stent is not a permanent solution to the problem of venous stenosis.",
"   </p>",
"   <p>",
"    The process underlying neointimal hyperplasia begins immediately after stent placement. Initially, after a stent is placed, a very thin layer of plasma proteins covers its metallic struts. This happens within seconds after placement. Ideally, stents should be placed in such a way that the metal struts are embedded in the wall away from the circumference of the lumen. The troughs or depressions resulting from this embedding become filled with thrombus that covers the metal surface; the tissue protruding between the depressions is not covered. This tissue retains its endothelium, which allows for re-endothelialization by multicentric growth.",
"   </p>",
"   <p>",
"    In a few days to a few weeks, the thrombotic layer covering the stent struts is progressively replaced by fibromuscular tissue, or neointima. Eventually, all of the thrombotic material is replaced by this neointima. With this process the stent has become firmly attached and embedded in the vessel wall.",
"   </p>",
"   <p>",
"    Initially, the neointimal covering consists of a thin layer of fibromuscular cells, neovascularity and intercellular matrix; however, with time, this has a tendency to continue to proliferate to produce an ever thickening layer that can eventually compromise the lumen of the vessel.",
"   </p>",
"   <p>",
"    The neointimal hyperplasia grows through the stent, generally involves its entire length, and is a relentlessly progressive process. In some instances, the process is adjacent to the stent, creating a \"candy-wrapper\" appearance. This has been the major problem with stent usage in the management of dialysis access dysfunction. It has made frequent retreatment a necessity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Vein depletion",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with surgical revision, a stent depletes a section of vein, and access sites can therefore be depleted if stents are not judiciously placed. As an example, if a lesion in the axillary vein is stented, it may be very difficult for the surgeon to create an upper arm brachial-axillary graft since the stent will be in the way. Thus, care must be exercised in the application of stents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Expense",
"    </span>",
"    &nbsp;&mdash;&nbsp;The charges generated by the stenting procedure itself can amount to over $4000. Stents are expensive, generally adding more than $1000 to the procedure. When this is considered in the light of the reinterventions that will be required to maintain long-term patency, surgical revision may be more economical",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Inaccessibility for cannulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stents can be damaged if struck with a needle during cannulation for dialysis or for insertion of a central venous line. This affects their use in an area that may be cannulated for dialysis. However, there are reports of cannulating through covered stents without a problem. Additional experience is needed in this area before final judgment can be passed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Stent migration",
"    </span>",
"    &nbsp;&mdash;&nbsp;After a stent has been in place for a few days, it is partially covered by endothelium, thereby becoming fixed in place. Until such endothelialization occurs, the stent can move. In some series, migration has occurred in as many as 20 percent of the cases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/36\">",
"     36",
"    </a>",
"    ]. This is particularly likely to happen in central veins because of the following reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Such vessels tend to be rather large in the patient with a peripheral dialysis access.",
"     </li>",
"     <li>",
"      These veins have the potential for significant changes in diameter with deep inspiration, especially a Valsalva maneuver.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Up to a point, the self-expanding stent is able to expand with changes in vein size. If its capacity to expand is exceeded and it has not yet become attached to the vessel wall, it can be released into the circulation to migrate centrally. This degree of migration is a rare but dangerous complication, because of its final destination &mdash; the right heart or pulmonary artery. This can obviously have serious consequences [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11944/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician should be very selective in the use of stents for the treatment of stenotic dialysis access. Stent placement is justified only when its use will clearly result in one or more of the following benefits:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Extension of access life",
"     </li>",
"     <li>",
"      Saving an otherwise failed access",
"     </li>",
"     <li>",
"      Avoidance of surgery",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although a stent can improve the appearance of a lesion, it is unclear if these devices provide benefits and long-term outcomes that justify their increased cost and potential complications. Angioplasty alone should therefore be used as the",
"    <strong>",
"     primary",
"    </strong>",
"    treatment modality for all venous lesions.",
"   </p>",
"   <p>",
"    At the present time, there are three possible indications for stent placement in the patient with dialysis vascular access abnormalities:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A peripheral lesion that has failed balloon angioplasty and one of the following is present: surgical access is difficult; surgery is contraindicated; or there are limited remaining access sites.",
"     </li>",
"     <li>",
"      A central vein lesion that has either failed balloon angioplasty (and is elastic) or recurred within a three-month period after an initially successful balloon angioplasty.",
"     </li>",
"     <li>",
"      Rupture of an outflow vein after balloon angioplasty that cannot be managed with more conservative measures.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It should be recognized that, in general, a stent is not a permanent solution; it only prolongs the life of the access and occasionally the extra time gained is not very great. This is due in part to the observation that stents promote intimal hyperplasia.",
"   </p>",
"   <p>",
"    There are several additional recommendations and admonitions that should be followed in placing a stent. Careful compliance will enhance the clinician's experience with stents.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Accurate localization of the lesion is important for deployment. Exposing a normal vein to a stent invites the proliferation of neointimal hyperplasia.",
"     </li>",
"     <li>",
"      Use the shortest stent that will do the job adequately. This is important for the same reason as above, which is the importance of not exposing normal vessel to the risk of injury.",
"     </li>",
"     <li>",
"      The optimal choice of stent is unclear. Most interventionalists prefer a nitinol stent rather than the stainless steel variety. The exact role of the stent graft is yet to be determined. Current data suggests that a stent graft might be preferable if the area to be stented is to be cannulated for dialysis (as in the treatment of a pseudoaneurysm).",
"     </li>",
"     <li>",
"      Use the angioplasty balloon to seat the stent after release. There should be complete contact between the vessel wall and the stent. Because placement of a stent in a stenotic vessel may be irreversible, the certainty that the stent will expand to occupy the complete lumen is critically important. Failure to expand a stent after placement may result in migration.",
"     </li>",
"     <li>",
"      A lesion that cannot be opened with angioplasty should not be stented. The stent will not open the lesion.",
"     </li>",
"     <li>",
"      In general, an uncovered stent should not be placed in an area that will need to be cannulated for dialysis. This could create problems for both the stent and the cannulation. This admonition does not necessarily apply to the stent graft (covered stent), which has been successfully used in cannulation areas as previously described.",
"     </li>",
"     <li>",
"      If the graft will ultimately need to be revised, it should not be jeopardized by injudicious stent placement. It is very difficult to revise a graft using a vein that has been stented. This should always be kept in mind when placing stents.",
"     </li>",
"     <li>",
"      The confluence of two vessels should be avoided when placing a stent if possible. A side branch may be sacrificed by the presence of a stent crossing its lumen.",
"     </li>",
"     <li>",
"      If there is a possibility that a graft is infected or that the patient is septic, a stent should not be placed.",
"     </li>",
"     <li>",
"      An attempt should not be made to advance a stent once it is even partially deployed. This can result in tearing of the vein.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/1\">",
"      Quinn SF, Schuman ES, Hall L, et al. Venous stenoses in patients who undergo hemodialysis: treatment with self-expandable endovascular stents. Radiology 1992; 183:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/2\">",
"      Vorwerk D, Guenther RW, Mann H, et al. Venous stenosis and occlusion in hemodialysis shunts: follow-up results of stent placement in 65 patients. Radiology 1995; 195:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/3\">",
"      Gray RJ, Horton KM, Dolmatch BL, et al. Use of Wallstents for hemodialysis access-related venous stenoses and occlusions untreatable with balloon angioplasty. Radiology 1995; 195:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/4\">",
"      Aruny JE, Lewis CA, Cardella JF, et al. Quality improvement guidelines for percutaneous management of the thrombosed or dysfunctional dialysis access. Standards of Practice Committee of the Society of Cardiovascular &amp; Interventional Radiology. J Vasc Interv Radiol 1999; 10:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/5\">",
"      Pan HB, Liang HL, Lin YH, et al. Metallic stent placement for treating peripheral outflow lesions in native arteriovenous fistula hemodialysis patients after insufficient balloon dilatation. AJR Am J Roentgenol 2005; 184:403.",
"     </a>",
"    </li>",
"    <li>",
"     Trerotola, S, Interventional radiologic approach to hemodialysis access management, in Venous interventional radiology with clinical perspectives, S. Salvader, Trerotola, SO, Editor. 1996, Georg Thieme Verlag: New York. p. 178.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/7\">",
"      Trerotola SO, Stavropoulos SW, Shlansky-Goldberg R, et al. Hemodialysis-related venous stenosis: treatment with ultrahigh-pressure angioplasty balloons. Radiology 2004; 231:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/8\">",
"      Vesely TM, Hovsepian DM, Pilgram TK, et al. Upper extremity central venous obstruction in hemodialysis patients: treatment with Wallstents. Radiology 1997; 204:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/9\">",
"      Chen CY, Liang HL, Pan HB, et al. Metallic stenting for treatment of central venous obstruction in hemodialysis patients. J Chin Med Assoc 2003; 66:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/10\">",
"      Zaleski GX, Funaki B, Rosenblum J, et al. Metallic stents deployed in synthetic arteriovenous hemodialysis grafts. AJR Am J Roentgenol 2001; 176:1515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/11\">",
"      Haage P, Krings T, Schmitz-Rode T. Nontraumatic vascular emergencies: imaging and intervention in acute venous occlusion. Eur Radiol 2002; 12:2627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/12\">",
"      Haage P, Vorwerk D, Piroth W, et al. Treatment of hemodialysis-related central venous stenosis or occlusion: results of primary Wallstent placement and follow-up in 50 patients. Radiology 1999; 212:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/13\">",
"      Funaki B, Szymski GX, Leef JA, et al. Treatment of venous outflow stenoses in thigh grafts with Wallstents. AJR Am J Roentgenol 1999; 172:1591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/14\">",
"      Zaleski GX, Funaki B. Use of stents for angioplasty-induced venous rupture. J Vasc Interv Radiol 1999; 10:1135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/15\">",
"      Rundback JH, Leonardo RF, Poplausky MR, Rozenblit G. Venous rupture complicating hemodialysis access angioplasty: percutaneous treatment and outcomes in seven patients. AJR Am J Roentgenol 1998; 171:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/16\">",
"      Funaki B, Szymski GX, Leef JA, et al. Wallstent deployment to salvage dialysis graft thrombolysis complicated by venous rupture: early and intermediate results. AJR Am J Roentgenol 1997; 169:1435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/17\">",
"      Itkin M, Kraus MJ, Trerotola SO. Extrinsic compression of the left innominate vein in hemodialysis patients. J Vasc Interv Radiol 2004; 15:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/18\">",
"      Silas AM, Bettmann MA. Utility of covered stents for revision of aging failing synthetic hemodialysis grafts: a report of three cases. Cardiovasc Intervent Radiol 2003; 26:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/19\">",
"      Najibi S, Bush RL, Terramani TT, et al. Covered stent exclusion of dialysis access pseudoaneurysms. J Surg Res 2002; 106:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/20\">",
"      Hausegger KA, Tiessenhausen K, Klimpfinger M, et al. Aneurysms of hemodialysis access grafts: treatment with covered stents: a report of three cases. Cardiovasc Intervent Radiol 1998; 21:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/21\">",
"      Rhodes ES, Silas AM. Dialysis needle puncture of Wallgrafts placed in polytetrafluoroethylene hemodialysis grafts. J Vasc Interv Radiol 2005; 16:1129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/22\">",
"      Vesely TM. Use of stent grafts to repair hemodialysis graft-related pseudoaneurysms. J Vasc Interv Radiol 2005; 16:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/23\">",
"      White JJ, Paulson WD, Schwab SJ. Treatment of hemodialysis AV graft stenosis: stents resurgent. Kidney Int 2005; 67:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/24\">",
"      Chan MR, Bedi S, Sanchez RJ, et al. Stent placement versus angioplasty improves patency of arteriovenous grafts and blood flow of arteriovenous fistulae. Clin J Am Soc Nephrol 2008; 3:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/25\">",
"      Rotmans JI, Pattynama PM, Verhagen HJ, et al. Sirolimus-eluting stents to abolish intimal hyperplasia and improve flow in porcine arteriovenous grafts: a 4-week follow-up study. Circulation 2005; 111:1537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/26\">",
"      Schuman E, Babu J. Sirolimus-loaded polyurethane graft for hemodialysis access in sheep. Vascular 2008; 16:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/27\">",
"      Hoffer EK, Sultan S, Herskowitz MM, et al. Prospective randomized trial of a metallic intravascular stent in hemodialysis graft maintenance. J Vasc Interv Radiol 1997; 8:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/28\">",
"      Bakken AM, Protack CD, Saad WE, et al. Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients. J Vasc Surg 2007; 45:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/29\">",
"      Vogel PM, Parise C. SMART stent for salvage of hemodialysis access grafts. J Vasc Interv Radiol 2004; 15:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/30\">",
"      Sreenarasimhaiah VP, Margassery SK, Martin KJ, Bander SJ. Salvage of thrombosed dialysis access grafts with venous anastomosis stents. Kidney Int 2005; 67:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/31\">",
"      Maya ID, Allon M. Outcomes of thrombosed arteriovenous grafts: comparison of stents vs angioplasty. Kidney Int 2006; 69:934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/32\">",
"      Farber A, Barbey MM, Grunert JH, Gmelin E. Access-related venous stenoses and occlusions: treatment with percutaneous transluminal angioplasty and Dacron-covered stents. Cardiovasc Intervent Radiol 1999; 22:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/33\">",
"      Haskal ZJ, Trerotola S, Dolmatch B, et al. Stent graft versus balloon angioplasty for failing dialysis-access grafts. N Engl J Med 2010; 362:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/34\">",
"      Kerlan RK Jr, LaBerge JM. Fistula first, stent graft second. N Engl J Med 2010; 362:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/35\">",
"      Shemesh D, Goldin I, Zaghal I, et al. Angioplasty with stent graft versus bare stent for recurrent cephalic arch stenosis in autogenous arteriovenous access for hemodialysis: a prospective randomized clinical trial. J Vasc Surg 2008; 48:1524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/36\">",
"      Verstandig AG, Bloom AI, Sasson T, et al. Shortening and migration of Wallstents after stenting of central venous stenoses in hemodialysis patients. Cardiovasc Intervent Radiol 2003; 26:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11944/abstract/37\">",
"      Schillinger F, Montagnac R, Milcent T, et al. [Pulmonary migration of an axillary stent in a chronic hemodialysis patient]. Nephrologie 2001; 22:49.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1911 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-C88E1676B6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_42_11944=[""].join("\n");
var outline_f11_42_11944=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Recurrent peripheral lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Elastic lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Vein rupture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Newer possible indications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Extrinsic compression of the left innominate vein",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Pseudoaneurysm formation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIFFERENT STENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Balloon expandable stent",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Self-expanding stents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Stainless steel stents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Nitinol stents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Stent grafts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Drug-eluting stents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Access patency with different stents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Choice of stent",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      CONCERNS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Neointimal hyperplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Vein depletion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Expense",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Inaccessibility for cannulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Stent migration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/1911\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/1911|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/45/9947\" title=\"table 1\">",
"      Patency definitions",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/37/18010?source=related_link\">",
"      Percutaneous angioplasty for the treatment of venous stenosis affecting hemodialysis access grafts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_42_11945="Overview of tracheostomy";
var content_f11_42_11945=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of tracheostomy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/42/11945/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/42/11945/contributors\">",
"     Robert C Hyzy, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/42/11945/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/42/11945/contributors\">",
"     Praveen N Mathur, MB, BS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/42/11945/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/42/11945/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/42/11945/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 21, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Airway access for mechanical ventilation can be provided either by endotracheal or tracheostomy tube. During episodes of acute respiratory failure, patients are generally ventilated through an endotracheal tube. Changing to a tracheostomy tube is often considered when the need for mechanical ventilation is expected to be prolonged. An overview of clinical issues related to tracheostomy will be discussed here. General issues regarding endotracheal intubation and prolonged ventilation are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/11/15545?source=see_link\">",
"     \"Endotracheal tube management and complications\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/61/9176?source=see_link\">",
"     \"Management of the difficult-to-wean patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37673?source=see_link\">",
"     \"Management and prognosis of patients requiring prolonged mechanical ventilation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TRACHEOSTOMY VERSUS INTUBATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relative advantages and disadvantages of tracheostomy and endotracheal intubation are outlined in the table (",
"    <a class=\"graphic graphic_table graphicRef76699 \" href=\"UTD.htm?40/28/41419\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Work of breathing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data from small studies suggest that work of breathing, pressure-time product, airway resistance, peak inspiratory pressures, and intrinsic positive end-expiratory pressure (ie, auto-PEEP) decrease after tracheostomy in both ventilated and spontaneously breathing patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. In addition, ventilator synchrony and triggering may be enhanced, although tidal volume, respiratory rate, and dead space ventilation remain unchanged [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/1,5\">",
"     1,5",
"    </a>",
"    ]. These changes &ndash; along with other variables such as secretion, clearance, and patient comfort &ndash; may facilitate weaning from mechanical ventilation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Aspiration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aspiration of oropharyngeal contents is common with both tracheostomy and endotracheal intubation. It is a result of both pharyngeal pooling of secretions above the airway cuff and delayed triggering of the swallow response [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. The risk of aspiration is directly related to the amount of oropharyngeal secretions.",
"   </p>",
"   <p>",
"    In patients who have a tracheostomy, aspiration occurs in 30 to 50 percent and is clinically silent in 75 to 82 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. Occlusion of the tracheostomy with a cap or finger for phonation does not significantly increase the frequency of aspiration [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/10\">",
"     10",
"    </a>",
"    ]. The likelihood of aspiration may decrease somewhat after a tracheostomy has been present for three weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients who are intubated, the type of endotracheal tube cuff affects the ability of fluid to leak around the endotracheal tube into the lower airway from the posterior pharynx. Polyurethane cuffs reduce the amount of leakage compared with polyvinyl chloride endotracheal tubes, although the clinical importance of this is unknown [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/11\">",
"     11",
"    </a>",
"    ]. PEEP may also reduce the amount of fluid leakage. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13433?source=see_link&amp;anchor=H13#H13\">",
"     \"Risk factors and prevention of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults\", section on 'Subglottic drainage'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Detection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several methods have been used to detect aspiration in patients with tracheal tubes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"       Methylene blue",
"      </a>",
"      &ndash; During the methylene blue test, dye is added to enteral feedings and then sought in tracheal secretions. Detection of the dye in tracheal secretions is suggestive of aspiration [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/10\">",
"       10",
"      </a>",
"      ]. However, the accuracy of the methylene blue test for identifying aspiration is uncertain. One study found a sensitivity of 100 percent in mechanically ventilated patients and 82 percent in all patients [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/12\">",
"       12",
"      </a>",
"      ]. Another study reported a 50 percent false negative rate [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Glucose oxidase testing &ndash; The glucose oxidase test uses test strips and a calibrated glucose meter to measure glucose in tracheal secretions (elevated glucose in the tracheal secretions is considered suggestive of aspiration). Aspiration can be more easily detected by glucose oxidase testing than by the",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"       methylene blue",
"      </a>",
"      test [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Direct visualization &ndash; Direct visualization methods remain the gold standard for detecting aspiration of oropharyngeal contents in patients with tracheostomies.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Patient communication",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonverbal communication can prove frustrating for patients with prolonged respiratory failure [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/15\">",
"     15",
"    </a>",
"    ]. Patient communication can be greatly enhanced following tracheostomy by use of specialized appliances, such as the Portex \"Talk\" tube and the Communitrach I. These utilize an additional small diameter tube that expels gas above the cuff of the tracheostomy tube when the proximal end has been manually occluded (",
"    <a class=\"graphic graphic_figure graphicRef60668 \" href=\"UTD.htm?17/49/18192\">",
"     figure 1",
"    </a>",
"    ). Limitations of this device include the requirement for manual occlusion and the frequent inability to speak in complete sentences. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/61/9176?source=see_link\">",
"     \"Management of the difficult-to-wean patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Passy-Muir one-way valves can also be employed to facilitate audible phonation, although the tracheostomy cuff must be deflated to permit this to occur (",
"    <a class=\"graphic graphic_figure graphicRef61596 \" href=\"UTD.htm?9/0/9216\">",
"     figure 2",
"    </a>",
"    ). One series showed that tidal volume must be increased an average of 50 percent when using a Passy-Muir valve to achieve the same peak airway pressure obtained before the tracheostomy cuff was deflated [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/16\">",
"     16",
"    </a>",
"    ]. However, increasing the tidal volume by less than this amount usually permits both adequate ventilation and phonation. Alternatively, bilevel positive airway pressure can be provided using positive end-expiratory pressure (PEEP) in conjunction with pressure support ventilation (PSV). This pressure-limited approach to ventilation avoids the need to adjust tidal volumes prior to speaking, and may result in improved phonation, particularly for patients with neuromuscular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A novel voice tracheostomy tube has been developed for use by patients on mechanical ventilation who require low levels of positive end expiratory pressure (PEEP) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/19\">",
"     19",
"    </a>",
"    ]. The cuff is constructed to inflate during inspiration and deflate on expiration, allowing phonation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Nosocomial pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients who have undergone tracheostomy, several factors may predict nosocomial pneumonia following tracheostomy. In a retrospective study of 137 patients who underwent tracheostomy, early nosocomial pneumonia (occurring within 5 days of tracheostomy) was associated with significant bacterial colonization (&gt;100,000",
"    <span class=\"nowrap\">",
"     cfu/mL),",
"    </span>",
"    fever on the day of tracheostomy, and the need for sedation beyond 24 hours after tracheostomy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/20\">",
"     20",
"    </a>",
"    ]. There was a 26 percent incidence of pneumonia in the study population, occurring at a mean of nine days after the tracheostomy.",
"   </p>",
"   <p>",
"    It is unclear whether tracheostomy alters the rate of nosocomial pneumonia because there are conflicting data:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Suggesting that tracheostomy is associated with a higher rate of nosocomial pneumonia, a prospective cohort study of over 800 mechanically ventilated patients found that tracheostomy was independently associated with a six-fold increase in the risk of nosocomial pneumonia [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Suggesting that tracheostomy is associated with a lower rate of nosocomial pneumonia, a case-control study of 354 patients who were mechanically ventilated for more than seven days found a lower rate of nosocomial pneumonia following tracheostomy (4.8 versus 9.2 episodes per 1000 ventilator days in patients ventilated for an equivalent duration who did not undergo tracheostomy) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/22\">",
"       22",
"      </a>",
"      ]. These findings were supported by a retrospective cohort study [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The timing of tracheostomy (early versus late) does not appear to impact the rate of nosocomial pneumonia following tracheostomy, according to a randomized trial and two observational studies [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/24-27\">",
"     24-27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     TIMING OF TRACHEOSTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many clinicians believe that patients should not be ventilated via an endotracheal tube for longer than three weeks unless they are either unstable or unlikely to benefit from tracheostomy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. This view is based upon the observation that tracheostomy enhances nursing care, improves patient comfort, and improves patient communication [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/31\">",
"     31",
"    </a>",
"    ]. An international multicenter study of 1638 patients suggested that this view is widespread, finding that tracheostomy was performed after a median of only 11 days [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is conflicting evidence about whether early tracheostomy improves outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/26,27,33-41\">",
"     26,27,33-41",
"    </a>",
"    ]. Meta-analyses comparing early versus late tracheostomy have not been helpful in resolving the conflicting evidence because of serious inconsistency among the included trials, which may be related to the variable ways in which trials have defined early and late tracheostomy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/26,40\">",
"     26,40",
"    </a>",
"    ]. Late tracheostomy was traditionally defined as a tracheostomy performed at three weeks, but more recent studies have defined late tracheostomy as a tracheostomy performed at two weeks.",
"   </p>",
"   <p>",
"    The best evidence suggests that early tracheostomy may improve some short-term clinical outcomes, but this comes at a cost of frequent surgical and stoma-related complications. There is no evidence that early tracheostomy improves long-term clinical outcomes. These findings were illustrated by a multicenter trial that randomly assigned 419 mechanically ventilated patients to undergo either early or late tracheostomy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/39\">",
"     39",
"    </a>",
"    ]. Patients in the early tracheostomy group underwent tracheostomy after a mean of seven days, whereas patients in the late tracheostomy group underwent tracheostomy after a mean of 14 days. The early tracheostomy group was significantly more likely to wean from the ventilator (77 versus 68 percent) and to be discharged from the ICU (48 versus 39 percent) within 28 days. There was also a trend toward less pneumonia (14 versus 21 percent), but no difference in survival. Adverse events occurred in 39 percent of patients who underwent tracheostomy, most frequently hypoxemia, stoma inflammation, stoma infection, and bleeding. Finally, early tracheostomy did not change any outcomes at one year. The major limitation of the trial was that many patients (31 and 43 percent in the early and late tracheostomy groups, respectively) did not undergo tracheostomy.",
"   </p>",
"   <p>",
"    We believe that the timing of tracheostomy should be individualized according to the clinical circumstances and the patient's preferences, since there are no proven long-term benefits from early tracheostomy and the potential short-term benefits do not clearly outweigh the high risk of complications. In other words, ongoing assessment of a patient's progress, readiness to wean, and need for tracheostomy is justified.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TRACHEOSTOMY TECHNIQUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bedside percutaneous tracheostomy has become an alternative to operative tracheostomy performed either at the bedside or in the operating room [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/42\">",
"     42",
"    </a>",
"    ]. Successful performance of the bedside percutaneous procedure is related to the expertise of the operator and ancillary personnel [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. It appears to be safe when performed by surgeons or well-trained critical care clinicians [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Percutaneous versus operative",
"    </span>",
"    &nbsp;&mdash;&nbsp;Percutaneous tracheostomy offers numerous advantages compared to operative tracheostomy: it requires less time to perform [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/46\">",
"     46",
"    </a>",
"    ], it is less expensive [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/46\">",
"     46",
"    </a>",
"    ], and it is typically performed sooner (because an operating room doesn't have to be scheduled) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. In addition, overall complications may be less frequent with percutaneous tracheostomy than surgical tracheostomy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/48-51\">",
"     48-51",
"    </a>",
"    ], even though percutaneous tracheostomy has an increased risk of anterior tracheal injury and posterior tracheal wall perforation (",
"    <a class=\"graphic graphic_figure graphicRef50738 \" href=\"UTD.htm?36/60/37824\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a meta-analysis of 17 randomized, controlled trials (1212 patients), percutaneous dilatational tracheostomy decreased wound infections (odds ratio 0.28, 95% CI 0.16-0.49) compared to both surgical tracheostomy performed in the ICU and surgical tracheostomy performed in the operating room [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/51\">",
"     51",
"    </a>",
"    ]. When compared to surgical tracheostomy performed in the operating room only, percutaneous dilatational tracheostomy also decreased bleeding (odds ratio 0.29, 95% CI 0.12-0.75) and mortality (odds ratio 0.71, 95% CI 0.50-1.0). These findings have not been universal. In a separate meta-analysis, perioperative complications (including death, serious cardiorespiratory events, and minor complications) were rare, but more common with percutaneous tracheostomy than surgical tracheostomy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The different outcomes of the two meta-analyses may reflect the different techniques used to perform percutaneous tracheostomy. The first meta-analysis included only studies that used percutaneous dilatational tracheostomy. In contrast, the second meta-analysis, included studies of percutaneous tracheostomies performed using a variety of techniques. A recent randomized controlled study showed no difference in long term (median 20 month) follow up [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Taken together, the data suggest percutaneous dilatational tracheostomy offers numerous advantages compared to surgical tracheostomy. However, the benefit of percutaneous tracheostomy may be substantially less depending upon the technique employed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Relative contraindications to percutaneous tracheostomy include: age under 15 years of age; uncorrectable bleeding diathesis; gross distortion of the neck from hematoma, tumor, thyromegaly, or scarring from previous neck surgery; documented or clinically suspected tracheomalacia; evidence of infection in the soft tissues of the neck; obese",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    short neck which obscures landmarks; and inability to extend the neck because of cervical fusion, rheumatoid arthritis, or other causes of cervical spine instability [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/54,55\">",
"     54,55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It should be reiterated that these contraindications are relative. Percutaneous dilatational tracheostomy has been performed successfully by skilled operators in patients who were very old, were morbidly obese, had a history of previous tracheostomy, or had thrombocytopenia (the patients received pre-procedure platelet transfusions) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/56-59\">",
"     56-59",
"    </a>",
"    ]. It has also been performed successfully in patients receiving high-frequency oscillation ventilation or positive end expiatory pressure (PEEP) at a level &gt;10 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/60,61\">",
"     60,61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A study that evaluated the rates of bleeding complications during percutaneous tracheostomy showed that bleeding complications could be predicted by a platelet count less than 50,000, an activated partial thromboplastin time longer than 50 seconds, or the presence of two or more coagulation disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/62\">",
"     62",
"    </a>",
"    ]. Administration of prophylactic subcutaneous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    did not increase the risk of bleeding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Technical aspects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory acidosis can occur during percutaneous tracheostomy, especially in brain-injured patients, so careful monitoring is required [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/63\">",
"     63",
"    </a>",
"    ]. If there are concerns regarding the possibility of worsening hypercapnia or hypoxemia during the procedure, a pediatric endotracheal tube can be placed prior to initiation of the procedure to allow continuous mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Percutaneous tracheostomy using the dilator (or Ciaglia) technique is superior to other percutaneous approaches including the single-forceps (Griggs) technique [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. One commercially available dilator set employs a single dilator (\"Blue Rhino\", Cook Critical Care) that decreases procedure time and does not differ in the incidence of complications [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/67\">",
"     67",
"    </a>",
"    ]. The snugly fitting stomal tissue tract around the tracheostomy tube may be less prone to stomal infection. In addition, there is the potential for less postoperative hemorrhage, because blood vessels are compressed rather than ligated or cauterized. However, one prospective, nonrandomized case series found that the conical dilator technique resulted in a greater number of bronchoscopically evident tracheal ring fractures than stepwise dilation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A second single-dilator set, PercuTwist (Rusch International), which employs a screw-like dilator using a rotational technique, was inferior to the Ciaglia technique using the Blue Rhino device in a small randomized, observational trial of 70 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/69\">",
"     69",
"    </a>",
"    ]. The overall complication rate was the same in both groups, however, two cases of posterior tracheal wall injury occurred with the PercuTwist technique. All 35 tracheostomies performed using the Blue Rhino device and Cigalia technique were successful, but 8 of 35 attempts using the PercuTwist device failed to cannulate the trachea.",
"   </p>",
"   <p>",
"    Endoscopic guidance can be utilized to help ensure proper partial withdrawal of the endotracheal tube and placement of the tracheostomy tube [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/70\">",
"     70",
"    </a>",
"    ]. This may be particularly relevant in situations of limited operator experience [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/71\">",
"     71",
"    </a>",
"    ]. Even so, endoscopic guidance is no guarantee of proper tracheostomy placement. Examination of patients following percutaneous tracheostomy using the Griggs approach and endoscopic guidance found that only 6 of 19 patients had their tracheostomy located between the first and second tracheal rings; five patients had tracheostomies between the cricoid cartilage and the first tracheal ring [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/72\">",
"     72",
"    </a>",
"    ]. Tracheal ring fractures causing subclinical tracheal deformities and low-grade tracheal stenosis were also noted in this study.",
"   </p>",
"   <p>",
"    Following percutaneous tracheostomy, a routine chest radiograph is probably unnecessary, provided the procedure had been uncomplicated. In a retrospective review of 60 patients undergoing tracheostomy with bronchoscopic guidance, a post-procedure chest radiograph was only useful in detecting complications following procedures deemed difficult by an experienced operator [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     OUTCOME FOLLOWING TRACHEOSTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patient comfort is an immediate benefit of tracheostomy. In an observational study of 312 patients undergoing mechanical ventilation for &ge;48 hours, 23 percent of patients underwent tracheostomy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/74\">",
"     74",
"    </a>",
"    ]. Following tracheostomy,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    administration decreased from 866 to 71",
"    <span class=\"nowrap\">",
"     mcg/patient-day",
"    </span>",
"    and from 44 to 7",
"    <span class=\"nowrap\">",
"     mg/patient-day,",
"    </span>",
"    respectively. In addition, time spent heavily sedated decreased from 7 to 1",
"    <span class=\"nowrap\">",
"     hour/day",
"    </span>",
"    with no increase in agitation time.",
"   </p>",
"   <p>",
"    The impact of tracheostomy on mortality is uncertain due to conflicting data, as illustrated by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Suggesting that tracheostomy may improve mortality, an international prospective cohort study of 5081 mechanically ventilated patients found that tracheostomy was associated with decreased ICU mortality, but not hospital mortality [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/75\">",
"       75",
"      </a>",
"      ]. Similarly, a case control study of over 500 patients found a decrease in both ICU and hospital mortality among patients who required long-term mechanical ventilation and underwent early (less than 12 days) tracheostomy [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/76\">",
"       76",
"      </a>",
"      ]. These study designs are susceptible to bias due to clinician selection [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/77,78\">",
"       77,78",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Suggesting that tracheostomy does not improve mortality, a multicenter prospective cohort study of 2186 mechanically ventilated patients found no significant difference in ICU mortality or nosocomial pneumonia in patients who underwent tracheostomy compared to those who did not [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/79\">",
"       79",
"      </a>",
"      ]. There was also no difference in ICU mortality when early tracheostomy was compared to late tracheostomy. Post-ICU mortality was higher among those who underwent tracheostomy, particularly those in whom the tracheostomy tube was left in position. This finding may be due to the comorbidities that are more common among patients who cannot be decannulated and that predispose to a poor outcome, rather than the tracheostomy itself.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The ability to wean from mechanical ventilation following tracheostomy may be predictive of mortality. In a retrospective series of 429 patients who underwent tracheostomy for respiratory failure, mortality was low at one year (8 percent) in patients liberated from mechanical ventilation and decannulated, but remained high in patients who required ongoing mechanical ventilation (57 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/80\">",
"     80",
"    </a>",
"    ]. Among the 191 patients who were weaned but still had a tracheostomy tube in place at discharge, subsequent successful decannulation was associated with the absence of hypertension, the ability to walk in the hospital hallway, and the ability to eat without tube feedings prior to discharge.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Percutaneous tracheostomy tubes can become partially obstructed by the posterior membranous trachea following initial placement, although symptomatic obstruction is uncommon [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/81\">",
"     81",
"    </a>",
"    ]. This complication appears to be related, in part, to the experience of the clinician performing the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incidence of subcutaneous emphysema and pneumothorax is 1.4 and 0.8 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/83\">",
"     83",
"    </a>",
"    ]. Cadaver models revealed that imperfect positioning of fenestrated cannula and posterior wall perforation are possible mechanisms for these complications [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/83\">",
"     83",
"    </a>",
"    ]. Swelling of the posterior tracheal wall can cause symptomatic compression of the tracheal tube even a week after tube placement [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/84\">",
"     84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients undergoing long-term mechanical ventilation by tracheostomy can develop symptoms of tracheal obstruction due to the development of granulation tissue, which differs from the stenosis that develops in endotracheally intubated patients (the latter tends to be web-like and emerges sooner) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/85,86\">",
"     85,86",
"    </a>",
"    ]. Stenosis of the trachea below the glottis, but above the tracheal stoma, has been reported following percutaneous tracheostomy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/87\">",
"     87",
"    </a>",
"    ]. Clinical manifestations include high peak airway pressures and inability to wean. Treatment includes the placement of a longer tracheostomy tube, surgical intervention, or the placement of a tracheal stent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/30/37351?source=see_link\">",
"     \"Diagnosis and management of central airway obstruction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/0/34823?source=see_link\">",
"     \"Airway stents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Massive hemorrhage due to a tracheoarterial fistula is the most devastating complication. In several studies, the incidence of a tracheoarterial fistula was less than 1 percent with both short-term and long-term tracheostomies [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/88-90\">",
"     88-90",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/24/14727?source=see_link&amp;anchor=H4#H4\">",
"     \"Etiology and evaluation of hemoptysis in adults\", section on 'Airways diseases'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4250001\">",
"    <span class=\"h1\">",
"     CHANGING A TRACHEOSTOMY TUBE",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no universally accepted indications for changing a tracheostomy tube. Therefore, the following indications are based upon clinical experience rather than empirical evidence [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/91\">",
"     91",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Routine changes &ndash; Tracheostomy tubes are routinely changed 7 to 14 days after initial insertion and then every 60 to 90 days",
"     </li>",
"     <li>",
"      Patient discomfort &ndash; Patient discomfort may respond to a reduction in the size of the tracheostomy tube",
"     </li>",
"     <li>",
"      Malposition &ndash; Tracheostomy tube malposition may respond to a change in the length or size of the tracheostomy tube",
"     </li>",
"     <li>",
"      Patient-ventilator asynchrony &ndash; Patient-ventilator asynchrony that is related to the tracheostomy tube may respond to changing the tube",
"     </li>",
"     <li>",
"      Cuff leak &ndash; A cuff leak may be due to malposition of the tracheostomy tube (particularly in the setting of tracheomalacia) and may respond to changing the tube",
"     </li>",
"     <li>",
"      Fracture &ndash; Fracture of the tracheostomy tube or flange is an indication for a new tracheostomy tube",
"     </li>",
"     <li>",
"      Type change &ndash; Changing a tracheostomy tube from one type to another may be indicated by the clinical circumstances; as an example, changing from a balloon cuff to either a foam cuff or a cuffless tracheostomy tube.",
"     </li>",
"     <li>",
"      Bronchoscopy &ndash; Flexible bronchoscopy generally requires a tracheostomy tube with an inner diameter of at least 7.5 mm; thus, the tracheostomy tube may need to be changed to one with a larger inner diameter to facilitate bronchoscopy",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DECANNULATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Appropriate candidates for tracheal decannulation after weaning from mechanical ventilation include patients who fulfill all the following criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/92\">",
"     92",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      No upper airway obstruction.",
"     </li>",
"     <li>",
"      The ability to clear secretions that are neither too copious nor too thick.",
"     </li>",
"     <li>",
"      The presence of an effective cough. In patients with neuromuscular disease, a peak cough flow greater than 160",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      generally predicts successful decannulation [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/93\">",
"       93",
"      </a>",
"      ]. The value of this measurement in patients without neuromuscular disease is unknown.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Several techniques for weaning patients from tracheostomy tubes have been described, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Progressively decreasing the size of the tracheostomy tube. This approach was shown to have a success rate of nearly 80 percent in a prospective, observational cohort study of over 100 patients with chronic respiratory failure [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/94\">",
"       94",
"      </a>",
"      ]. A decisional flow chart was used to determine whether the tracheostomy was downsized to at least a 6 mm tube or, if the patient had an insufficient cough, a Minitrach (Portex), for at least one week prior to decannulation.",
"     </li>",
"     <li>",
"      Progressive capping of a fenestrated tracheostomy tube until tolerated for 12, 24, or 48 hours.",
"     </li>",
"     <li>",
"      Use of a tracheostomy plug (tracheostomy button) (",
"      <a class=\"graphic graphic_figure graphicRef58958 \" href=\"UTD.htm?20/52/21312\">",
"       figure 4",
"      </a>",
"      ). A tracheostomy plug may be particularly useful in patients who have borderline clearance of secretions and require maintenance of the stoma during a prolonged observation period [",
"      <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/95\">",
"       95",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Passy-Muir valves can be used as an alternative to capping prior to decannulation. While they may be more comfortable for the patient, the time to decannulation does not differ from traditional capping [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/96\">",
"     96",
"    </a>",
"    ]. Ideally, the use of a one-way valve should:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Reduce the level of inspiratory pressure required because valve resistance is low.",
"     </li>",
"     <li>",
"      Facilitate secretion clearance because flow proximal to the larynx is only upward.",
"     </li>",
"     <li>",
"      Promote reestablishment of laryngeal reflex activity, phonation, and cough, resulting from continued airflow through the larynx.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Role of bronchoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prospective bronchoscopic visualization in patients with long-term tracheostomies about to undergo decannulation reveals a high frequency of obstructive airway abnormalities, mostly tracheal granulomas [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/97\">",
"     97",
"    </a>",
"    ]. However, these are often not clinically significant. The initial tolerance to capping indicates the likelihood of subsequent success and decreases the need for airway inspection. In one uncontrolled series, 16 percent of patients did not tolerate an initial 30-minute trial of capping. At bronchoscopy, these patients were found to have &gt;50 percent tracheal obstruction. All the patients that tolerated their initial capping trial went on to successful decannulation without requiring bronchoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/42/11945/abstract/98\">",
"     98",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tracheostomy is the surgical formation of an opening in the trachea. It allows mechanical ventilation via a tracheostomy tube instead of an endotracheal tube. Tracheostomy is generally considered when the duration of mechanical ventilation is expected to be prolonged. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tracheostomy decreases the work of breathing and improves patient comfort when compared to an endotracheal tube. However, there is no conclusive proof that tracheostomy decreases the risk of aspiration or nosocomial pneumonia. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Tracheostomy versus intubation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The timing of tracheostomy should be individualized, since there are no proven long-term benefits from early tracheostomy and the potential short-term benefits of early tracheostomy do not clearly outweigh the high risk of surgical and stoma-related complications. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Timing of tracheostomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Factors that increase the likelihood that a tracheostomy will be required include poor prehospitalization functional status, poor nutritional status, poor pulmonary function, advanced age, nosocomial pneumonia, administration of aerosol treatments, a witnessed aspiration event, or reintubation. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Timing of tracheostomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Percutaneous dilatational tracheostomy is an alternative to surgical tracheostomy. Both techniques have a low risk of complications when performed by an experienced operator. Percutaneous tracheostomy is usually a shorter procedure, does not require an operating room, and may yield a better cosmetic result. However, the results vary according to the dilator that is used. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Tracheostomy Techniques'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tracheoinnominate fistula formation and massive hemorrhage occur in less than 1 percent of tracheostomies, but can be life-threatening. Other complications are also uncommon, including subcutaneous emphysema, pneumothorax, tracheal stenosis, and tracheal ring rupture. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Decannulation can be performed when mechanical ventilation is no longer required, the cough is adequate, secretions are well controlled, and upper airway obstruction is absent. Readiness for decannulation can be assessed by progressively decreasing the size of the tracheostomy tube or by capping a fenestrated tube for progressively longer periods of time. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Decannulation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/1\">",
"      Diehl JL, El Atrous S, Touchard D, et al. Changes in the work of breathing induced by tracheotomy in ventilator-dependent patients. Am J Respir Crit Care Med 1999; 159:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/2\">",
"      Davis K Jr, Campbell RS, Johannigman JA, et al. Changes in respiratory mechanics after tracheostomy. Arch Surg 1999; 134:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/3\">",
"      Moscovici da Cruz V, Demarzo SE, Sobrinho JB, et al. Effects of tracheotomy on respiratory mechanics in spontaneously breathing patients. Eur Respir J 2002; 20:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/4\">",
"      Lin MC, Huang CC, Yang CT, et al. Pulmonary mechanics in patients with prolonged mechanical ventilation requiring tracheostomy. Anaesth Intensive Care 1999; 27:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/5\">",
"      Mohr AM, Rutherford EJ, Cairns BA, Boysen PG. The role of dead space ventilation in predicting outcome of successful weaning from mechanical ventilation. J Trauma 2001; 51:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/6\">",
"      DeVita MA, Spierer-Rundback L. Swallowing disorders in patients with prolonged orotracheal intubation or tracheostomy tubes. Crit Care Med 1990; 18:1328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/7\">",
"      Amathieu R, Sauvat S, Reynaud P, et al. Influence of the cuff pressure on the swallowing reflex in tracheostomized intensive care unit patients. Br J Anaesth 2012; 109:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/8\">",
"      Elpern EH, Scott MG, Petro L, Ries MH. Pulmonary aspiration in mechanically ventilated patients with tracheostomies. Chest 1994; 105:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/9\">",
"      Leder SB. Incidence and type of aspiration in acute care patients requiring mechanical ventilation via a new tracheotomy. Chest 2002; 122:1721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/10\">",
"      Donzelli J, Brady S, Wesling M, Theisen M. Secretions, occlusion status, and swallowing in patients with a tracheotomy tube: a descriptive study. Ear Nose Throat J 2006; 85:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/11\">",
"      Lucangelo U, Zin WA, Antonaglia V, et al. Effect of positive expiratory pressure and type of tracheal cuff on the incidence of aspiration in mechanically ventilated patients in an intensive care unit. Crit Care Med 2008; 36:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/12\">",
"      Belafsky PC, Blumenfeld L, LePage A, Nahrstedt K. The accuracy of the modified Evan's blue dye test in predicting aspiration. Laryngoscope 2003; 113:1969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/13\">",
"      Donzelli J, Brady S, Wesling M, Craney M. Simultaneous modified Evans blue dye procedure and video nasal endoscopic evaluation of the swallow. Laryngoscope 2001; 111:1746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/14\">",
"      Potts RG, Zaroukian MH, Guerrero PA, Baker CD. Comparison of blue dye visualization and glucose oxidase test strip methods for detecting pulmonary aspiration of enteral feedings in intubated adults. Chest 1993; 103:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/15\">",
"      Leder SB. Importance of verbal communication for the ventilator-dependent patient. Chest 1990; 98:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/16\">",
"      Manzano JL, Lubillo S, Henr&iacute;quez D, et al. Verbal communication of ventilator-dependent patients. Crit Care Med 1993; 21:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/17\">",
"      Prigent H, Samuel C, Louis B, et al. Comparative effects of two ventilatory modes on speech in tracheostomized patients with neuromuscular disease. Am J Respir Crit Care Med 2003; 167:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/18\">",
"      Hoit JD, Banzett RB, Lohmeier HL, et al. Clinical ventilator adjustments that improve speech. Chest 2003; 124:1512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/19\">",
"      Nomori H. Tracheostomy tube enabling speech during mechanical ventilation. Chest 2004; 125:1046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/20\">",
"      Georges H, Leroy O, Guery B, et al. Predisposing factors for nosocomial pneumonia in patients receiving mechanical ventilation and requiring tracheotomy. Chest 2000; 118:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/21\">",
"      Ibrahim EH, Tracy L, Hill C, et al. The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest 2001; 120:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/22\">",
"      Nseir S, Di Pompeo C, Jozefowicz E, et al. Relationship between tracheotomy and ventilator-associated pneumonia: a case control study. Eur Respir J 2007; 30:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/23\">",
"      M&ouml;ller MG, Slaikeu JD, Bonelli P, et al. Early tracheostomy versus late tracheostomy in the surgical intensive care unit. Am J Surg 2005; 189:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/24\">",
"      Ahmed N, Kuo YH. Early versus late tracheostomy in patients with severe traumatic head injury. Surg Infect (Larchmt) 2007; 8:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/25\">",
"      Arabi Y, Haddad S, Shirawi N, Al Shimemeri A. Early tracheostomy in intensive care trauma patients improves resource utilization: a cohort study and literature review. Crit Care 2004; 8:R347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/26\">",
"      Griffiths J, Barber VS, Morgan L, Young JD. Systematic review and meta-analysis of studies of the timing of tracheostomy in adult patients undergoing artificial ventilation. BMJ 2005; 330:1243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/27\">",
"      Rumbak MJ, Newton M, Truncale T, et al. A prospective, randomized, study comparing early percutaneous dilational tracheotomy to prolonged translaryngeal intubation (delayed tracheotomy) in critically ill medical patients. Crit Care Med 2004; 32:1689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/28\">",
"      Stone DJ, Bogdonoff DL. Airway considerations in the management of patients requiring long-term endotracheal intubation. Anesth Analg 1992; 74:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/29\">",
"      Heffner JE. Timing of tracheotomy in mechanically ventilated patients. Am Rev Respir Dis 1993; 147:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/30\">",
"      Plummer AL, Gracey DR. Consensus conference on artificial airways in patients receiving mechanical ventilation. Chest 1989; 96:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/31\">",
"      Bishop MJ. The timing of tracheotomy. An evolving consensus. Chest 1989; 96:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/32\">",
"      Esteban A, Anzueto A, Al&iacute;a I, et al. How is mechanical ventilation employed in the intensive care unit? An international utilization review. Am J Respir Crit Care Med 2000; 161:1450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/33\">",
"      Scales DC, Thiruchelvam D, Kiss A, Redelmeier DA. The effect of tracheostomy timing during critical illness on long-term survival. Crit Care Med 2008; 36:2547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/34\">",
"      Colice GL, Stukel TA, Dain B. Laryngeal complications of prolonged intubation. Chest 1989; 96:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/35\">",
"      Colice GL. Resolution of laryngeal injury following translaryngeal intubation. Am Rev Respir Dis 1992; 145:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/36\">",
"      Blot F, Similowski T, Trouillet JL, et al. Early tracheotomy versus prolonged endotracheal intubation in unselected severely ill ICU patients. Intensive Care Med 2008; 34:1779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/37\">",
"      Teoh WH, Goh KY, Chan C. The role of early tracheostomy in critically ill neurosurgical patients. Ann Acad Med Singapore 2001; 30:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/38\">",
"      Trouillet JL, Luyt CE, Guiguet M, et al. Early percutaneous tracheotomy versus prolonged intubation of mechanically ventilated patients after cardiac surgery: a randomized trial. Ann Intern Med 2011; 154:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/39\">",
"      Terragni PP, Antonelli M, Fumagalli R, et al. Early vs late tracheotomy for prevention of pneumonia in mechanically ventilated adult ICU patients: a randomized controlled trial. JAMA 2010; 303:1483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/40\">",
"      Wang F, Wu Y, Bo L, et al. The timing of tracheotomy in critically ill patients undergoing mechanical ventilation: a systematic review and meta-analysis of randomized controlled trials. Chest 2011; 140:1456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/41\">",
"      Gomes Silva BN, Andriolo RB, Saconato H, et al. Early versus late tracheostomy for critically ill patients. Cochrane Database Syst Rev 2012; 3:CD007271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/42\">",
"      Futran ND, Dutcher PO, Roberts JK. The safety and efficacy of bedside tracheotomy. Otolaryngol Head Neck Surg 1993; 109:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/43\">",
"      Marx WH, Ciaglia P, Graniero KD. Some important details in the technique of percutaneous dilatational tracheostomy via the modified Seldinger technique. Chest 1996; 110:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/44\">",
"      D&iacute;az-Rega&ntilde;&oacute;n G, Mi&ntilde;ambres E, Ruiz A, et al. Safety and complications of percutaneous tracheostomy in a cohort of 800 mixed ICU patients. Anaesthesia 2008; 63:1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/45\">",
"      Seder DB, Lee K, Rahman C, et al. Safety and feasibility of percutaneous tracheostomy performed by neurointensivists. Neurocrit Care 2009; 10:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/46\">",
"      Freeman BD, Isabella K, Lin N, Buchman TG. A meta-analysis of prospective trials comparing percutaneous and surgical tracheostomy in critically ill patients. Chest 2000; 118:1412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/47\">",
"      Friedman Y, Fildes J, Mizock B, et al. Comparison of percutaneous and surgical tracheostomies. Chest 1996; 110:480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/48\">",
"      Silvester W, Goldsmith D, Uchino S, et al. Percutaneous versus surgical tracheostomy: A randomized controlled study with long-term follow-up. Crit Care Med 2006; 34:2145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/49\">",
"      Hazard P, Jones C, Benitone J. Comparative clinical trial of standard operative tracheostomy with percutaneous tracheostomy. Crit Care Med 1991; 19:1018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/50\">",
"      Holdgaard HO, Pedersen J, Jensen RH, et al. Percutaneous dilatational tracheostomy versus conventional surgical tracheostomy. A clinical randomised study. Acta Anaesthesiol Scand 1998; 42:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/51\">",
"      Delaney A, Bagshaw SM, Nalos M. Percutaneous dilatational tracheostomy versus surgical tracheostomy in critically ill patients: a systematic review and meta-analysis. Crit Care 2006; 10:R55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/52\">",
"      Trottier SJ, Hazard PB, Sakabu SA, et al. Posterior tracheal wall perforation during percutaneous dilational tracheostomy: an investigation into its mechanism and prevention. Chest 1999; 115:1383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/53\">",
"      Dulguerov P, Gysin C, Perneger TV, Chevrolet JC. Percutaneous or surgical tracheostomy: a meta-analysis. Crit Care Med 1999; 27:1617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/54\">",
"      Warren WH. Percutaneous dilational tracheostomy: a note of caution. Crit Care Med 2000; 28:1664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/55\">",
"      El Solh AA, Jaafar W. A comparative study of the complications of surgical tracheostomy in morbidly obese critically ill patients. Crit Care 2007; 11:R3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/56\">",
"      Kluge S, Meyer A, K&uuml;hnelt P, et al. Percutaneous tracheostomy is safe in patients with severe thrombocytopenia. Chest 2004; 126:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/57\">",
"      Meyer M, Critchlow J, Mansharamani N, et al. Repeat bedside percutaneous dilational tracheostomy is a safe procedure. Crit Care Med 2002; 30:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/58\">",
"      Heyrosa MG, Melniczek DM, Rovito P, Nicholas GG. Percutaneous tracheostomy: a safe procedure in the morbidly obese. J Am Coll Surg 2006; 202:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/59\">",
"      Drendel M, Primov-Fever A, Talmi YP, et al. Outcome of tracheostomy in patients over 85 years old (oldest-old patients). Otolaryngol Head Neck Surg 2009; 140:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/60\">",
"      Shah S, Morgan P. Percutaneous dilation tracheostomy during high-frequency oscillatory ventilation. Crit Care Med 2002; 30:1762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/61\">",
"      Beiderlinden M, Groeben H, Peters J. Safety of percutaneous dilational tracheostomy in patients ventilated with high positive end-expiratory pressure (PEEP). Intensive Care Med 2003; 29:944.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/62\">",
"      Beiderlinden M, Eikermann M, Lehmann N, et al. Risk factors associated with bleeding during and after percutaneous dilational tracheostomy. Anaesthesia 2007; 62:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/63\">",
"      Reilly PM, Sing RF, Giberson FA, et al. Hypercarbia during tracheostomy: a comparison of percutaneous endoscopic, percutaneous Doppler, and standard surgical tracheostomy. Intensive Care Med 1997; 23:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/64\">",
"      Ferraro F, Capasso A, Troise E, et al. Assessment of ventilation during the performance of elective endoscopic-guided percutaneous tracheostomy: clinical evaluation of a new method. Chest 2004; 126:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/65\">",
"      Friedman Y, Mayer AD. Bedside percutaneous tracheostomy in critically ill patients. Chest 1993; 104:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/66\">",
"      Steele AP, Evans HW, Afaq MA, et al. Long-term follow-up of Griggs percutaneous tracheostomy with spiral CT and questionnaire. Chest 2000; 117:1430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/67\">",
"      Johnson JL, Cheatham ML, Sagraves SG, et al. Percutaneous dilational tracheostomy: a comparison of single- versus multiple-dilator techniques. Crit Care Med 2001; 29:1251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/68\">",
"      Beiderlinden M, Karl Walz M, Sander A, et al. Complications of bronchoscopically guided percutaneous dilational tracheostomy: beyond the learning curve. Intensive Care Med 2002; 28:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/69\">",
"      Byhahn C, Westphal K, Meininger D, et al. Single-dilator percutaneous tracheostomy: a comparison of PercuTwist and Ciaglia Blue Rhino techniques. Intensive Care Med 2002; 28:1262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/70\">",
"      Winkler WB, Karnik R, Seelmann O, et al. Bedside percutaneous dilational tracheostomy with endoscopic guidance: experience with 71 ICU patients. Intensive Care Med 1994; 20:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/71\">",
"      Hazard PB. Further refinement of percutaneous tracheostomy technique. Intensive Care Med 1994; 20:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/72\">",
"      Dollner R, Verch M, Schweiger P, et al. Laryngotracheoscopic findings in long-term follow-up after Griggs tracheostomy. Chest 2002; 122:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/73\">",
"      Datta D, Onyirimba F, McNamee MJ. The utility of chest radiographs following percutaneous dilatational tracheostomy. Chest 2003; 123:1603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/74\">",
"      Nieszkowska A, Combes A, Luyt CE, et al. Impact of tracheotomy on sedative administration, sedation level, and comfort of mechanically ventilated intensive care unit patients. Crit Care Med 2005; 33:2527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/75\">",
"      Frutos-Vivar F, Esteban A, Apeztegu&iacute;a C, et al. Outcome of mechanically ventilated patients who require a tracheostomy. Crit Care Med 2005; 33:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/76\">",
"      Combes A, Luyt CE, Nieszkowska A, et al. Is tracheostomy associated with better outcomes for patients requiring long-term mechanical ventilation? Crit Care Med 2007; 35:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/77\">",
"      Kollef MH, Ahrens TS, Shannon W. Clinical predictors and outcomes for patients requiring tracheostomy in the intensive care unit. Crit Care Med 1999; 27:1714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/78\">",
"      Freeman BD, Borecki IB, Coopersmith CM, Buchman TG. Relationship between tracheostomy timing and duration of mechanical ventilation in critically ill patients. Crit Care Med 2005; 33:2513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/79\">",
"      Clec'h C, Alberti C, Vincent F, et al. Tracheostomy does not improve the outcome of patients requiring prolonged mechanical ventilation: a propensity analysis. Crit Care Med 2007; 35:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/80\">",
"      Engoren M, Arslanian-Engoren C, Fenn-Buderer N. Hospital and long-term outcome after tracheostomy for respiratory failure. Chest 2004; 125:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/81\">",
"      Trottier SJ, Ritter S, Lakshmanan R, et al. Percutaneous tracheostomy tube obstruction: warning. Chest 2002; 122:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/82\">",
"      Schmidt U, Hess D, Kwo J, et al. Tracheostomy tube malposition in patients admitted to a respiratory acute care unit following prolonged ventilation. Chest 2008; 134:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/83\">",
"      Fikkers BG, van Veen JA, Kooloos JG, et al. Emphysema and pneumothorax after percutaneous tracheostomy: case reports and an anatomic study. Chest 2004; 125:1805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/84\">",
"      Polderman KH, Spijkstra JJ, de Bree R, et al. Percutaneous dilatational tracheostomy in the ICU: optimal organization, low complication rates, and description of a new complication. Chest 2003; 123:1595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/85\">",
"      Rumbak MJ, Walsh FW, Anderson WM, et al. Significant tracheal obstruction causing failure to wean in patients requiring prolonged mechanical ventilation: a forgotten complication of long-term mechanical ventilation. Chest 1999; 115:1092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/86\">",
"      Zias N, Chroneou A, Tabba MK, et al. Post tracheostomy and post intubation tracheal stenosis: report of 31 cases and review of the literature. BMC Pulm Med 2008; 8:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/87\">",
"      Koitschev A, Graumueller S, Zenner HP, et al. Tracheal stenosis and obliteration above the tracheostoma after percutaneous dilational tracheostomy. Crit Care Med 2003; 31:1574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/88\">",
"      Scalise P, Prunk SR, Healy D, Votto J. The incidence of tracheoarterial fistula in patients with chronic tracheostomy tubes: a retrospective study of 544 patients in a long-term care facility. Chest 2005; 128:3906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/89\">",
"      Jones JW, Reynolds M, Hewitt RL, Drapanas T. Tracheo-innominate artery erosion: Successful surgical management of a devastating complication. Ann Surg 1976; 184:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/90\">",
"      Arola MK. Tracheostomy and its complications. A retrospective study of 794 tracheostomized patients. Ann Chir Gynaecol 1981; 70:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/91\">",
"      White AC, Kher S, O'Connor HH. When to change a tracheostomy tube. Respir Care 2010; 55:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/92\">",
"      O'Connor HH, White AC. Tracheostomy decannulation. Respir Care 2010; 55:1076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/93\">",
"      Bach JR, Saporito LR. Criteria for extubation and tracheostomy tube removal for patients with ventilatory failure. A different approach to weaning. Chest 1996; 110:1566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/94\">",
"      Ceriana P, Carlucci A, Navalesi P, et al. Weaning from tracheotomy in long-term mechanically ventilated patients: feasibility of a decisional flowchart and clinical outcome. Intensive Care Med 2003; 29:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/95\">",
"      Heffner JE. The technique of weaning from tracheostomy. Criteria for weaning; practical measures to prevent failure. J Crit Illn 1995; 10:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/96\">",
"      Le, HL, Aten, JL, Chiang, JT, et al. Comparison between conventional cap and one-way valve in the decannulation of patients with long-term tracheostomies. Respir Care 1993; 38:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/97\">",
"      Law JH, Barnhart K, Rowlett W, et al. Increased frequency of obstructive airway abnormalities with long-term tracheostomy. Chest 1993; 104:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/42/11945/abstract/98\">",
"      Rumbak MJ, Graves AE, Scott MP, et al. Tracheostomy tube occlusion protocol predicts significant tracheal obstruction to air flow in patients requiring prolonged mechanical ventilation. Crit Care Med 1997; 25:413.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4389 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-190.81.197.98-D795AC79FE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_42_11945=[""].join("\n");
var outline_f11_42_11945=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TRACHEOSTOMY VERSUS INTUBATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Work of breathing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Aspiration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Detection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Patient communication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Nosocomial pneumonia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      TIMING OF TRACHEOSTOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TRACHEOSTOMY TECHNIQUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Percutaneous versus operative",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Contraindications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Technical aspects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      OUTCOME FOLLOWING TRACHEOSTOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4250001\">",
"      CHANGING A TRACHEOSTOMY TUBE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DECANNULATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Role of bronchoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/4389\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4389|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/49/18192\" title=\"figure 1\">",
"      Talking tracheostomy tube",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/0/9216\" title=\"figure 2\">",
"      Passy Muir speaking valves",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/60/37824\" title=\"figure 3\">",
"      Tracheal wall perforation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/52/21312\" title=\"figure 4\">",
"      Tracheostomy button",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4389|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/28/41419\" title=\"table 1\">",
"      Tracheostomy versus intubation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/0/34823?source=related_link\">",
"      Airway stents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/30/37351?source=related_link\">",
"      Diagnosis and management of central airway obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/11/15545?source=related_link\">",
"      Endotracheal tube management and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/24/14727?source=related_link\">",
"      Etiology and evaluation of hemoptysis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37673?source=related_link\">",
"      Management and prognosis of patients requiring prolonged mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/61/9176?source=related_link\">",
"      Management of the difficult-to-wean patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13433?source=related_link\">",
"      Risk factors and prevention of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_42_11946="BL neoplastic cells";
var content_f11_42_11946=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F59619&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F59619&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Burkitt lymphoma neoplastic cells",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    At high power magnification, the neoplastic cells are of intermediate size, similar to the size of benign histiocyte nuclei. The neoplastic cells have round nuclear contours, multiple nucleoli, frequent mitoses, and basophilic cytoplasm. Macrophages with engulfed pyknotic nuclei and nuclear debris are also present. Hematoxylin-eosin stain.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Ioachim HL, Medeiros LJ. Burkitt lymphoma. In: Ioachim's Lymph Node Pathology, 4th ed, Lippincott Williams &amp; Wilkins, Philadelphia 2009. Copyright &copy; 2009 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_42_11946=[""].join("\n");
var outline_f11_42_11946=null;
var title_f11_42_11947="Glomerular v extraglomerular";
var content_f11_42_11947=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F54067&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F54067&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Distinguishing extraglomerular from glomerular hematuria",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Extraglomerular",
"       </td>",
"       <td class=\"subtitle1\">",
"        Glomerular",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Color (if macroscopic)",
"       </td>",
"       <td>",
"        Red or pink",
"       </td>",
"       <td>",
"        Red, smoky brown, or \"Coca-Cola\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clots",
"       </td>",
"       <td>",
"        May be present",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Proteinuria",
"       </td>",
"       <td>",
"        &lt;500 mg/day",
"       </td>",
"       <td>",
"        May be &gt;500 mg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        RBC morphology",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Some RBCs are dysmorphic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        RBC casts",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"       <td>",
"        May be present",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_42_11947=[""].join("\n");
var outline_f11_42_11947=null;
var title_f11_42_11948="Egs pathophys epilepsy";
var content_f11_42_11948=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F75633&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F75633&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Examples of specific pathophysiological defects leading to epilepsy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Level of brain function",
"       </td>",
"       <td class=\"subtitle1\">",
"        Condition",
"       </td>",
"       <td class=\"subtitle1\">",
"        Pathophysiologic mechanism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neuronal network",
"       </td>",
"       <td>",
"        Cerebral dysgenesis, post-traumatic scar, mesial temporal sclerosis (in TLE)",
"       </td>",
"       <td>",
"        Altered neuronal circuits: Formation of aberrant excitatory connections (\"sprouting\")",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neuron structure",
"       </td>",
"       <td>",
"        Down syndrome and possibly other syndromes with mental retardation and seizures",
"       </td>",
"       <td>",
"        Abnormal structure of dendrites and dendritic spines: Altered current flow in neuron",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neurotransmitter synthesis",
"       </td>",
"       <td>",
"        Pyridoxine (vitamin B",
"        <sub>",
"         6",
"        </sub>",
"        ) dependency",
"       </td>",
"       <td>",
"        Decreased GABA synthesis: B",
"        <sub>",
"         6",
"        </sub>",
"        , a co-factor for GAD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neurotransmitter receptors: Inhibitory",
"       </td>",
"       <td>",
"        Angelman syndrome, juvenile myoclonic epilepsy",
"       </td>",
"       <td>",
"        Abnormal GABA receptor subunit(s)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neurotransmitter receptors: Excitatory",
"       </td>",
"       <td>",
"        Non-ketotic hyperglycinemia",
"       </td>",
"       <td>",
"        Excess glycine leads to activation of NMDA receptors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Synapse development",
"       </td>",
"       <td>",
"        Neonatal seizures",
"       </td>",
"       <td>",
"        Many possible mechanisms, including the depolarizing action of GABA early in development",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ion channels (\"channelopathies\")",
"       </td>",
"       <td>",
"        Benign familial neonatal convulsions",
"       </td>",
"       <td>",
"        Potassium channel mutations: Impaired repolarization",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     TLE: temporal lobe epilepsy; GABA: &Gamma;-aminobutyric acid; GAD: glutamic acid decarboxylase.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rho, JM, Stafstrom, CE. Neurophysiology of epilepsy. In: Pediatric Neurology: Principles and Practice, 4th ed, Swaiman, KF, Ashwal, S, Ferreiro, DM (Eds). Mosby Elsevier. Philadelphia 2006. Copyright &copy;2006.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_42_11948=[""].join("\n");
var outline_f11_42_11948=null;
var title_f11_42_11949="Two-step algorithm";
var content_f11_42_11949=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F62532&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F62532&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    The two-step algorithm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 446px; height: 207px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Drs. Ashfaq Marghoob and Natalia Jaimes.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_42_11949=[""].join("\n");
var outline_f11_42_11949=null;
var title_f11_42_11950="Internal rotation exercise for frozen shoulder";
var content_f11_42_11950=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F83380&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F83380&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Internal rotation exercise for frozen shoulder",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 179px; height: 309px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    To stretch the posterior portion of the shoulder capsule, the patient stands in a door frame with their hand behind their lower back and their forearm against the frame and then internally rotates the shoulder by turning their body toward the arm. The door frame keeps the forearm in place.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Tore Prestgaard, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_42_11950=[""].join("\n");
var outline_f11_42_11950=null;
var title_f11_42_11951="Hilgenreiner Perkins lines";
var content_f11_42_11951=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F55366&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F55366&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hilgenreiner and Perkins lines",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 365px; height: 235px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hilgenreiner line is a horizontal line through the upper margin of the radiolucent triradiate cartilage. Perkins line is a vertical line drawn from the most lateral ossified margin of the roof of the acetabulum and perpendicular to Hilgenreiner line. In the normal hip, the medial end of the ossified upper femoral metaphysis lies medial to Perkins line and inferior to Hilgenreiner line. In the subluxated hip, it lies lateral to Perkins line. In the dislocated hip, the medial end of the ossific metaphysis of the femoral neck lies lateral to Perkins line and superior to Hilgenreiner line.",
"    <div class=\"footnotes\">",
"     DDH: developmental dysplasia of the hip.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_42_11951=[""].join("\n");
var outline_f11_42_11951=null;
